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'SUMMARY 
Trialkyl tin compounds have been shown to be potent 
inhibitors of oxidative phosphorylation, oligomycin sensitive 
ATPase activity and other ATP-dependent reactions of beef heart 
mitochondria. Unlike oligomycin inhibition of these reactions, 
trialkyl tin inhibition is reversible by dithiols such as 
2,3-dimercaptopropanol. The OS-ATPase activity was found to be 
6-10 times more sensitive than oxidative phosphorylation to 
inhibition by trialkyl tins. This differential sensitivity to 
trialkyl tin inhibition is discussed in relation to the current 
theories on energy coupling. 
Binding studies with [3H]-DBCT have indicated the 
presence of two types of binding sites designated high affinity 
(kD ~ 0.3 pM) and low affinity (~ ~ 30 ~M) binding sites. The 
concentration of the high affinity binding site is ~ 2.0 nmol/mg 
protein in submitochondrial particles and saturation of these 
sites correlated with the inhibition of the oligomycin sensitive 
ATPase activity. Extraction and isolation experiments have shown 
that DBCT binds to a small lipophilic, non-protein molecule. 
Dihydrolipoic acid has been shown to drive ATP synthesis 
by acting as a NAD-linked substrate. Fatty acids, oleoyl-phosphate, 
oleoyl-lipoate and other lipids were found to inhibit succinate 
driven ATP synthesis and other energy-linked reactions in mitochondria 
and submitochondrial particles. In addition, a new method for the 
measurement of nanomoles amount of lipoic acid and lipoamide is 
reported. The method involves the cyclic reduction of S,S-dithiobis 
(2-nitrobenzoic acid) by NADHvia a system containing lipoamide 
dehydrogenase and lipoic acid (or lipoamide). 
"There are few, if any, certainties in science; 
we build up our knowledge by testing preconceived 
models experimentally, thus detecting and 
discarding the concepts that are false and 
retaining the concepts that show by their 
survival that they are factually serviceable 
because they represent reality as far as it 
is known." 
P. Mitchell, 1977 
Ann. Rev. Biochem. 
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I. INTRODUCTION 
I • J GENERAL INTRODUCTION 
Elucidation of the mechanism by which energy liberated 
in cellular electron transport is conserved and utilised for ATP 
synthesis, has been a major challenge in biochemistry ever since 
the occurrence of phosphorylation in the respiring cell was first 
recognised in the 1930s [see (I, 2, 3) for reviews]. Today, it is 
well established that the electron transport system associated with 
the inner membrane of mitochondria, the thylakoid membra~ of 
chloroplasts and the plasma membrane of respiring and photosynthetic 
prokaryotes are functionally linked to an ATP-synthesising system 
by a mechanism that is fundamentally similar in all living cells. 
It is also well established that the energy deriving from the oxidation 
of reducing equivalents by the respiratory chain is converted to ATP 
by the ATP-synthase complex. Before discussing the mechanisms 
involved in this process, the structure and function of the respiratory 
chain will be briefly outlined [see (6, 7, 8) for more in depth 
reviews] • 
1.2 THE RESPIRATORY CHAIN 
Current ideas of the component composition and s~q~~nce of 
the electron transport chain are shown, in Fig. 1.1 (4). This scheme 
has emerged from the confluence of several lines of investigation. 
They include measurement of the redox potential of individual 
components (6), kinetic determination of the reaction sequence 
(6, 7), studies on the donor and acceptor specificity of isolated 
components (6) and the interaction of electron transfer inhibitors 
with the respiratory chain (6, 8). Chemical fractionation 
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Fig. 1.1 The electron transfer components of the respiratory chain arranged as a continuous sequence from NADH to 
oxygen. The points of entry of electrons from various substrates are shown, as well as the sites of inhibition 
of electron transport. The symbol FP designates flavoproteins; FAD, flavin adenine dinucleotide; FMN, 
flavin mononucleotide; (Fe-S), iron-sulphur centres where the subscript N or S indicates NADH and succinate. 
UQ is ubiquinone (coenzyme Q) and Cyt. the cytochromes bK, br, C,C}, aanda3,Cu copper. The bracketed 
portions list the total component in each complex. [Adopted from Ohnishi 1975 (4»). 
r 
I 
N 
I 
-3-
studies by Hatefi et ale have shown that the respiratory chain can 
be split into four complexes, designated complex I, II, III and IV 
according to the classification of D. E. Green (9-11). The complexes 
catalyse the partial reactions shown in Fig. ].2 and can be 
recombined stoichiometrically to give a reconstituted respiratory 
chain which behaves in a similar manner in its responses to electron 
transfer inhibitors, as the respiratory chain found in intact 
mitochondria (9-1]). 
Redox potential measurements on both 'in situ' and isolated 
components of the respiratory chain have enabled the presentation of 
the electron carriers on a potential diagram (Fig. 1.3) (12). In 
Fig. ].3 it is shown, that when the components associated with three 
levels of mid-potentials are classed or grouped together, there are 
three spans or gaps in the chain in whi~h relatively large decreases 
in free energy occurs, each sufficient to provide the energy for 
the formation of ATP from ADP and inorganic phosphate. The sites 
are designated Site I, II and III and represents the span between 
NADH and coenzyme Q; cyt.b and cyt.c and cyt.a and oxygen 
respectively. Chance, in his review of ]972 (12), suggested that 
the three groups of electron carriers having fixed mid-potentials 
(or isopotential pool) were linked with one another by means of 
energy-transducing carriers of variable potential. The energy-
transducing carriers of site I, II and III are proposed to be 
(Fe-S)N2' cyt.bT and cyt.a3 respectively, based on the findings 
that their mid-potentials were ATP and pH dependent (4, 12, 13). 
The isopotential pools functions as isopotential redox ballasts 
involving rapid equilibriating electron transfer reactions that 
are independent of energy coupling reactions. The respiratory 
chain therefore acts by an energy transduction process that 
NADH 
Succinate 
I 
II .. 
III .. 
IV .. 
Fig. J. 2 
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Complex I 
) I , FMN )Cyt.b Cu FeS ~ --. - ~ - -a a3 - -+-°2 
FAD ) Cyt,c1 FeS Cu 
Complex II Complex III Complex IV 
NADH-ubiquinone reductase complex which catalyses 
the reaction: + + NADH + Q + H ~ NAD + QH2 
Succinic Ubiquinone reductase complex which catalyses 
the reaction: Succinate + Q ~ Fumarate + QH2 
Ubiquinol cytochrome c reductase complex which catalyses 
the reaction: QH2 + 2 ferricyt. c ~ Q + 2 ferrocyt. c 
Cytochrome c oxidase complex which catalyses the 
reaction: 2 ferrocyt. c + 2H+ + 102 ~ 2 ferricyt. c + H20 
The four complexes and their sequential arrangement in 
the respiratory chain (9). 
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The electron carriers of the respiratory chain arranged 
as a group of fixed potential (or isopotential 'pools') 
and individual components of variable mid-potentials 
(bT, (a3) Bnd Z). The other components are the same 
as in Fig. 1.1, from [Modified from Chance 1972 (12)]. 
(Z = (Fe-S)N2) 
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operates through a series of quasi-equilibrium steps. In the 
case of cyt.bT for example, there are four species; oxidised 
high mid-potential, oxidised low mid-potential, reduced high 
mid-potential and reduced low mid-potential. bT in its low 
mid-potential form can only react with group II carriers and in 
its high mid-potential form can only react with group III carriers. 
The actual site of ATP synthesis is now known to 
reside on the multi-enzyme ATP synthase complex, which although 
located in the inner membrane of the mitochondria, is not directly 
linked to the respitatory chain. It is therefore important, to 
consider the problem of how energy from the respiratory chain is 
made available to the ATP synthase in such a form that it drives 
ATP synthesis. 
1.3 MECHANISMS OF ENERGY TRANSDUCTION 
Currently, the theories available to describe the 
phenomenon of oxidative phosphorylation, falls mainly into three 
broad categories: 
(a) chemical, 
(b) conformational, and 
(c) protonic. 
All the theories propose that the respiratory chain generates a 
high energy intermediate which can drive ATP synthesis, transhydro-
genation, ion transport as well as reversed electron transport. 
However, they differ in the nature of high energy intermediate 
proposed. 
-7-
1.4 THE CHEMICAL HYPOTHESIS 
The chemical hypothesis as originally proposed [Slater 
1953 (14)] was based on a mechanism of substrate level phosphorylation 
(15). The central feature of the hypothesis is that the respiratory 
chain generates high energy chemical intermediates which can be 
used to drive ATP synthesis or other energy-linked reactions. Using 
the notation of Chance and Williams (16), the hypothesis can be 
represented by the following sequence of reactions: 
1 • AH2 + B + I 
* 
A 
'" 
I + BH2 
2. A 
'" 
I + X 
* 
A + X 
'" 
·1 
3. X 
'" 
I + Pi ~ X 
'" 
P + I 
4. X 
'" 
P + ADP 
* 
X + ATP 
AHZ and B are two adjacent respiratory carriers and '",' refers to 
a high energy bond (probably anhydride or thioester bond). The 
nature of X and I is unknown. X '" I is regarded as the common energy 
transducing intermediate. This is considered as being the target 
of action of uncoupling agents, which, directly or indirectly, 
catalyse its hydrolysis (19, 20). Oligomycin is thought to block 
reaction 3, and transhydrogenation and ion transport are both driven 
by utilisation of X '" I, produced either by respiration or by ATP 
(17-20). Evidence for the chemical hypothesis is largely based on the 
actions of inhibitors like oligomycin, and on the fact that partial 
reactions such as transhydrogenation and reversed electron transfer 
can be driven either by energy deriving from respiration or ATP • 
• However, there are a number of disquieting features in the chemical 
hypothesis. It provides no explanation for: 
(a) the apparent dependence of oxidative phosphorylation 
on the integrity of the mitochondrial membrane 
-8-
structure; and 
(b) the fact that a wide range of molecules of wid~ly 
different structures will uncouple respiration 
from phosphorylation. 
The inability to isolate and identify the proposed high energy 
intermediate adds considerable complication to the chemical hypothesis 
(21, 22). 
1.5 THE CHEMIOSMOTIC HYPOTHESIS 
The chemiosmotic hypothesis, proposed by Mitchell in 1961 
(23) is based on the following four main postulates which are 
summarised in Fig. 1.4: 
1. The ATP synthase is a chemiosmotic membrane-located 
reversible protonmotive ATPase, having characteristic 
+/ " h" H P st01C 10metry. 
2. The respiratory chain is a membrane located vectorial 
metabolic proton trans locating system, having a 
characteristic H+/2e stoichiometry and having the 
same polarity of proton translocation across the 
membrane for normal forward redox activity as 
the ATPase for ATP hydrolysis. 
3. There are proton (or hydroxyl) linked solute porter 
systems for osmotic stabilisation and metabolite 
transport. 
4. Systems ]-3 are 'plugged' through a topologically 
closed insulating membrane, called the coupling 
membrane, which is impermeable to H+ and OH-. 
-9-
Fig. 1.4 Fundamental postulates of chemiosmosis (23-28) 
ADP + POH 
+ + (+ H /P)H ~ 
ATP + H2O 
AH2 + B 
+ (+H/e)H ( 2. Respiratory chain 
A ) cation linked ~ A 
C+~ porters 
Cytosol 4. Membrane Matrix 
+ . H+-----~l - - il leak- - -- + ---~) H (stimulated 
by uncouplers) 
Mitchell pointed out that, since the basis of oxidative 
phosphorylation was a dehydration reaction to form an acid anhydride 
link, a system which causes the removal of water from the active site 
of the ATPase would favour the formation of ATP (Fig. 1.5). The 
system Mitchell sur.gested for causing this dehydration consisted of 
an anisotropically organised respiratory chain consisting of 
alternating electron carriers and hydrogen carriers (Fig. 1.6) 
and an anisotropic membrane ATPase. He proposed that phosphorylation 
was linked to electron transport by a protonic electrical potential 
set up across the coupling membrane by the action of the respiratory 
chain which pump protons from one side of the membrane to the other. 
+ The protonic electrical potential cause the removal of (H20 as) H 
in one direction and OH- in the opposite direction from the active 
-)0-
centre of the ATPase (Fig. 1.5). The protonic electrical potential 
or protonmotice force (~p) is the sum of the pH gradient (~pH) and 
the membrane potential (~~) according to the equation (23-28): 
z~pH • 
Fig. 1.5 Proton translocation by the FIFo ATPase (26) 
r'- - -- - - - - - -t ---
I 
-, 
I 
I F 1 
I MgATP ~ ADP-O-P03Mg 
Fa I 
I 
/H~HOHiH20 
o I 
"H 
I 
ADP +
1+ 2H " 2H ~"'--I~" 
ADP-O Mg 
I 
---+- _______ --. _ ..J 
When the membrane is not leaky and most of the proton 
current generated by the redox system passes back through the 
reversible ATPase, there will be stoichiometric coupling between 
oxidation-reduction and phosphorylation. The P/O (P/2e-) quotient of 
the overall process is given by the ~H+/2e- quotient of the redox 
+ system divided by the ~H /p quotient of the ATPase, that is: 
+ + (~H /2e)/ (~ll /p). 
A short circuiting proton pathway across the membrane [as provided 
by uncouplers (23-28)] would,collapse ~p, uncouple phosphorylation, 
and allow redox activity to accelerate. 
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Fig. 1.6 Proton translocating redox loops (26) 
SH2 
NAD (NAD-linked) 
2H+ S LooE 
Fe(S) 
2H+ 
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SH2 
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2H+ 
CoQ 
2H+ 
Cyt'C 1 
1 1°2 + 2H+ LooE 3 Cyt.c 
~ / Cyt.a/a3 Cu 
'. '. -
H2O 
Detailed arrangement of the respiratory carriers according to 
Mitchell. The scheme provides for the translocation of 6H+/O 
for the oxidation NAD~linked substrates and 4H+/O for succinate 
oxidation (29). 
With the chemiosmotic hypothesis, Mitchell, circumvented 
two of the major objections to the chemical hypothesis. Firstly, 
the integrity of the coupling membrane is essential to maintain a 
membrane potential and pH gradient. Secondly, there is no need to 
postulate the existence of energy-rich intermediates to couple 
respiration and phosphorylation since the ATPase transferspi 
directly to ADP. 
That the chemiosmotic hypothesis has gained such wide 
acceptance in studies on membrane bioenergetics, may be ascribed 
to evidence derived from studies on mitochondria, submitochondrial 
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particles, and reconstituted vesicles, summarised below. 
1. 
2. 
3. 
4. 
5. 
Vectorial, transmembrane movement of H+ and other ions 
accompany both respiration and ATP hydrolysis (30-35). 
Most if not all the various types of energy transducing 
systems can generate a proton gradient and/or a membrane 
potential across the membrane in which they are located 
(35) • 
Energy transfer between energy-transducing systems 
located in the same membrane can take place yia a 
proton gradient and/or membrane potential (35). 
The action of some uncoupler's depends on their ability to 
dissipate the transmembrane proton gradient, since almost 
all are lipophilic weak acids (35-38). 
Artificially generated electrochemical proton gradients 
are kinetically competent in driving ATP synthesis 
(39, 40). 
Although the'chemiosmotic hypothesis offer a generally 
acceptable framework for energy transduction, the proposed mechanisms 
for H+ translocation (Fig. 1.6) and ATP synthesis (Fig. 1.5) are 
no less hypothetical than those involving high energy intermediate 
(14). Mitchell'~ suggestion that the prolon gradient is generated 
by the action of H+ translocating 'redox loops', formed by 
alternating hydrogen carriers and electron carriers of the respiratory 
chain (Fig. 1.6), has been refuted by a number of workers (30). 
Harmon et al. have pointed out, that although complexes I and III 
contain both hydrogen (NAD, FMN, CoQ) and electron carriers 
(Fe-S, cyt.b and c), (unlike complex IV, which contains only 
electron carriers), they do not form transmembrane loops (30, 40). 
The lack of support for his 'redox loop' concept, led Mitchell 
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to propose his 'protonmotive ubiquinone cycle' (Q cycle) for H+ 
translocation [see (42, 43) for reviews]. However, the 'Q cycle' 
requires the movement of Q and QH2 across the membrane, and a 
certain distribution of b cytochromes across the membrane. 
Available evidence suggests that these situations are unlikely 
(30). In the case of the ATPase system, much evidence has been 
compiled, which indicates that the FOF) ATPase complex may 
+ function as a H trans locator (44, 45). However, the direct 
interaction of pi and ADP, with the intermediate formation of a 
phosphonium ion [P03]+' to yield ATP at the catalytic site (Fig. 1.5) 
proposed by Mitchell (46, 47) has been questioned on theoretical 
grounds by Boyer and Williams. (48, 49). 
The mechanisms by which the respiratory chain and the ATPase 
complex transport H+ and the H+/site quotient are matters of 
considerable controversy. In both cases the problem concerns 
whether proton translocation proceeds directly, involving the 
catalytic site(s) of the enzyme, or whether it proceeds indirectly 
via a 'proton pump'. Information deriving from investigation of the 
membrane topology of the catalysts involved and measurement of the 
+ + ~H /2e and ~H /ATP ratios, support an indirect mechanism involving 
proton pumps (50). Direct coupling redox loops would require 
a stoichiometry of two H+ translocated per two electron translocated 
through each coupling site (i.e., ~H+/site = 2). Similarly, 
direct coupling between the ATPase and the transmembrane 'proton 
well', of the type postulated by Mitchell (26), predicts a stoich-
iometryof two H+ per molecule of ATP synthesised (i.e., ~H+/site • 2). 
Results supporting these predictions have been reported by Mitchell 
and Moyle, who have shown that electron transport from NADH to 
oxygen cause the translocation of 6H+ (23-28). However, other 
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workers have obtained significantly higher ~H+/site ratios, often 
exceeding 3, for both the electron transport and the ATPase 
systems (35, 5J-54). These stoichiometries (~H+/site ratio ~ 3) 
are not compatible with the proposed 'redox loop' and 'proton well' 
mechanisms, but can be readily accommodated by a mechanism involving 
proton pumps (32). The reported transmembrane location of Fe.S 
centres 1 and 2 in complex I (55-56) or the two b cytochromes in the 
case of complex III (55-58) is equally compatible with the 
occurrence of transmembrane proton pumps driven by nonvectorial 
electron transfer catalyst. However, the mechanism by which protons 
are translocated through the 'pumps' is not defined. 
1.6 LOCALISED PROTON HYPOTHESES 
Two alternative hypothesis envisaging proton coupling 
have been put forward to explain the inadequacies of the chemiosmotic 
hypothesis. They are the 'Localised proton hypothesis' of Williams 
(59-60) and the 'Electrodic hyPothesis' of Kell (61). Only a summary of 
these hypotheses will be presented, because they have been presented, 
only as logical models for discussion [for in depth reviews see 
ref. (219-22 J )). 
In the 'localised proton hypothesis', Williams proposes that 
the protons produced by the respiratory chain, and which are 
responsible for ATP synthesis, are not pumped across the membrane 
as proposed by Mitchell (23-28), but remain in the membrane where 
they lower the activity of the "solvent- : 'water" in the ATPase region 
(Fig. J. 7) • The energy of the redox reactions is thus transferred 
I 
to the ATPase complex as anhydrous (or partially hydrated) H+, which 
moves in the membrane through a channel of fixed water molecules, 
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which is connected to the ATPase (Fig. 1.8). 
Fig. 1.7 The localised proton model for ATP synthesis (59) 
Aqueous (A) Aqueous (C) 
ADP 
Organic (B) 
~------------2e-------------­
,..-------
• 
I 
f 
--------~ 
ATPase 
, I 
The solid lines (box) represent a very hydrophobic particle within 
which ADP and pi are condensed to ATP by the ATPase. 
Thus during the synthesis of ATP from ADP and pi the H+ moves so 
as to pull H20 molecules from the polyphosphate condensation site 
into the diffusion channel [Fig. 1.8 (60-63)]. 
The obvious advantages of Williams' hypothesis over 
the chemiosmotic hypothesis are that it offers: 
(a) more efficient energy utilisation, 
(b) better control, and 
(c) discriminatory coupling of energy to different 
processes. 
However, although a certain degree of localisation of H+ takes place 
between the electron transport and ATPase system (64-65), Mitchell 
has pointed out that Williams' hypothesis is very limiting and not 
experimentally falsifiable (28). In particular, it lacks explanation 
for transport, and because it lacks stoichiometry, it cannot 
be used to explain the experimentally observed plo quotients. 
In his 'electrodic hypothesis', Kell proposes that the 
protons that are responsible for ATP synthesis are pumped across 
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Fig. 1.8 Indirect localised proton coupling model (63) 
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An open channel model is shown so that it could in principle be 
linked to chemiosmotic gradient, although this is not required 
in the hypothesis. 
the membrane from one S-phase (SR-phase) (membrane-liquid interphase) 
to the other (SL-phase) by the electron transfer complex (Fig. 1.9). 
The protons then flow along the SL-phase to the ATPase through which 
they re-enter the original SR-phase completing the protonic circuit. 
The flow of protons along the S-phase is 'conducted' by 'structured 
+ water molecules' (or membrane water) which allows H tunnelling 
(66, 67). The movement of protons between the S-phases results in 
charging the membrane surfaces relative to the bulk aqueous phases, 
and it is the potential drop across the membrane/solution (electrode/ 
electrolyte) intersurface which drives ATP synthesis. 
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Fig. 1.9 Electrodic hyPothesis (61) 
I 
ETC 
I 
I 
I 
if , I H+ H+ I H+ H 
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- I 
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ATPase 
A typical protic circuit. The diagram represents a phospholipid 
membrane phase (M) separating two aqueous phases Land R 
repsectively. Interphase SL and SR exist between the M phase 
and the two aqueous phases. The M phase contains the protonmotive 
electron transport complex (FTC) and protonmotive ATPase of the 
appropriate polarities, and the radial and lateral flow of the 
proton current, i.e., a two-dimensional proton current flow, 
between them is indicated by the arrows. Adopted from Kell 
(61) • 
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Whilst the postulates of Kell (61) are in broad agreement 
with the proposals of Williams (59-63), the electrodic hypothesis is 
chemiosmotic because a transmembrane-phase H+ gradient is involved. 
Kell has layed particular emphasis on localised interphase 
phenomena based on generally accepted physical, chemical and 
electrochemical principles, and ha's provided explanations for -~ 
ion transport, and the action of uncouplers (61, 68, 69). However, 
like the chemiosmotic and 'localised proton' hypotheses, it lacks 
detailed molecular mechanisms for H+ translocation and ATP 
synthesis. 
1.7 CONFORMATIONAL HYPOTHESIS 
The conformational hypothesis in its original form 
[Boyer 1965 (72)] proposed that the energy generated by electron 
transport, was conserved in a 'high-energy' conformational state 
of the respiratory carrier. The energy inherent in this conformation 
being used to drive ATP synthesis: 
A* 
AH2 
+ ADP 
+ B ~ A* 
+ Pi =t. A 
+ 
+ ATP + 
Support for this hypothesis is obtained from Green (73) and Hackenbrock 
(74) who observed that the structure of the mitochondria was energy 
dependent)and from the observations that electron flow in bacteria, 
chloroplast and mitochondria is accompanied by changes in the 
conformation of their FI ATPase (70, 75-77). However, little 
compelling evidence has been found to support direct interaction 
between the ATPase and the redox centres. Mitchell (28) has pointed 
out that such an interaction does not occur. 
In the new conformational hypothesis Boyer and Slater 
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proposed that ATP synthesis occursat the active site of the ATPase 
complex prior to the input of energy; which is necessary, only, 
to bring about the release of ATP from the active site, via an 
energy dependent conformational change [Fig. 1.10, (70, 79)]. 
This hypothesis was based on the finding that the exchangeability 
of adenine nucleotides bound to FI was dependent on the flow of 
electrons (70, 79) and on the insensitivity of the anhydride 
formotion to uncouplers of oxidative phosphorylation (80). These 
findings although intimately correlating with the suggested molecular 
explanation for exchange reactions; namely that they result from the 
dynamic reversal of ATP formation, are difficult to reconcile with 
Mitchell's proposal that the protons are directly involved in the 
anbydride formation (28). 
Fig. 1.10 New conformational couplirtg model (70) 
) 
energy 
~ ADP+Pi 
Dotted line represents changing conformational state due to 
energisation. The energy is derived from electron transport. 
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1.8 THE MITOCHONDRIAL ATPase COMPLEX 
The mitochondrial ATPase complex appears to be one of 
the most complex enzyme systems known to date, performing 'in situ' 
a number of reactions such as ATP-pi exchange, ATP synthesis and 
hydrolysis. These reactions are affected by a variety of inhibitors 
~ 
including oligomycin, DCCD, venturicidin and trialkyltins. The 
inhibitor studies have proved to be very useful in trying to 
determine the subunit/activity relationships in the complex, and 
in some cases, have proved to be instrumental in the proposal of 
new mechanisms for coupling ATP synthesis and respiration. Inhibitor 
studies have also indicated that the ATPase complex is at least 
bifunctional. Of interest are those experiments which show that 
some inhibitors such as AMP-P-NP are capable of either activating 
or inhibiting ATP hydrolysis without altering ATP synthesis (81). 
Work presented in Chapter 2 of this thesis has shown that such a 
differential effect on ATP synthesis and ATP hydrolysis can be demon-
strated with trialkyltin compounds in beef heart mitochondria. A 
brief description of the ATPase will now be presented. For more 
in depth reviews see references (81-88). 
The mitochondrial ATPase complex is located exclusively 
in the inner membrane where it protrudes into the matrix space 
(82). In general, it accounts for about 2% of the mitochondrial 
mass (81). The 'complete' ATPase complex (Fig. 1.IIA) is depicted 
by many authors as consisting of four major components: a headpiece 
called Fl which is water soluble, catalyses the hydrolysis of nucleoside 
triphosphates and binds the inhibitor aurovertin; a basepiece or 
membrane sector, which is detergent soluble and binds the inhibitors 
oligomycin and DCCD; a"stalk connecting the headpiece and basepiece; 
and one or more small peptide inhibitors of ATP hydrolytic activity. 
\ 
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Peptide inhibitor 
.. Headpiece 
..... Stalk l .. Basepiece 
'-Membrane section J 
Fig. I.IIA Schematic re£resentation of the mitochondrial ATPase 
complex (81) 
F 
I 
FO 
Fig. I.IIB Plan view Fig.I.IIC Side view 
Three dimensional structure of FIFo-ATPase (109) 
The numbers on Fig. I.IIB and C refer to the subunit type. The 
position of the other subunits of the ATPase complex, notably 3, 
5, 7 and 8 is as yet unidentified. 
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The stalk and basepiece are referred to collectively as FO. 
The FIFO ATPase complex (or complex V) of beef heart 
mitochondria has been prepared by a variety of methods (81, 87-89), 
all of which involves solubilisation of the inner mitochondrial 
membrane with chaotrophic detergents such as Triton-X-IOO and 
deoxycholic acid. These treatments result in severe delipidation 
of the final purified form of the FIFO ATPase complex, and the 
expression of its maximal enzymic activities is dependent on the 
presence of exogenous lipids (81). The purified complex has an 
estimated molecular weight of 460-480,000 and contains 8-12 
different subunits (84, 88-90). Hatefi etal. have recently 
shown that the FIFO ATPase complex of beef heart mitochondria 
contained at least 12 subunits, most of which have been tentatively 
described on a functional basis in Tabl~ 1.1 (84). 
The purified FIFO ATPase complex catalyses ATP 
hydrolysis and ATP-pi exchange; however maximal catalytic 
activity is dependent on the addition of exogenous phospholipids 
(81). Both the ATP-pi exchange and ATP hydrolytic activities are 
sensitive to inhibitors such as oligomycin, venturicidin, trialkyltins 
and DCCD. The FIFO ATPase complex appears to be divided into two 
functionally dissimilar portions: the hydrophylic FIATPase which 
protrudes from the inner membrane into the matrix; and the FO 
portion which is hydrophobic in nature and is buried in the inner 
membrane, both of which, have been isolated in purified form 
(92, 93, 104, 105). 
The FI ATPase has been isolated from the inner mitochondrial 
membrane by a variety of methods, including sonication (92, 93) and 
chloroform treatment (94). The enzyme prepared from beef heart 
mitochondria has a molecular weight of 347-360,000 and has been 
shown using SDS-gel electrophoresis to be composed of five different 
Table 1.1 
Subunit M.W. 
53,000 
50,000 
33,000 
30,000 
23,000 
22,000 
15,000 
12,000 
8,000 
11-13,000 
6,000 
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Identity of subunits of the FIFO ATPase Complex (84) 
a subunit Fl ATPase 
a subunit Fl ATPase 
y subunit FI ATPase 
uncoupler binding protein 
Fa component; pantotheine binding protein (86) 
oligomycin sensitivity conferring protein (OSCP) 
~ subunit FI ATPase 
DceD binding protein 
coupling factor F6 (85) 
ATPase inhibitor or coupling factor B (87, 91) 
E subunit FI ATPase 
Numbers in brackets are references; M.W. = molecular weight. 
subunits (84, 93). These subunits are designated a, a, y, ~ and E 
in Table 1.1. Measurement of the subunit stoichiometry, using 
dye staining and amino acid frequency methods, indicate that there are 
at least 9-10 polypeptide components per FI ATPase molecule (92, 93). 
Senior has suggested a subunit stoichiometry of a3~3YI~El for the 
beef heart enzyme (92) and a similar stoichiometry has been proposed 
for the rat liver enzyme by Catterall and Pedersen (95) and for the 
yeast enzyme, by Tzagoloff and Meagher (90). An additional 10,000 
molecular weight subunit found in certain preparations of FI ATPase 
has been proposed to be the 'ATPase inhibitor protein' which regulates the 
ATPase activity 'in vivo' (96). 
Purified F) ATPase exhibits only ATP hydrolytic activity 
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and is insensitive to inhibitors such as oligomycin, DCCD, 
venturicidin and trialky1tin compounds. However, F1 ATPase is 
inhibited by aurovertin and efrapeptin. The true substrate 
of the enzyme is the Mg ATP complex; however, inosine and uridine 
triphosphate can also act as substrates (97). 'In situ' the F1 ATPase 
catalyse ATP synthesis, hydrolysis and ATP-dependent reactions such 
as transhydrogenation. This has been demonstrated by a series of 
reconstitution experiments, in which F1 ATPase was shown to couple' 
ATP synthesis and ATP-dependent activities in F]-ATPase depleted 
membrane vesicles (81). 
1.9 NUCLEOTIDE BINDING SITES 
The binding of nucleotides to FI has been studied 
extensively using many different techniques (98-101). Slater et ale 
have suggested that there are at least seven ATP and ADP binding 
sites on each FI ATPase molecule and that these could characterise 
into four types, designated type I, II, III and IV (99). Types I 
and II bind ATP and ADP respectively, very strongly and are thought 
to be involved in ATP synthesis, since their binding affinities 
are weakened in membrane bound FI , when the membrane is energised 
by electron flow through the respiratory chain (99, 102, 103). 
There are two type III binding sites, one on each B-subunit, and 
these are proposed to be the catalytic site for ATP hydrolysis. 
One type IV binding site is found on each a-subunit and these sites 
are proposed to be allosteric anion binding sites (99, 101). Based 
on these binding studies, Slater et ale (99) have suggested that 
there are at least two catalytic sites on the FI ATPase, one 
specialised for ATP synthesis and the other specialised for ATP-
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dependent reactions. Support of this suggestion comes from the 
differential effects of aurovertin (124), AMP-PNP (125), 
quercetin (126) and the inhibitor protein of Pullman and Munroy 
(127) on oxidative phosphorylation andATP dependent reactions. 
It is well known that a ten-fold greater concentration 
of aurovertin is required to inhibit ATPase than to inhibit 
oxidative phosphorylation. Chang and Penefsky (128) have suggested 
that there are two aurovertin binding sites, one involved in the 
inhibition of oxidative phosphorylation, and the other in the 
inhibition of the ATPase. 
The FO component of the F}FO ATPase complex unlike 
the F} ATPase component is not catalytically active. However, 
it is required for the expression of oligomycin sensitivity and 
ATP-dependent reactions. The FO sector. is supposed to be the 
region in which the hi~h energy state '~', generated by coupled 
electron transport, is transduced to activate inorganic phosphate. 
In the chemiosmotic hypothesis the FO component is considered to 
be a proton conducting well spanning the inner membrane, through 
which protons flow to the active site of the FI ATPase. This 
view is supported by the findings that the increased proton per-
meability in submitochondrial particles depleted of FI can be 
inhibited by oligomycin, which binds to the FO component (}04, 105). 
The FO component contains 5-7 different subunits, the most 
well characterised of which are, the DCCD binding protein, the 
oligomycin sensitivity conferring protein (OSCP) and coupling 
factor F6 (see Table 1.1). The OSCP binds directly to F} (in 
a 1:1 ratio) and to the membrane (106, 107). F6 appears to 
facilitate the binding of FI to the membrane by binding OSCP 
(84, 108). The OSCP form the stalk of the FIFO ATPase complex 
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shown in Fig. 1.11. 
Although the distribution of subunits between the Fl 
and FO portions of the FIFO ATPase complex has been known since 
1973 (92), little is known about the spatial arrangement of these 
subunits in the FI or FIFO ATPase complexes. However, Enns and 
Criddle have recently investigated the 3-dimensional arrangement 
of these subunits in the FI and FIFO ATPase complexes, using 
cleavable and non-cleavable cross-linking reagents (e.g. 
mercaptobutyriimidate) and 2-dimensional SDS-gel electrophoresis 
(109). From these investigations Enns and Criddle found that the 
following pattern of cross-linking occurs; 8-e, a-a, a-B, y-€. 
The B and a subunits were also found to link with each of the 
other subunits. From the results of these studies Enns and Criddle 
proposed the structure presented in Fig. I.IIB, and I.IIC as a 
diagramatic representation of the 3-dimensional structure of the 
FIFO ATPase complex (109). 
I. 10 A GENETIC APPROACH TO OXIDATIVE PHOSPHORYLATION 
As outlined in the preceding sections of this Chapter, 
the chemical transformations occurring in oxidative phosphorylation 
have been difficult to resolve with the usual biochemical techniques. 
The fundamental problem is that the catalytic units are often an 
integral part of the membrane structure. This observation has 
prompted a number of laboratories to tackle the problem of energy 
conservation by means of a mutant approach. Much of the work to 
date has been carried out on the eucaryote, SQcchc:lrGmycE's cerevisiae 
Kovac has reviewed the advantages of yeast as suitable 
organisms for biochemical genetic studies of oxidative phosphorylation 
(lID). Briefly, its main advantages are: 
1 • 
2. 
3. 
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it possesses mitochondria with properties very similar 
to mammalian mitochondria; 
its biochemistry, genetics and cytology are known in 
great detail; 
and it can survive major genetic lesions affecting the 
mitochondria, since it can grow on fermentable 
substrates. 
He concluded that the most suitable yeast for these studies is the 
strain Saccharomyces cerevisiae, largely because its biochemistry, 
genetics and cytology are the most well documented. 
The basic approach has been to make use of the fact that 
mitochondria are semi-autonomous organelles possessing their own 
DNA (mtDNA) and protein synthesising systems. Moreover, mitochondrial 
protein synthesis can be specifically iuhibited by chloramphenicol 
and erythromycin but not by cycloheximide which inhibits cytoplasmic 
protein synthesis (Ill, 112). This has enabled Schatz et a1. (113) and 
Tzago10ff et a1. (114) to produce results which indicate that three 
subunits of cytochrome oxidase, two subunits of ubiquinone -
cytochrome c reductase and four subunits of the ATPase system are 
mitochondrial1y synthesised. 
The first type of mutant to be actively investigated 
were the resp~ratory deficient mutants known as petites. Petites 
can form spontaneously, but they are usually induced by the action 
interca1.ating drugs such as ethidium bromide. They are usually 
characterised by the fact that they form smaller than normal size 
colonies on media containing glucose as energy source, their 
inability to grow on non-fermentable substrates, and their cyanide 
insensitivity (1]5). The petite mutation represents a major deletion 
of the mtDNA and is expressed as an inability to carry out 
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mitochondrial protein synthesis (116). Schatz (113) and Tzagoloff 
and Meagher (90) have shown that the ATPase present in petite 
mitochondria is F1-ATPase and that the FO components were absent. 
Mitochondria of petite mutants do not catalyse an ATP-Pi exchange 
reaction and are not energised by ATP as is shown by the lack of 
fluorescence with ANS (110). The conclusion from these experiments 
is that the FO subunits are necessary for the ATPase to participate 
in energy conservation and transduction. 
An alternative approach to the isolation of mutants 
with altered components of the energy conservation system has 
been adopted by Griffiths (117-121). Mutants are selected for 
growth on non-fermentable substrate in the presence of inhibitors 
of oxidative phosphorylation. Any such mutants not due to cell or 
mitochondrial membrane impermeability OP detoxification may be due 
to a modified ATPase complex. Mutanffiresistant to oligomycin (1]8), 
triethyltin (119, 121) and venturicidin (117, 120) have been isolated. 
The oligomycin-resistant mutants can be grouped into two classes 
(Class I and Class II) on the basis of cross resistance to other 
mitochondrial drugs (118). Class I mutants show cross resistance 
to aurovertin, Dio-9, venturicidin, triethyltin, uncouplers and 
other mitochondrial drugs. In contrast, Class II mutants 
are specifically resistant to oligomycin and structurally related 
antibiotics and shows no cross resistance to venturicidin, 
triethyltin, DCCD or uncoupling agents (122). All the Class II 
mutants exhibit tyPical cytoplasmic inheritance and the resistance 
determinants are located on the mtDNA. Genetic analysis indicates 
that two loci (OLI and OLII) located on independent cistrons on 
mtDNA are involved (118). Biochemical studies (121, 123) on the 
Class II mutants revealed that the ATPase, ATP-pi exchange and ADP 
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stimulated respiration in isolated mitochondria were all less 
sensitive to oligomycin. Class II triethyl tin mutants have also been 
shown to be cytoplasmic and map at the T locus (121). Decreased 
sensitivity to triethyl tin is found in the ATPase and ADP 
stimulated respiration of Class II mutants (121). 
Mitochondrial venturicidin resistant mutanGmap at 
two loci, those exhibiting cross-resistance to oligomycin mapping 
at the OLIII locus which is closely linked to OLI, and those 
exhibiting cross-resistance to triethyl tin mapping at the 
VI locus (120). Venturicidin mutants mapping at VI are very 
similar to the triethyl tin mutants mapping at T{ and it seems 
likely that Ti and VI are identical. All the available evidence 
suggests that OLI, OLII and VI are located on separate cistrons 
(120). 
The resistance phenomenon may be explained by a binding 
of oligomycin at three attachment points, modification of which arise 
by mutation of OLI, OLII and OLIII. Venturicidin is complexed by 
two attachment points, one of which it has in common with 
oligomycin, the other being equivalent to the triethyl tin binding 
site (117, 120, 121). 
CHAPTER 2 
2. 
2. 1 
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THE EFFECTS OF TRIALKYL TIN COMPOUNDS ON 
ENERGY-LINKED FUNCTIONS OF BEEF HEART 
MITOCHONDRIA AND SUBMITOCHONDRIAL PARTICLES 
. INTRODUCTION 
Trialkyl tin compounds have been shown to be potent 
inhibitors of mitochondrial oxidative phosphorylation, oligomycin 
sensitive ATPase (OS-ATPase) and some energy-linked reactions, 
e.g. 32pi_ATP exchange (135-138). The mechanism by which the 
organotin compounds cause inhibition of these energy-linked reactions 
is not known. However, Aldridge·et ·al. have proposed rhat inhibition 
is brought about by anyone of/or a combination of the following three 
mechanisms [summarised in Fig. 2.1 (140)]: 
1. binding to a component of the energy conservation system 
to produce an oligomycin-like response; 
2. uncoupling, due to their abllity to mediate the exchange 
of halide for hydroxyl ions across membranes; and 
3. uncoupling, due to induced gross swelling of the 
mitochondria. 
Support for an oligomycin-like action of trialkyl tin 
compounds is obtained from the demonstration by Dawson and Selwyn 
(141) and Cain (142), that tributyl tin chloride and dibutyl-chloromethyl 
tin chloride (DBCT) block ADP stimulated respiration in mitochondria 
and lower the proton permeability of F1-ATPase depleted ("stripped") 
submitochondrial particles (141). Studies on the binding of 
trialkyl tin compounds to submitochondrial particles of rat 
liver (143), beef heart (14J) and yeast (145) have indicated 
the presence of one high affinity and one low affinity binding site for 
trialkyl tins. Aldridgeet·al. (143) have reported that the dissociation 
• -8 M\ constant of the hlgh affinity site of triethyl tin (kD ~ 10 ~.~as 
similar to the concentration required for the inhibition of 
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Fig. 2.1 Two mechanism by which trialkyl tins may inhibit 
oxidative phosphorylation. An oligomycin type 
inhibition; direct binding of trialkyl tin (TAT) 
to FIFO ATPase complex; and uncoupler type action; 
catalysis of OH-/Cl- exchange across the coupling 
membrane; M, (140). 
oxidative phosphorylation. Biochemical genetic studies by Griffiths 
and Lancashire (121) and binding studies by Cain et a1. (144) 
have indicated that the high affinity binding sites of trialkyl tins 
were localized in the FIFO ATPase complex. However, genetic studies 
on tria1ky1 tin resistant mutants of yeast by Griffiths et ale (111) 
and extraction of the 'trialkyl tin-X' complex (X - tin binding 
component) by Cain (142) (see Chapter 3 of this thesis), have shown 
that the high affinity sites are not localized on any of the protein 
components of the ATP synthesising system. These findings make it 
difficult to relate the mechanism of trialkyl tin inhibition to 
that of oligomycin or dicyc10hexy1carbodiirnide. 
Tria1ky1 tins have also been proposed by Stockdale et a1. 
(139, 145) to act as uncouplers of (see Appendix I) of oxidative 
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phosphorylation. These authors showed that tria1ky1 tins cata1yse 
an anion/hydroxyl (C1-/0H-) exchange across the inner membrane of 
mitochondria and chloroplasts, which results in the breakdown of 
the proton gradient responsible for driving ATP synthesis. An 
uncoup1er mode of action has also been proposed by Selwyn et a1. 
(146, 147) who have shown that tria1kyl tins facilitate the swelling 
of mitochondria in C1- containing media. However, it is not known if 
the C1-/0H- exchange system in mitochondria represents a specific 
property of the tria1ky1 tin compounds, or whether it is the result 
of interaction with specific sites in the mitochondrial membrane (e.g. 
components of the FIFO ATPase complex). 
Although an uncoupling mode of action might be used to 
explain tria1kyl tin inhibition of oxidative phosphorylation, it cannot 
be used to explain the inhibition of mitochondrial membrane ATPase 
activity (145-147). It is thus, clearly important to establish the 
molecular basis for trialky1 tin inhibition of energy-linked reactions. 
Two approaches have been made: 
(a) a study of the chemical specificity of trialkyl tins 
for the few proteins to which they bind (148), and 
(b) the use of dibutylchloromethyl tin chloride (DBCT) as 
a covalent inhibitor of mitochondrial ATP synthase, 
followed by the isolation of the component(s) to which 
it is attached (142, 149). 
The 'simple' chemical nature of trialkyl tin compounds, combined with 
their high biological activity and limited chemical reactivity, in 
addition to the fact that they appear to specifically inhibit oxidative 
phosphorylation and energy-linked reactions, make tria1ky1 tins useful 
probes in the investigation of the molecular mechanism of these 
reactions. 
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The present chapter describes the inhibitory properties 
of a number of trialkyl tin compounds; including dibutylchloro-
methyl tin chloride (DBCT) and a penta-coordinate tin compound 
{2-[(dimethylamino)methylJphenyl}diethyl tin bromide (Ve2283 ) 
on mitochondrial energy-linked reactions. In contrast to other trialkyl 
tin compounds, DBCT has been proposed to act as a specific covalent 
inhibitor of OS-ATPase activity and oxidative phosphorylation (150). 
Preliminary results showing that the OS-ATPase activity was 6-10 times 
more sensitive to all trialkyl tin compounds than oxidative phosphory-
lation was investigated more thoroughly using DBCT. 
2.2 MATERIALS 
All chemicals were of AnalaR or similar grade. Organic 
solvents of AnalaR grade were redistilled before use. Trialkyl tin 
chlorides and dicyclohexylcarbodiimide (DCCD) were obtained from BDH 
Chemicals Ltd., Poole, Dorset. Dibutylchloromethyl tin chloride was 
synthesised in this laboratory by Dr. D. E.Griffiths. {2-[(dimethyl-
amino)methylJphenyl}diethyl tin bromide (Ve 2283 ) and 4,S,6,7-tetra-
chloro-2-trifluoro-rnethylbenzimidazole (TTFB), were gifts from 
Professor B. Beechey, Shell Research Ltd., Sittingbourne, Kent. 
Oligomycin, valinomycin, gramicidin D, ATP, ADP hexokinase, glucose, 
rotenone, carbonyl-cyanide-rn-chlorophenyl hydrazone (CCCP), 
dihydrolipoic acid, ~-lipoic acid, glutathione 2,3-dimercaptopropanol, 
dithiothreitol and B-rnercaptoethanol were obtained from Sigma 
Chemical Company. Antimycin A was obtained from Calbiochem, San Diego, 
California. 
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2.3 METHODS 
Beef heart mitochondria and submitochondrial particles 
were prepared by the method of Low and Vallin (153). Freshly 
excised bovine hearts were brought on ice from a nearby slaughter 
house; all subsequent operations, preparation of submitochondrial 
particles and enzymes, were carried out at 4°C unless otherwise 
stated. Fat, connective tissue and ligaments were carefully trimmed 
from the muscle tissue which was then cut up into 3 on cubes and 
passed through a meat grinder. The resulting minced tissue was 
resuspended in 2 volumes ice cold 0.25 M sucrose, the pH adjusted 
to pH 7.0-7.5 by addition of M Tris base, and the suspension 
homogenised in a Waring tissue blender for 40 seconds at maximum 
speed. The suspension was then pH'd to a stable pH 7.0-7.5 by the 
addition of I M Tris base with rapid stirring; care being taken at 
this stage to ensure that the pH is stabilised and is not above 
7.5. The suspension was then centrifuged at 2,000 r.p.m. in a 
Mistral 6 L centrifuge 4 x 1.25 L rotor for 30 minutes at 4°C. 
The supernatant was passed through 4 layers of muslin and the pH 
adjusted to 7.5 with I M Tris base before being centrifuged at 
10,000 r.p.m. for 20 minutes in a SorvallRC-2B centrifuge G.S.A. rotor, 
o pre-cooled to 4 C. The supernatant from this spin was carefully 
removed by aspiration, as was the top light layer of the pellet. 
Any fat lining the centrifuge bottle was then carefully removed by 
wiping with a tissue. The dark brown mitochondrial pellet was then 
resuspended and homogenised in a glass homogeniser fitted with a 
teflon pestle in 0.25 M sucrose; )0 roM Tris-CI, pH 7.5, diluted to 
0.5-1.0 litres in the same buffer and recentrifuged at )0,000 r.p.m. 
for 20 minutes in a Sorvall RC-2B centrifuge G.S.A. rotor. The 
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supernatant was removed as previously and the pellet resuspended in 
0.25 M sucrose; 10 mM Tris-CI, pH 7.5 buffer and recentrifuged as 
above. The pellet from this centrifugation was resuspended in 0.25 M 
sucrose; 10 mM Tris-CI, pH 7.5; 5 roM MgCl 2 and recentrifuged as 
above. The mitochondrial pellet was resuspended to 40 mg protein/ml in 
0.25 M , sucrose; 10 roM Tris-CI, pH 7.5; 1 mM EDTA, 5 mM MgCl 2 ;5mM succinate 
2 mM ATP'.and the mitochondrial suspefllsiOneither frozen innnediately or kept 
at 4°C as required. 
Submitochondrial particles were prepared by sonication of 
mitochondria. Frozen mitochondria were thawed rapidly and diluted to 
approximately 10 mg/ml protein concentration and sonicated for 
I minute (4 bursts of IS seconds interspersed by 30 second gaps) 
in an MSE 60 W sonicator at maximum amplitude. The suspension was 
centrifuged at 15,000 r.p.m. for IS min~tes in a Sorvall RC-2B 
centrifuge 5534 rotor. The supernatant was then centrifuged at 
100,000 g for 30 minutes in a Beckman L2-50 centrifuge, 40, 50 Ti 
or 65 rotor. The pellet from this centrifugation was resuspended 
in 0.25 M sucrose; 10 roM Tris-CI, pH 7.5; I mM EDTA and recentrifuged 
as above. The submitochondrial pellet was resuspende~ in the same 
buffer to a final protein concentration of ~ 20 mg/ml. 
Electron transport particles (ETPH) were prepared by 
the same method as submitochondrial particles except that the 
sonication buffer contained 2 roM sodium succinate; 2 roM ATP and 5 roM 
Complex V ATPase (FIFO ATPase) was prepared by Hatefi and 
co-workers (lSI), using bovine heart submitochondrial particles 
(SMP's) as a starting materia1. SMP' s were pelleted and resuspended in 
0.66 M sucrose; 50 mM Tris-CI, pH 8.0; I mM histidine to a protein 
concentration of 23 mg/ml. Potassium deoxycholate was added to a final 
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concentration of 0.3 mg/mg protein from a stock solution 10% w/v, 
pH 9.0. Potassium chloride was then added to 12 g/l and allowed 
to dissolve at 40 C with stirring. The suspension was then centrifuged 
at 30,000 r.p.m. for 30 minutes in a Beckman 30 rotor. The precipitate 
was discarded while the reddish supernatant was diluted with 0.25 volumes 
of double distilled water and recentrifuged at 30,000 r.p.m. for 
40 minutes in the No. 30 rotor. The supernatant from this step was 
dia1ysed against 10-20 volumes 10 mM Tris-Cl pH 8.0 for 3 hours at 40 
C. The dialysate was centrifuged for 90 minutes at 30,000 r.p.m. in 
the No. 30 rotor. The upper 2/3 of the supernatant from this step 
was removed from the loosely packed pellet, frozen in liquid 
nitrogen and stored until used. This supernatant was then passed 
through a Sephadex G25 column pre-equilibrated and eluted with 
10 mM Tris-acetate, pH 7.5 at 100-130 ml per column of size 10 x 
o 22 cm at 4 C. The pink column eluant was taken to 42% saturation 
w~th neutral saturated (NH4)2S04 at 4
0 C and centrifuged for 
15 minutes at 70,000 g. The pellet from this step was resuspended 
in 0.25 M sucrose; 10 mM Tris-acetate, pH 8.00t a concentration of 
15-20 mg/m1 protein. Potassium cholate was then added to 0.35-0.38 
mg cho1ate/mg protein (from a 20i. w/v stock solution pH 7.9) 
followed by (NH4)2S04 to 25i. saturation. The suspension was then 
centrifuged after 10 minutes stirring at 40 C at 40,000 r.p.m. for 
25 minutes in a No. 40 rotor. The precipitate was discarded and 
the supernatant taken to 42% saturation with saturated (NH4)2S04 
at 40 C. The suspension was centrifuged as before and the pellet 
collected, redissolved to ~ 20 mg/m1 in 0.60 M sucrose; 50 mM 
Tris-el; pH 8.0; ) roM histidine, frozen in liquid nitrogen and 
stored until used. This is complex V. 
F) ATPase was prepared essentially as described by 
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Tyler and Webb (152), using bovine heart submitochondrial particles 
as starting material. Submitochondrial particles suspended at 
10 mg protein/ml in buffer contain 0.25 M sucrose; 10 roM Tris-CI, pH 
7.5; J roM EDTA; and 4 roM ATP; (STE-ATP buffer), were vortex-
mixed rigorously on a Whirlimixer, and 0.5 vol. of chloroform 
added rapidly dropwise. When the chloroform addition was complete, 
vortex-mixing was continued for a further 20 seconds. The chloroform/ 
water emulsion was broken by centrifugation in a bench centrifuge for 
2 minutes. The upper aqueous layer was removed, diluted 1:1 with the 
initial buffer and centrifuged at 100,000 g for 30 minutes in 
Beckman L2-50 centrifuge 65 rotor. The supernatant containing the FJ 
ATPase was stored in a water bath at 250 C. The ATPase was purified 
o All procedur~we~ carried out at 25 C. 
Solid (NH4)2S04 (0.39 g/m1) was added slowly to a stirred sample of 
the supernatant. When all the (NH4)2S04 had been added and dissolved, 
the sample was left for 15 minutes and then recentrifuged at 12,000 g 
for 10 minutes. The supernatant was discarded and the white sediment 
redissolved in a volume of STE-ATP solution equal to 1 vol. of the 
supernatant. The solution was left for IS minutes and centrifuged 
for 4 minutes in an Eppendorf Microcentrifuge 3200 to remove a small 
amount of insoluble material. This supernatant contains the 
Fl ATPase, which can be stored at 20 C as the (NH4)2S04 precipitate. 
Oxidative phosphorylation: Oxidative phosphorylation was 
assayed in a glucose-hexokinase trap system. Assays contain 1.0-2.0 mg 
enzyme in 1.0 m1 of 0.25 M sucrose; 20 rnM glucose; 20 mM Tris-CI, pil 7.4; 
2 mM MgC1 2; 0.5 roM EDTA; 5.0 mM K2HP04; 2 mM ADP and 5 units of 
hexokinase (usually either Sigma type F-300 or C-300. Enzymes were 
pre incubated with any inhibitors, e.g. rotenone, antimycin A, 
oligomycin, uncouplers, etc., for 5 minutes prior to initiation of 
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assay in a wide-based phosphorylation tube in a shaking, heated 
o 
water bath at 30 C. Assays were usually run for 20-30 minutes 
prior to termination. Assays were usually terminated by taking 
0.5 ml aliquots into 0.2 ml 10% trichloroacetic acid (TCA) or 
0.2 ml 1 M perchloric acid (PCAl Coagulated protein was removed 
by centrifugation in a bench centrifuge. Oxidative phosphorylation 
was measured either as the disappearance of phosphate from the 
medium or as the appearance of glucose-6-phosphate. 
Estimation of glucose-6-phosphate: ATP can act as a 
phsophate donor to glucose in the presence of the enzyme hexokinase 
producing ADP and glucose-6-phosphate: 
ATP + D-glucose -pexokinase~ D-glucose-6-phosphate + ADP 
This reaction is used as the basis for the assay of ATP produced by 
oxidative phosphorylation. ATP is used by a glucose-hexokinase 
trap system to produce glucose-6-phosphate; the ADP released by 
this reaction can be rephosphlJrylated by the ATP synthase system 
to produce ATP. This allows the ADP concentration of the assay to 
be kept low as ADP can recycle until the free phosphate concentration 
of .the assay becomes limiting. 
After oxidative phosphorylation was terminated by taking 
0.5 ml aliquot from the glucose-hexokinase trap system in 0.2 ml 1 M 
P.C.A., coagulated protein was removed by centrifugation. 0.5 ml 
aliquots from the supernatant of this step was taken into a tube 
containing enough 6 M KOH to neutralise it (75 ~l). The tubes were 
o kept at 0 C for 20 minutes to ensure complete precipitation of 
KCl04 which was then removed by centrifugation. A 0.1 ml supernatant 
aliquot was taken into 1.9 ml 0.5 M Tris-CI, pH 7.5, containing 
0.5 ~moles NADP+ and 2-3 units glucose-6-phosphate dehydrogenase 
which converts glucose-6-phosphate to glucono-5-1actone-6-phosphate 
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with the concomitant reduction of NADP+ to NADPH. NADPH was 
estimated from its absorption at 340 nm: 
2 NADPH EmM • 6.22 cm /~mole 
Estimation of inorganic phosphate: Phosphate was 
determined by the method of Fiske and SubbaRow (156). This method 
is based on the formation of a phsophate molybdate complex which can 
be assayed spectrophotometrically. Phosphate will, in acid conditions, 
form a phosphomolybdous complex with ammonium molybdate. This can be 
reduced by an appropriate reducing agent (l-amino-2-naphthol-4-sulphonic 
acid) to form a phosphomolybdic complex which has a characteristic blue 
colour that can be assayed spectrophotometrically. 
Assay Procedure: Inorganic phosphate (10-500 nmoles) in 
0.5 ml water is added to an assay tube containing 1.5 ml water and 
0.3 ml 2.5% ammonium molybdate in 5 N HZS04• The contents are mixed 
on a vortex mixer and 0.2 ml of a 0.2% l-amino-2-naphthol-4-sulphonic 
acid; 12% NaHS03; 2.4% Na2S03 .7H20 solution (ANSA reagent) is added. 
The tube is vortex mixed and allowed to stand for 20 minutes at 
room temperature after which time the optical density at 691 nm is read 
against a blank containing water, molybdate reagent and ANSA reagent. 
The A691 values obtained can be used to construct a standard curve 
for phosphate. Free phosphate concentration in assays, e.g. ATPase 
assays can be obtained by taking aliquots through the procedure 
above and comparing the A691 values to the standard curve. 
ATPase assay: ATPase activity was determined by assaying 
phosphate released by the hydrolysis of ATP. Assays containing 
100-200 ~g mitochondrial protein or 10-20 ~g purified ATPase protein 
were incubated in 1 ml 50 mM Tris-CI, pH 8.5; 5 mM MgCI2; I mM EDTA 
(assays were carried out at pH 8.5 unless specified otherwise) for 
5 minutes with effectors and inhibitors, if any were present in 
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the assay at 300 C prior to initiation of the assay with 5 ~moles 
ATP. Assays were terminated after 5-15 minutes by addition of 
0.5 ml 10% TCA. Coagulated protein was removed by centrifugation in 
a bench centrifuge, and a 0.5 ml aliquot of the supernatant was taken 
into an assay to determine inorganic phosphate (Pi). 
Protein determination: Mitochondrial protein was 
estimated by the biuret method of Cornall et al. (]54). Purified 
enzyme protein was estimated by the Folin-Lowry method described by 
Lowry et al. (155). 
Energy linked transhydrogenase assay: Assays of ATP 
and succinate driven trans hydrogenase were as described by Beechey 
et al. (157). ].0-1.2 mg submitochondrial particles were incubated 
in 3.0 ml 50 mM Tris-CI, pH 8.0 buffer containing 5.0 mM MgC12 , 
. + + 
0.25 M sucrose; 66 ~M NAD , 330 ~M NAD£ , ]0 mM ethanol, 300 ~g 
of yeast ethanol dehydrogenase and I ~M KCN for 3 minutes at 300 C 
with or without inhibitor. ATP, 5 ~mol or succinate, 50 ~mol was 
then added to initiate the reaction. Reduction of NADP+ to NADPH 
was followed at 340 nm in a Unicam S.P. ]800 spectrophotometer. 
1 ~g rotenone and 1 ~g antimycin A were also added to the ATP driven 
reaction. 
Preparation of dihydrolipoate solutions: Unless otherwise 
stated, dihydrolipoic acid solutions were normally prepared as follows. 
Dihydrolipoic acid (obtained from Sigma Chemicals) was weighed out into 
a de-ionised glass or borosilicate vial: enough 0.25 M sucrose; 
10 mH Tris-CI, pH 7.5; I roM EDTA was added to give 0.4 M (or 0.2 M) 
solution. Tris base (I M) was then added until dissolution of 
dihydrolipoate was obtained; the final concentration of the solution 
was adjusted to 0.2 M (or 0.1 M) by addition of the requisite volume 
of 0.25 M sucrose; 10 roM Tris-CI, pH 7.5; 1 mM EDTA buffer. The 
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final pH of these solutions was usually 7.5-7.8. The concentration of 
dihydrolipoic acid was usually checked, using the method of Ellman 
(158) which assay the presence of thiols. Dihydrolipoic acid solutions 
are usually made up fresh (when required), they were never stored or 
kept for any length of time. Solutions of 2,3 dimercaptopropanol were 
usually made up in methanol. 
2.4 RESULTS 
The results presented on Figi. 2.2 and 2.3 show that most 
of the organotiminvestigated were potent inhibitors of the OS-ATPase 
activity of mitochondria and submitochondrial particles. A comparison 
of the 150 values of the different organotin compounds for the OS-ATPase 
of mitochondria and submitochondrial pa~ticles, show that the inhibitory 
potency of DBCT (150 ~ 1.0 ! 0.15 nmol/mg protein) was similar to that 
of the other tria1ky1 tin compounds, both in mitochondria and 
submitochondrial particles (Table 2.1). In contrast Ve2283 ~50 ~ 0.1 
nmol/mg protein) was found to be 10 times more potent than DBCT, 
while trimethy1 tin chloride was almost ineffective as an inhibitor. 
Dibutyl tin dichloride (DBT) was also found to be a good inhibitor of 
the OS-ATPase activity of mitochondria and submitochondrial particles. 
The latter finding is in agreement with that reported by Cain et ale 
(159) but disagrees with the proposal of Aldridge that dialky1 tins 
were effective inhibitors, only of the a-keto acid dehydrogenase of 
the TCA cycle (160, 161). 
The data presented in Table 2.2, shows that, like 
oligomycin DBCT, Ve2283 and the other trialkyl tin compounds were 
potent inhibitors of the OS-ATPase activity in mitochondria, 
submitochondrial particles and complex V [prepared by the method of 
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1 2 3 4 
Inhibitor (nmol/mg) 
Inhibition of OS-ATPase activity in beef 
heart mitochondria by trialkyl tins 
5 
Mitochondria suspended at 10 mg protein/ml in 0.25 M sucrose; 
6 
10 roM Tris-Cl, pH 7.5; 1 mM EDTA, was pre incubated with varying 
concentrations or trialkyl tins at 40 C for 30 minutes and the 
ATPase activity assayed as described in Methods. The specific 
activity of the starting mitochondria was 0.8 ~mole8 ATP hydrolysed/ 
min/mg. Experimental data have been expressed in the figure as a 
per cent inhibition of this original value. (0), Ve2283; (.) , 
tripropyl tin chloride; (0). DBeT; (0 >. tributyl tin chloride; 
{ A >. dibutyl tin dichloride. 
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Inhibitor (nmol/mg) ----------~~ 
Inhibition of OS-ATPase activity in beef heart 
submitochondrial particles by trialkyl tins 
Submitochondrial particles suspended at 10 mg protein/ml in 0.25 M 
sucrose; 10 roM Tris-Cl, pH 7.5; 1 mM EOTA, were preincubated 
with varying concentrations of trialkyl tins at 40 C for 30 minutes 
and the ATPase activity assayed as described in Methods. The 
specific activity of the starting submitochondrial particles was 
2.4 ~mole. ATP hydrolysed/min/mg. Experimental data have been 
expressed in the figure as a per cent inhibition of this original 
value. (O), Ve2283; (.), OBCT; (0), tributyl tin chloride; 
(0 ), tripropyl tin chloride; (Til), dibutyl t in dichloride. 
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Table 2.1 Trialkyl tin inhibition of OS-ATPase activity in 
mitochondria and submitochondrial particles 
Trialkyl tin 
Trimethyl tin chloride 
Triethyl tin chloride 
Tripropyl tin chloride 
Tributyl tin chloride 
Dibutylchloromethyl tin chloride (DBCT) 
Triphenyl tin chloride 
Tetraethyl tin 
Ve2283 
Dibutyl tin dichloride 
Mitochondria SMP 
ISO (nmo~es/ ISO (nmoles/ 
mg prote~n) mg protein) 
2.4 + 0.1 2.8 + 0.2 
-
O.S + 0.1 1.8 + 0.3 
- -
0.8 + 0.2 1.2 + 0.15 
- -
0.8 + 0.1 0.8 + 0.2 
- -
1.6 + 0.3 1.2 = 0.2 
-
0.10 1.2 + 0.05 
2.00 + 0.2 1.8 + 0.1 
ATPase activity was assayed as in Methods. Conditions of incubation 
with trialkyl tins were as described in the legends of Fig. 2.2 and 
Fig. 2.3. Each value presented is the mean + standard deviation 
(s.d.) of five duplicates. Specific ATPase ;ctivities were for 
mitochondria 0.85 ~mol/min/mgj SMP's, 2.4~mol/min/mg. 
Hatefi et ale (151)], but they did not affect the FJ ATPase 
activity. The ISO value was found to increase from 0.8 ! 0.1 nmol/mg 
protein in mitochondria to 4.8 ! 0.2 nmol/mg protein in complex V 
when DBCT was the inhibitor. This represents a 5-6 fold increase in 
the ISO value for DBCT. In general, a 3-6 fold increase in the ISO 
value was found for the other trialkyl tins investigated (Table 2.2). 
This 3-6 fold increase in the ISO values migh~ be due to an 
equivalent increase in the number of trialkyl tin binding sites/mg 
protein, caused by the 'effective' purification of the OS-ATPase 
complex. The finding that-the F} ATPase is insensitive to inhibition 
by trialkyl tins is in agreement with the effect of trialkyl tins on 
Table 2.2 
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Comparison of the ISO values of trialkyl tins 
of various ATPase preparations 
ISO values of ATPase preparations 
nmoles/mg protein Trialkyl tin 
Mitochondria SMP Complex V FI-ATPase 
Triethyl tin chloride 2.4 2.8 6.3 
Tributyl tin chloride 0.8 1.2 5.4 
Tripropyl tin chloride 0.5 1.8 5.8 
nBCT 0.8 0.8 4.8 
Ve22S3 0.1 0.2 0.6 
Triphenyl tin chloride 1.6 1.2 4.7 
Dibutyl tin dichloride 2.0 1.8 
All conditions of inhibition and assay of OS-ATPase activity were 
identical to those described in the legend of Table 2.1. Each 
value presented is the mean of four dupiicates. The specific ATPase 
activities of the starting mitochondria was 0.8 ~mol/min/mg; 
submitochondrial particles, 2.4 ~mol/min/mg; complex V, 14.8 ~mol/ 
min/mg; FI-ATPase, 38.6 ~mol/min/mg. 
FI-ATPase reported by Cain et al. (142) and others (139-143). The 
obvious interpretation of these results, is that ~he FO component 
of the OS-ATPase is necessary for the inhibition of the OS-ATPase 
activity by trialkyl tins; that is, trialkyl tins are specific 
OS-ATPase inhibitors. 
Cain et al. (142, 159) found that triethyl tin chloride 
and dibutyl tin dichloride (DBT) like oligomycin, inhibited ADP 
stimulated respiration in beef heart mitochondria utilizing 
pyruvate/malate or succinate as substrate, but did not affect 
uncoupler stimulated respiration. These results suggest a direct 
action of the trialkyl tins on the ATP-synthase complex. This 
suggestion was examined by studying the effect of DBCT, Ve2283 and 
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other trialkyl tins on ATP synthesis in beef heart mitochondria and 
submitochondrial particles. Fig. 2.4 and Fig. 2.5 respectively 
show that succinate driven ATP synthesis in mitochondria and 
submitochondrial particles is inhibited by all the trialky1 tins 
examined. From the results presented in Table 2.3 (and on Fig. 2.4 
and Fig. 2.5), it can be seen that Ve22S3 with an ISO value of 
1.0 ! 0.1 nmol/mg protein and causing maximal inhibition of oxidative 
phosphorylation at 2.0 ! 0.12 nmol/mg protein, is the most potent of 
the organotin compounds so far examined. DBCT with an !50 value 
of 5-7 nmol/mg protein and causing maximal inhibition at 15-20 nmo1/mg 
protein, is similar in potency to most of the other trialkyl tins 
examined (Table 2.3). The data presented in Table 2.3 also shows 
that the ISO values of the trialkyl tin compounds are not significantly 
different for oxidative phosphorylation~in mitochondria 
and submitochondrial particles. These results are in agreement with 
the findings of Cain et ale (142, 159), but contradicts with the 
findings of Aldridge (161), that 30 times the amount of trialky1 tin was 
needed to inhibit oxidative phosphorylation in mitochondria than was 
needed to inhibit oxidative phosphorylation~ in submitochondrial 
particles. 
Pre1iminaty data, presented in Tables 2.2 and 2.3 and 
by Cain et ale (142, 159) and Aldridge (161), indicating differential 
sensitivity of the OS-ATPase activity and oxidative phosphorylation 
in mitochondria and submitochondrial particles to inhibition by 
trialkyl tins,was investigated more thoroughly using DBCT and 
tributyl tin chloride. The results presented on Figs. 2.6 and 2.7 
show that the OS-ATPase activity in both mitochondria and submitochondrial 
particles was 85-90% inhibited at low concentration of DBCT (2-3 nmol/mg 
protein) which did not significantly affect oxidative phosphorylation 
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5 10 15 20 
Organotin (nmol/mg protein) 
Inhibition of succinate driven ATP synthesis in 
beef heart mitochondria by trialkyl tins 
Mitochondria suspended at 10 mg protein/ml in 0.25 M sucrose; 
10 mM tris-CI. pH 7.5; I roM EDTA; buffer. were preincubated 
with varying concentrations of trialkyl tins at 40 C for 30 minutes. 
Aliquot. (I mg = 100 ~l) were then removed and assayed for 
succinate driven ATP synthetic activity as described in Methods. 
The specific AtP synthetic activity of the starting mitochondria was 
130 nmol AtP synthesised/min/mg protein. Experimental data 
have been expressed in the figure as a per cent inhibition of 
this original value. Each data point is the average of duplicates. ( A). Ve228); (6). DBCT. (0). triphenyl tin chloride; 
(Ill >. tributyl tin chloride. 
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4 8 12 16 20 
Inhibitor (nmol/mg) ---------+. 
Inhibition of succinate driven ATP synthesis in 
beef heart submitochondrial particles 
24 
Submitochondrial particles (SMP) suspended at 10 mg protein/ml in 
0.25 M sucrose; 10 mM Tris-CI, pH 7.5, 1 mM EDTA, were pre incubated 
with varying concentrations of trialkyl tin compounds at 40 C for 
30 minutes and ATP synthetic activity assayed as described in 
Methods. The specific ATP synthetic activity of the starting 
SMP's was 90 nmol of ATP synthesised/min/mg. Experimental data 
have been expressed in the figure a. a percent inhibition of this 
original value. (0). Ve228)_ (0). DBCT; (.). tributyl tin 
chloride. Each data point i. the average of 4 duplicates. 
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Table 2.3 Inhibition of succinate driven ATPSynthesis in 
mitochondria and submitochondrial particles by 
trialkyl tins 
Mitochondria Submitochondrial particles 
Trialkyl tin ISO (nmoles/mg ISO (nmoles/mg protein) 
protein) 
Triethyl tin chloride 9.8 10.6 
Tripropyl tin chloride 7.6 8.6 
Tributyl tin chloride 7.8 10.0 
DBCT 5.6 6.6 
Ve2283 1.2 1.0 
Triphenyl tin chloride 5.8 6.6 
All conditions of inhibition and assay of ATP synthetic activity were 
identical to those described in the legends of Fig. 2.4 and Fig. 2.5. 
Each value presented is the average of four duplicates. The specific 
ATP synthetic activity of mitochondria is 130 nmol ATP synthesised/ 
min/mg and of submitochondrial particles is 90 nmol ATP synthesised/ 
min/mg. 
in submitochondrial particles, but cause 20-30% inhibition in 
mitochondria. Similar results were obtained with tributyl tin 
chloride (Figs. 2.6, 2.7). The ATPase and oxidative phosphorylative 
activities were assayed under (close to) identical conditions, except 
that hexokinase, ADP,and inorganic phosphat~were omitted from 
the ATPase assay buffer. which contained 0.25 M sucrose; 5 mM 
MgCI2; 20 mM Tris-CI, pH 7.5; 20 mM succinate; 0.5 mM EDTA and 
20 mH glucose. The residual 60-80% ATP synthetic activity of 
mitochondria and submitochondrial particles was sensitive to 
oligomycin, Ve2283 and the uncoupler 2,4-dinitrophenol (Table 2.4). 
These results indicate that the mode of inhibition of oxidative 
phosphorylation and ATP hydrolysis by DBCT (or tributyl tin chloride) 
might be different, or that the catalytic or inhibitor binding sites 
o 
Fig. 2.6 
-50-
1 2 3 4 5 6 7 8 9 10 11 
DBCT (nmol/mg) 
Inhibition of succinate driven ATP synthesis and ATP 
h drol sis in beef heart mitochondria b OBeT and 
tributyl tin chloride (TBT • 
12 
Mitochondria was preincubated with varying concentrations of DBCT or 
TBT, under the conditions described in Table 2.4. ATP synthesis 
and hydrolysis were assayed as in Table 2.4. The specific activiti 
of the starting mitochondria were: ATPase, 0.5 ~mol ATP hydrolysed/ 
min/mg; ATP synthesis, 120 nmol ATP synthesised/min/mg. Experi~ 
mental data were ejpressed in the figure as a per cent of these 
original values <\f), DBeT (f.1>. TBT inhibition of ATP 
bydrolysis; (0), DBeT, (h);-1BT inhibition of ATP synthesis. 
Each point i. the average o~he 4 duplicates. 
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Fig. 2.1 Inhibition of succinate driven ATP 
IS) 
All conditions of inhibition and assay of ATP synthetic and ATP 
hydrolytic activities were as described in Fig. 2.6. The specific 
activities of the starting SMP'. were: ATPase, 1.4 ~mo1 ATP 
hydrolysed/min/mg; ATP synthesis, 100 nmol ATP synthesised/min/mg. 
Experimental data have been expressed in the figure as a2er.cent 
of these original value.. <.), DBCT, (a ) TBT inhibition of 
ATP hydrolysi.; <<», DBCT, ([) ), TBT inhibition of ATP synthesis. 
Data point. are the average of 4 duplicates. 
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involved in ATP synthesis and ATP hydrolysis are different. 
Table 2.4 Differential sensitivity of the ATP synthetic and 
ATP hydrolysing activities in mitochondria and 
submitochondrial particles toDBCT 
Additions 
Mitochondria 
Mitochondria + DBCT (3.3 nmol/mg) 
Mitochondria + DBCT + DNP (2 ~g) 
Mitochondria + DBCT + Ve2283 (4 nmol) 
Mitochondria + DBCT + Oligomycin (2 ~g) 
SMP + DBCT (3.3 nmol/mg) 
SMP + DBCT + DNP (2 ~g) 
SMP + DBCT + Ve2283 (4 nmol) 
SMP + DBCT + Oligomycin (2 ~g) 
ATPase ATP synthesis 
~mol/min/mg nmol/min/mg 
0.5 120.0 
0.0 75.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
].40 100.0 
0.10 95.0 
0.]0 0.0 
0.0 0.0 
0.0 0.0 
0.0 
Mitochondria and submitochondrial particles suspended at ]0 mg proteinl 
ml in 0.25 M sucrose; ]0 mM Tris-CI, pH 7.5; 1 roM EDTA, were 
preincubated at 3.3 nmol/mg protein with DBCT at 40 C for 30 min. 
The ATPase activity was assayed as in }tethods, in a 20 mM Tris-CI 
buffer pH 7.5 containing: 20 roM succinate; 0.5 roM EDTA, 0.25 M 
sucrose 5 mM MgCl2 and 20 mM glucose. Succinate driven ATP synthesis 
was assayed as described in Methods. Oligomycin, 2 ~g; 2,4-dinitro-
phenol (DNP) 2 ~g and Ve 2 8 ' 3 nmoles were added as methanolic 
solutions. Experimental aaia have been expressed in the Table as 
specific activities of the system assayed. The data presented are 
the mean of four duplicates. 
To gain more insight into the mode(s) of action of trialkyl 
tin compounds, the effect of DBCT, Ve2283 and other trialkyl tins on 
energy-linked NADH/NADP transhydrogenase was investigated. The results 
presented on Fig. 2.8 show that DBCT, Ve2283 and the other trialkyl tins 
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1 2 3 4 5 6 7 8 9 10 11 12 
Inhibitor (nmol/mg) 
Inhibition of ATP-driven transhydrogenase in beef 
heart submitochondrial particles by trialkyl tin . 
compounds 
The condition of inhibition with trialkyl tins were identical to 
those described in the legend of Table 2.5. ATP driven transhy-
drogenase was assayed as described in Methods. The specific 
transhydrogenase activity of the starting submitochondrial particles 
was 38.0 ! 3.6 nmol NADPH formed/min/mg. Experimental data have 
been expressed in the figure as a percent inhibition of this 
original value. Data points are the average of duplicates. 
(~ >. Ve228J; (. >. triphenyl tin chloride: (0 >, DBCTj ( • >, dibutyl tin dichloride. 
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1 2 3 4 5 6 7 8 9 10 
Inhibitor (nmol/mg) 
The effect of trialkyl tin compounds on succinate 
driven transhrdrogenase activity in beef heart 
submitochondrial particles 
11 12 
The condition of inhibition with trialkyl tins were identical to 
those described in the legend of Table 2.5. The specific 
transhydrogenase activity of the starting submitochondrial 
particle. was 60 ! 5.0 nmol of NADPH formed/min/mg. Experimental 
data have been expressed in the figure as a e~cent of this 
original value. Each data point is the mean of duplicates. 
Transhydrogenase activity was measured as described in Methods. 
(.0 >, Ve2283; (D >, oligomycin; <0 >, DBCT; <.), triphenyl 
tin chloride; (y >, dibutyl tin chloride. 
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were potent inhibitors of ATP driven transhydrogenation. The ISO values 
of these compounds, presented in Table 2.5, show that the sensitivity of 
the ATP-driven reaction is similar to that obtained for the OS-ATPase 
activity in submitochondrial particles (Table 2.1). Similar ISO 
values have been reported by Cain (142) for the ATP driven succinate 
reduction of NAD+ by submitochondrial particles (e.g. 0.9 nmol 
DBCT/mg protein), suggesting that the OS-ATPase plays an important 
role in these ATP-dependent reactions. In the case of succinate driven 
transhydrogenation (Fig. 2.9), all the organotins except dibutyl tin 
dichloride, were found to stimulate the succinate driven transhydro-
genase reaction at low concentrations (1-4 nmol/mg protein). However, 
unlike oligomycin, higher concentrations (10-15 nmol/mg protein) of 
trialkyl tins were found to inhibit succinate driven transhydrogenation. 
The results of the energy-linked reactions, indicate that 
the trialkyl tins studied have two possible modes of action: 
2.5 
I. an oligomycin like action responsible for the inhibition 
of OS-ATPase and ATP-driven energy linked reactions; 
2. and an uncoupling action (cf. CCCP) responsible 
for the inhibition of succinate driven (respiratory 
dependent) transhydrogenation and oxidative phosphorylation. 
REVERSAL OF ORGANOTIN INHIBITION WITH DITHIOLS 
Cain et al. have shown that the normally irreversible 
inhibition of the OS-ATPase activity of beef heart mitochondria by 
DBCT and dibutyl tin dichloride, could be reversed by dihydrolipoic 
acid (IS9). Consequently, we have investigated the effect of a 
number of monothiols and dithiols on the inhibition of OS-ATPase, 
oxidative phosphorylation and ATP-driven transhydrogenation by a 
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Table 2.5 Trialkyl tin inhibition of ATP-driven transhydrogenase 
activity in submitochondrial particles 
Trialkyl tin 
Triethyl tin chloride 
Tripropyl tin chloride 
Tributyl tin chloride 
DBCT 
Dibutyl tin dichloride 
Triphenyl tin chloride 
ISO values 
nmal/mg protein 
2.6 
1.8 
1.4 
1.2 
3.2 
0.8 
0.2 
ATP driven transhydrogenase activity was assayed as described in 
Methods. Submitochondrial particles suspended at 10 mg protein/ml 
in 0.25 M sucrose; 10 mM Tri-Cl, pH 7.5; . 1 wi EDTA; were 
pre incubated with varying concentration~ or organotin compounds 
at 40 C for 30 min. 100 ~l aliquots were removed and assayed for 
ATP-driven transhydrogenase activity. The specific activity of 
the starting submitochondrial particles was 38.0 nmol NADPH formed/ 
min/mg. The values presented are the mean of four duplicates. 
number of trialkyl tin compounds. 
The inhibition of succinate driven oxidative phosphory-
lation by most of the trialkyl tin compounds examined, except 
Ve2283 , was found to be completely reversible by 2,3-dimercaptopropanol. 
In the case of DBCT inhibition of oxidative phosphorylation in 
mitochondria (Fig. 2.10) and submitochondrial particles (Fig. 2.11) 
60 nmol/mg and 20 nmol/mg protein of 2,3-dirnercaptopropanol 
respectively were found to give complete reversal. Dithiothreitol 
(DTT) and dihydrolipoic acid were found to be totally ineffective 
as reversal agents at such low concentrations (Table 2.6); 100 nmol/mg 
protein dithiothreitol or dihydrolipoic acid giving less than 10% 
reversal. However, dihydrolipoic acid and dithiothreitol were found 
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20 40 60 80 100 120 140 160 180 200 220 24 
Dithio1s (nmol/mg) 
Dithiol reversal of DBCT inhibition of succinate 
driven ATP-synthesis in beef heart mitochondria 
Mitochondria suspended at 10 mg/ml were pre incubated with DBCT 
(15 nmo1/mg), treated with dithiols and the ATP synthetic activity 
assayed as described in Fig. 2.12. Specific ATP synthetic activity 
of starting mitochondria was 140 nmol ATP aynthesised/min/mg. 
Data expressed in figure as a pe~ cent of- this original value. 
Data points are the average of 4 duplicates. <<». 2.3-dimer-
captopropanol; (~), dihydro1ipoic acid; <0 },dithiothreitol. 
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20 40 60 80 100 
Dithiol (nmol/mg protein) 
Dithiol reversal of DBCT inhibition of succinate 
driven ATP synthesis in beef heart submitochondrial 
particles (SMP's) 
120 
DBCT-treabD submitochondrial particles (20 nmo1es DBCT/mg) suspended 
at 10 mg/ml were treated with dithio1 as described in Fig. 2.IG, 
and assayed for oxidative phosphorylation activity as described 
in Methods~ Specific ATP synthesising activity of the starting 
SMP'. was 94 nmol ATP synthesised/min/mg. Experimental data 
have been expressed in the figure as a percent of· this original 
value. (4'), 2,3-dimercaptopropanol; (.), dihydrolipoic acid; 
(0), dithiothreitol. Each data point is the average of 4 
duplicate •• 
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Table 2.6 Dithiol reversal of DBCTand DBT inhibition of 
'oxidative phosphorylation in mitochondria 
Additions 
None 
DBCT (15 nmol/mg) 
DBCT + 2,J-dimercaptopropanol 
(50 runol/mg) 
DBCT + dihydrolipoic acid (50 runol/mg) 
DBCT + dithiothreitol (50 runol/mg) 
DBCT + mercaptoethanol (50 nmol/mg) 
DBCT + Glutathione (50 nmol/mg) 
DBT (30 runol/mg) 
DBT + 2,3-dimercaptopropanol 
(50 nmol/mg) 
DBT + dihydrolipoic acid (50 runol/mg) 
DBT + dithiothreitol (50 runol/mg) 
DBT + mercaptoethanol (50 nmol/mg) 
DBT + glutathione (50 nmol/mg) 
ATP Synthesised 
runol/min/mg 
140 
23 
135 
25 
20 
20 
20 
25 
140 
135 
130 
30 
30.0 
% Activity 
100.0 
16.4 
96.5 
17.9 
14.3 
14.3 
14.3 
17.9 
100 
96.5 
92.9 
21.4 
21.4 
Mitochondria suspended at 10 mg/ml in 0.25 M sucrose; 10 mM Tris-CI, 
pH 7.5; 1 mM EDTA, were preincubated with 15 nmol DBCJ1mg protein 
or 30 runol DBT/mg protein at 40 C for 30 min. 100 pI (1 mg protein) 
aliquots were then placed in 1 ml phosphorylation buffer in a 
reaction tube (containing 2 Pg rotenone); 50 runol of the thiol or 
dithiol was added to each tube and preincubated for 5 minutes at 
300 C. Succinate driven oxidative phosphorylation was assayed as 
described in methods. Each value presented 'is the average of 
four duplicates. 
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to be much more effective at higher concentrations; 500 nmol/mg giving 
48% and 28% reversal respectively. Triphenyl tin chloride and dibutyl 
tin dichloride inhibition of oxidative phosphorylation in mitochondria 
and submitochondrial particles were totally reversed by dithiothreitol, 
dihydrolipoic acid and 2,3-dimercaptopropanol at 50-100 nmol/mg. 
However, tributyl tin inhibition of oxidative phosphorylation could 
only be reversed 50% by 20 nmol 2,3-dimercaptopropanol/mg protein, 
and was not significantly reversed by dihydrolipoic acid or 
dithiothreitol. 
No significant reversal of trialkyl tin inhibition of 
OS-ATPase activity in mitochondria or submitochondrial particles was 
obtained with the dithiols at the relatively low concentrations that 
(20-60 nmol/mg) caused reversal of oxidative phosphorylation (Fig. 2.10, 
Fig. 2.11). However,oat higher concent~tion, 2,3-dimercaptopropanol 
(1 ~mol/mg protein) was found to reverse inhibition by nBCT (Fig. 2.12), 
triphenyl tin chloride tributyl tin chlorid~ and dibutyl tin dichloride 
(Table 2.7) 80-100%. In all cases of organotin inhibition (except 
inhibition by dibutyl tin dichloride) of OS-ATPase, activity was found 
to be irreversible by dithiothreitol or dihydrolipoic acid 
(Table 2.7). 
The inhibition of the ATP-driven NADH/NADP transhydrogenase 
activity of beef heart submitochondrial particles by most of theorganotin 
compounds studied, was found to be reversible by dithiols. In the 
cases of nBCT (Fig. 2.13), dibutyl tin dichloride (Fig. 2.14) and 
triphenyl tin (Fig. 2.15) inhibition of the ATP-driven transhydrogenase 
activity, complete reversal was obtained with 300 nmol/mg, 100 nmol/mg 
and 500 nmol/mg protein of 2,3-dimercaptopropanol respectively. In 
most cases dithiothreitol and dihydrolipoic acid were found to be 
ineffective as reversal agenmat 500 nmol/mg protein (Table 2.8). 
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Fig. 2.12 Oithiol reversal or OBCT inhibited OS-ATPase activity 
in beef heart submitochondrial particles 
Submitochondrial particles suspend at 10 mg protein/ml, in 0.25 M 
sucrose, 10 mM Tris-CI. I mM EOTA buffer wwere preincubated with 
OBCT (4 nmol/mg) at 40 C for 30 minutes. The OBCT treated 
particles were then incubated at various concentrations of 
dithiols at 4° C for 30 minutes. The ATPase activity was assayed 
as described in Methods. The specific ATPase activity of the 
starting submitochondrial particles was 2.1 ~mol ATP hydrolysed/ 
min/mg. Experimental data were expressed in the figure as a 
~r cent of this original value. (0), dithiothreitol; (.), 
dihydrolipoic acid; (~), 2,3-dimercaptopropanol. Each point 
i. the average of 4 duplicates. 
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2.7 Dithiol reversal of DBCT and DBT inhibition of 'OS-ATPase 
activity in mitochondria and submitochondrial particles 
% OS-ATPase activity in: 
Additions 
Mitochondria .SMP 
DBCT (5 nmol/mg) 
DBCT + 2,3-dimercaptopropanol (I ~mol/mg) 
DBeT + dihydrolipoic acid (I ~mol/mg) 
DBCT + dithiothreitol (1 ~mol/mg) 
DBT (6.6 nmol/mg) 
0.0 18.0 
100.0 80.0 
0.0 32.0 
0.0 18.0 
0.0 
DBT + 2, 3-dimercaptopropanol (I ~mol/mg) 100.0 100.0 
DB + dihydrolipoic acid (1 ~mol/mg) 100.0 100.0 
DBT + dithiothreitol (I ~mol/mg) 
Ve2283 (2 nmol/mg) + 2,3-dimercaptopropanol (1 ~mol/mg) 
Oligomycin (5 nmol/mg) + 2,3-dimercapto-
propanol (1 ~mol/mg) 
10.0 
0.0 
0.0 
Mitochondria and submitochondrial particles suspended at 10 mg/ml 
were pre incubated with DBCT (5 nmol/mg); DBT, (6.6 nmol/mg); 
Ve2283 (2 nmol/mg) or oligomycin 5.0 nmol/mg as described in 
Table 2.7. The particles were then incubated with dithiols at 
1 ~mol/mg for 30 minutes at 40 C, and the ATPase activity assayed 
as in methods. The specific ATPase activities of controls were: 
20.0 
on 
0.0 
in mitochondria 0.85 ~mol ATP hydrolysed/min/mg; in SMP 2.6 ~mol ATP 
hydrolysed/min/mg. Experimental data have been expressed in the 
Table as a per cent of these original values. Each value is the 
mean of 4 duplicates. 
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100 200 300 400 500 
Dithiol (nmol/mg)------------~ 
Dithiol reversal of DBCT inhibition of ATP-driven 
transhydrogenase activity in submitochondrial 
particles 
60 
Submitochondrial particles were pre incubated with DBCT (10 nmol/mg) 
treated with dithiols and ATP-driven transhydrogenase activity 
assayed as described in Fig. 2.14. Specific activity of starting 
SMP's was 38.0 nmol NADPH formed/min/mg. Experimental data have 
been presented in the figure as a per cent of this original value. 
«()}, 2.3-dimercaptopropanol; (. >. dihydrolipoic acid; 
( 0), dithiothreitol. Data points are average of duplicates. 
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50 100 150 200 250 
Dithiol (nmol/mg) 
Dithiols reversal of dibutyl tin dichloride (DBT) 
inhibited ATP-driven transhydrogenase activity in 
beef heart submitochondrial particles 
300 
Submitochondrial particles suspended at 10 mg protein/ml was pre-
incubated with DBT (10 nmol DBT/mg) and then treated with dithiols 
as described in Fig. 2.11. The ATP-driven transhydrogenase activity 
was assayed as in Methods. Specific transhydrogenase activity of 
starting SMP's was 38.0 nmol NADPH formed/min/mg. Experimental 
data have been presented in the figure as apercent of this 
original value. Each data point is the average of duplicate. (. >, 2,3-dimercaptopropanol; (~), dihydrolipoic acid; 
( 0 >,dithiothreitol. 
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100 200 300 400 500 600 
Dithiol (nmol/mg) 
Dithiols reversal of triphenyl tin (TPT) inhibition 
of ATP-driven transhydrogenase in beef heart submito-
chondrial particles 
Submitochondrial particles were pre incubated with TPT (8.0 nmol/mg) 
then treated with dithiols as described in Fig. 2.11. Transhydro-
genase activity assayed as in Methods. Specific transhydrogenase 
activity of starting SMP's was 38.0 nmol NADPH formed/min/mg. 
Experimental data have been presented in the figure as a per 
cent of this original value. <<», 2,3-dimercaptopropanol; 
(~ >. dihydrolipoic acid; «) >. dithiothreitol. Data points 
are average of duplicates. 
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Table 2.B Dithiol reversal of DBCTand DBT"inhibition of 
ATP-driven transhydrogenase "in submitochondrial 
particles (SMP's) 
Additions 
None 
DBCT (10 nmol/mg) 
DBCT + 2,3-dimercaptopropanol (500 nmol/mg) 
DBCT + dihydrolipoic acid (500 nmol/mg) 
DBCT + dithiothreitol (500 nmol/mg) 
DBT (10 nmol/mg) 
DBT + 2,3-dimercaptopropanol (500 nmol/mg) 
DBT + dihydrolipoic acid (500 nIDol/mg) 
\ 
DBT + dithiothreitol (500 nmol/mg) 
Ve2283 + 2,3-dimercaptopropanol (500 nmol/mg) 
Oligomycin + 2,3-dimercaptopropanol (500 nIDol/mg) 
% ATP-driven 
Transhydrogenase 
activity 
100.0 
0.0 
100.0 
IB.O 
10.0 
0.0 
100.0 
100.0 
20.0 
0.0 
0.0 
Submitochondrial particles suspended at 10 mg/ml in 0.25 M sucrose; 
10 mM Tris-CI, pH 7.5; 1 mM EDTA, were preincubated with DBCT; 
DBT, Ve2~B3 and oligomycin 10, 10, 2 and 5 nmol/mg respectively 
for 30 m~nutes at 40 C. The particles were then incubated with 
dithiols at 500 nmol/mg at 40 C for 30 minutes and the ATP driven 
transhydrogenase activity assayed as described in methods. 
The specific ATP-driven transhydrogenase activity of the original 
SMP's was 42.5 nmol NADPH formed/min/mg. Experimental data have 
been expressed as a per cent of this original value. Each value 
presented is the mean of 3 duplicates. 
Table 2.9 Sensitivity of dithiol reversedDBCT, and DBT inhibition of succinate driven ATP synthesis 
and ATP-dependent reactions in SMP's to inhibitors and uncouplers of oxidative phosphorylation 
Additions 
% ATP % OS-ATPase % ATP-driven 
Synthesis. activity Transhydrogenase 
None 100.0 100.0 100.0 
DBer (15 nmol/mg) 15.0 0.0 0.0 
DBer + BAL (400 nmol/mg) 100.0 60.0 100.0 
DBer + BAL + TTFB (2 ~g/mg) 0.0 65.0 0.0 
DBCT + BAL + Ve2283 (2 nmol/mg) 0.0 0.0 0.0 
DBer + BAL + oligomycin (5 nmol/mg) 0.0 0.0 0.0 
DBT (30 nmol/mg) 18.0 0.0 0.0 
DBT + BAL (400 nmol/mg) 100.0 100.0 100.0 
DBT + BAL + TTFB (2 ~g/mg) 0.0 100.0 0.0 
DBT + BAL + Ve2283 (2 nmol/mg) 0.0 0.0 0.0 
DBT + BAL + oligomycin (5 nmol/mg) 0.0 0.0 0.0 
Submitochondrial particles (SMP's) suspended at 10 mg/ml were preincubated with nBCT (15 nmol/mg) or DBT (30 nmol/mg) 
under the conditions described in Table 2.7. The particles were then incubated with 2,3-dimercaptopropanol (BAL) 
at 400 nmol/mg for 30 minutes at 40 C. Aliquots were then removed and assayed for OS-ATPase, ATP-driven transhydro-
genase and succinate drivenoxidative phosphorylation as described in Methods. The specific activities of the 
starting SMP's were: OS-ATPase, 2.4 ~mol ATP hydrolysed/min/mg; transhydrogenase 42.5 nmol NADPH formed/min/mg; 
succinate driven oxidative phosphorylation, 80 nmol ATP synthesised/min/mg. Experimental data have been expressed 
as a per cent of these original values. Each value presented is the average of duplicates. TTFB, Ve2283 and 
~ligomycin were added as methanolic solutions in the amount indicated directly to the assay system. 
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However, dihydrolipoic acid was found to be an effective reversal 
agentofdibutyltin dichloride inhibition of the transhydrogenase 
activity. With dibutyl tin dichloride inhibition, dihydrolipoic 
acid was found to be as effective a reversal agent as 2,3-dimercapto-
propanol (Fig. 2.14); dihydrolipoic acid at 100 nmol/mg protein, 
giving 90-100% reversal of dibutyl tin dichloride inhibited ATP-driven 
transhydrogenase. As in the cases of oxidative phosphorylation 
and OS-ATPase, inhibition of ATP driven transhydrogenase by Ve2283 
was irreversible by dithiols. 
The oxidised form of lipoic acid, and monothiols such as 
glutathione, cysteine and 2-mercaptoethanol were found to be totally 
ineffective in reversing trialkyl tin inhibition of OS-ATPase 
oxidative phosphorylation or ATP-driven transhydrogenase activity. 
The results presented in TaQle 2.9, show that the dithiol 
reversed trialkyl tin inhibition of oxidative phosphorylation and 
ATP-driven transhydrogenase were inhibited by oligomycin, Ve2283 
and the uncoupler TTFB, but not by the addition of more (= 10 nmol/mg) 
DBCT or DBT when the dithiol was present in excess. The reversed 
OS-ATPase activity was similarly inhibited by oligomycin and Ve2283 • 
Prior treatment of submitochondrial particles with 2,3-dimercapto-
propanol (500 nmol/mg) was found to 'provide protection against 
inhibition of oxidative phosphorylation, ATP-driven transhydrogenase 
and OS-ATPase activity by DBCT and DBT, but not inhibition by 
oligomycin or Ve2283 • 
2.6 DISCUSSION 
The results presented in this Chapter have shown that 
DBCT, Ve22a3 and most of the trialkyl tin compounds studied, were 
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potent inhibitors of mitochondrial energy-transfer reactions. However, 
unlike oligomycin and DCCD inhibition of the energy-transfer reactions, 
inhibition by most tria1ky1 tins examined was reversible by dithio1 
(Tables 2.6-2.9). The mechanism(s) by which the trialkyl tins inhibits 
these processes is (are) not known, but the experimental findings 
seem to suggest that the modes of inhibition of respiratory dependent 
and the ATP-dependent reactions were different. The results obtained 
indicate, that while an oligomycin-like activity is responsible for the 
inhibition of OS-ATPase and ATP-driven transhydrogenase, an uncoupling 
mode of action is responsible for the inhibition of oxidative phosphory-
lation and succinate-driven transhydrogenation (see Fig. 2.1). 
Aldridge and Street (140, 162, 163) have proposed that 
inhibition of the OS-ATPase was brought about by penta-coordinate 
binding of the trialkyl tin compounds a~ the inhibitor binding sites. 
The penta-coordinate binding proposal, provides explanations for the 
relative ineffectiveness of tetrabuty1 tin and the potency of dibutyl 
tin dichloride (DBT) as inhibitors of the OS-ATPase. The presence 
of the fourth butyl group in tetrabutyl tin, sterically hinders 
penta-coordination and therefore its binding to the inhibitor binding 
site. However, dibutyl tin dichloride can undergo penta-coordination 
(with a hydroxyl group forming the 5th ligand) and will therefore bind 
the inhibitor binding sites. The ability of a tria1kyl tin compound to 
undergo penta-coordination is not the only criterion which 
determines its inhibitory potency; the nature of the alkyl groups 
is a very important factor. Aldridge and Street have proposed, 
that for efficient interaction of trialkyl tins with the binding site 
and therefore efficient inhibition of the OS-ATPase, a certain 
minimum size for the alkyl group is required (143). Thus, according 
to the 'penta-coordinate hypothesis', the potency of the trialkyl 
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tin compound as an inhibitor of the OS-ATPase would depend on how 
closely the molecule approaches a certain optimum snape and size. 
For example, although trimethyl tin chloride undergoes penfa";'·Cdordination 
it is a poor inhibitor of the OS-ATPase of beef heart (Table 2.]), 
rat liver (]39) and yeast mitochondria '(]42). Aldridge'et 'al. (J43) 
have proposed that this is due to the low binding affinity of the 
trimethyl tin (which is ]0 times lower than that of triethyl tin 
in rat liver mitochondria) for the inhibitor binding site, and is a 
result of the size of the methyl group. Penta-coordination is 
supported by the fact that the penta-coordinate compound Ve22S3 is a 
good inhibitor of the OS-ATPase. 
Aldridge et al. (]43) have postulated that the mechanism 
of trialkyl tin binding to the inhibitor site on the OS-ATPase, 
involves the formation of tin-nitrogen ,(Sn-N) linkages between the 
trialkyl tin and paired histidine residues (Fig. 2.J6); similar to 
that proposed by Rose (164) for the binding of triethyl tin to rat 
haemoglobin; and by Davidoff and Carr (165) for the binding of 
triethyl tin to pyruvate kinase. However, the lack of involvement 
of tin-nitrogen linkage in the mechanism of trialkyl tin inhibition, 
has been demonstrated by Gould (J66); who has shown that triphenyl 
tin inhibition of OS-ATPase functions cannot be reversed by large 
excess of exogenous histidine. Furthermore, triphenyl germanium, 
which unlike triphenyl tin does not under penta-coordination 
(i.e. form 5-coordination compounds) in imidazole model systems, 
exhibits inhibitory properties identical to those seen with triphenyl 
tin (J66). This is inconsistant with the proposals of Aldridge' 
et al. (J43),Rose (164) and Davidoff and Carr (165). However, it 
is known that trialkyl tin compounds form polymeric coordination 
complexes with certain heterocyclic nitrogen-coordinated ring 
, 
... 
Protein chain 
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i 
N~/~ V R R 
Protein chain 
Fig. 2.16 Proposed structure for trialkyl tin binding in haemo-
globin, pyruvate kinase,OS-ATPase (143, 164, 165). 
The trialkyl tin is proposed to form a pentAcoordinate 
complex with the histidines at the binding site. 
complexes such as imidazole (167, 168)., 
The results presented above (Table 2.6-2.9, Fig. 2.10-
2.15) have shown that the inhibition of oxidative phosphorylation, 
OS-ATPase and ATP-driven transhydrogenase activities by most 
organotin compounds can be effectively reversed by dithiols, but 
not by monothiols. Similar findings have been reported by Cain et ale 
(159) who have shown that inhibition by dibutyl tin dichloride could 
be reversed by dithiols. Gould (169) has also shown that triphenyl 
tin inhibition of photophosphorylation and the increased proton 
permeability in eF I deficient chloroplast were specifically reversed 
by dithiols. Although these results do not provide conclusive 
proof, they can nevertheless be taken as suggestive evidence for a 
role of vicinal dithiol residues in the mechanism of organotin 
inhibition of OS-ATPase function • 
Reversal of organotin inhibition of mitochondrial functions 
by dithiols have been proposed to be due to: 
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1. a 'scavenging' effect, resulting in the removal of the 
organotin from the system; 
2. and/or the displacement of the cofactor to which the 
organotin binds by dithiol interchange reaction; 
3. and/or the replacement of the cofactor by the added 
dithio1 (150, 159). 
The proposals were put forward by Aldridge et a1. (161) and Griffiths 
et a1. (150, 159) who proposed that organotins inhibit mitochondrial 
functions by binding to a cofactor containing a vicinal dithio1, such 
as dihydro1ipoic acid, which acts as a high energy chemical inter-
mediate. Tria1kyl tins and dialkyl tins are proposed to act in a 
similar manner to arsenite and Lewisite; forming very stable 
5 or 6-membered ring, penta-coordinatecomplexes with the cofactor, as 
shown below: 
SnR2CI2 + 
(dia1kyl tin) 
(OH-/C1-) 
" //R Sn + 2HCI 
s/ "R 
Cofactor-dia1kyl tin complex 
~: 
(Cofactor) 
+ SnR3C1 
(trialky1 tin) 
+ HCI 
Cofactor-trialky1 tin complex 
Thus in analogy with the reversal of arsenite or Lewisite inbl~ition 
by dithiol interchange (170), reversal of dia1kyl tin and trialkyl 
tin by dithiols can be represented as follows: 
.... 
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R HS=l f=:H R S ",,/ R-!/ Sn + HS -+ SH + /\'R CH20H i "'s R 
'free' CH20H Cofactor-trialkyl 2,3-dimercapto- cofactor 
tin complex propanol trialkyl tin dimer-
captopropanol complex 
The specific reversal of DBCT inhibition of mitochondrial 
oxidative phosphorylation, OS-ATPase and ATP-driven transhydrogenase 
activities by dihydrolipoic acid reported by Cain et ale (159) led 
Grififths to suggest that dihydrolipoic acid might be the dithiol 
cofactor proposed in the equations above (150). However, contrary 
to the finding of Cain et al. (159),2,3-dimercaptopropanol and not 
dihydrolipoic acid, was found to be the best reversal agent in all 
cases of organotin inhibition. In most cases 2,3-dimercaptopropanol 
was found to be 15-25 times more effective than dihydrolipoic acid as 
a reversal agent (Figs. 2.10-2.15; Tables 2.6-2.9). Only in the reversal 
of dibutyl tin dichloride inhibition of ATP-driven transhydrogenase, 
OS-ATPase and oxidative phosphorylation (Fig. 2.14, Tables 2.6-2.8) 
were they found to be equally effective. Dithiothreitol and monothiols 
were found to be ineffective as reversal agents in most cases. The 
fact that 2,3-dimercaptopropanol is a better reversal agent than 
dihydrolipoic acid and dithiothreitol, might be due to its electrically 
neutral and hydrophobic nature; andior, that the rate of oxidation of 
its thiol groups is much slower. Results presented in Chapter 3 show 
that most of the organotin is present in the lipid fraction of the 
mitochondrial membrane. The hydrophobic nature of 2,3-dimercaptopropanol 
thus allows easy access to the organotin. The hydrophilic nature of 
dihydrolipoic acid combinedwith the fact that it has a negatively 
-74-
charged carboxylic group (under the conditions of the experiment), 
hinder the availability of the dihydrolipoic acid to the organotin 
in the membrane. 
Although the results on dithiol reversal of organotin 
inhibition of energy coupling reactions are consistant with the 
proposal that a vicinal dithiol is involved in the binding of trialkyl tins 
to the inhibitor site, they do not support the proposal of 
Griffiths (159) that dihydrolipoic acid is the vicinal dithiol. 
Although DBCT, Ve2283 and the other trialkyl tins studied 
were found to be potent inhibitors of the OS-ATPase and succinate 
driven oxidative phosphorylation, the two processes exhibit different 
degrees of sensitivity to these organotins. In all cases, the OS-ATPase 
was found to be 6-10 times more sensitive to organotin inhibition than 
oxidative phosphorylation (Tables 2.1-2-3) and Figs. 2.2-2.7). The 
results presented on Fig. 2.6 and Fig. 2.7 show that it is possible 
to inhibit the OS-ATPase activity by 90 % in mitochondria and submitochondrial 
, 
particles with DBCT, without significantly affecting succinate driven 
oxidative phosphorylation. These results indicate that the modes of 
trialky1 tin inhibition of oxidative phosphorylation and OS-ATPase 
were different, and/or that ATP synthesis and ATP hydrolysis occurs 
at different sites on the OS-ATPase complex. Separate sites for ATP 
synthesis and ATP hydrolysis have been suggested by Penefsky (171) 
and Pedersen et al. (81, 172) to exist on the OS-ATPase, based on 
the observation that AMP(PNP) inhibited ATP hydrolysis but did not 
affect oxidative phosphorylation. In the 'separate site model' it is 
assumed that the inhibitor, DBCT, or AMP (PNP) binds preferentially to 
the ATP hydrolysing site, thus inhibiting the OS-ATPase activity 
(81, 172). However, a 'conformational model' could also be used to 
explain the differential sensitivity of the ATP hydrolytic and the 
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ATP synthetic reactions to trialkyl tins. In this 'model' ATP 
synthesis and hydrolysis occurs at the same catalytic site on the 
enzyme; however, whether ATP synthesis or hydrolysis occurs 
depends upon the conformation of the enzyme. The binding of DBCT 
or another trialkyl tin to the inhibitor site, induces the 
attainment of that conformation that favour synthesis of ATP and 
inhibition of ATP hydrolysis. In both the 'conformational' and 
'separate site' models, inhibition of ATP synthesis at the higher 
concentrations (15-20 nmol/mg protein) of trialkyl tins~ would be 
due to uncoupling of oxidative phosphorylation. Uncoupling being 
brought about either through the detergent effect of the trialkyl 
tins on the mitochondrial membrane, or by discharging of the proton 
gradient through their ability to catalyse Cl-/OH- exchange across 
the membrane (140). This is supported 8y the finding (Fig. 2.8) 
that at 15-20 nmol trialkyl tin/mg protein succinate driven 
transhydrogenation is also inhibited. 
The proposals of Griffiths (150, 150) of a pool of 
cofactor involved in energy coupling wh ich ore titratable by 
trialkyl tins, cannot be used to explain the differential inhibition 
of the OS-ATPase and oxidative phosphorylation by trialkyl tins, or the 
significant increase (10-20%) in the rate of ATP synthesis in 
submitochondrial particles at 0.5-0.8 nmol DBCT/mg protein (Fig. 2.7), 
since the same catalytic site is involved in both reactions. Such 
an increase has also been obtained by G. Solaini (173) using tributyl 
tin as the inhibitor. The increase could be due to either the 
inhibition of the ATPase which would otherwise hydrolyse the 
ATP synthesised during oxidative phosphorylation (an apparent 
increase), or the inhibition of proton leakage resulting in increase 
coupling efficiency (a real increase). 
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The differential sensitivity of the OS-ATPase and 
oxidative phosphorylation to trialkyl tin inhibition, if it is not 
artificial, is consistant with the proposals that trialkyl tin 
inhibition of ATP synthesis and ATP hydrolysis are brought about by 
tvo different mechanisms and that the OS-ATPase is at least 
bifunctional. The findings, that, in general, 20-30 times more 
2,3-dimercaptopropanol vas needed to reverse trialkyl tin 
inhibition of the OS-ATPase activity than vas needed to reverse 
trialkyl tin inhibition of oxidative phosphorylation sensitive to 
oligomycin and uncoupler {Table 2.9}, corroborate the differential 
effect of trialkyl tins on the two processes and provide support for 
different mechanisms of inhibition of the two processes. 
The most 'interesting' of the organotin compounds examined 
is Ve2283 • This compound is the most poLent organotin so far 
examined. Its inhibition of mitochondrial energy-transfer reactions 
is irreversible by dithiols or monothiols. Using the 2,6-dichlorophenol-
indophenol technique described by Aldridge and Cremer (175), Carver 
(174) has shown that Ve2283 does not react with dithiols or 
monothiols. This compound {especially radioactively labelled} 
because of its specificity, will be very useful in mapping the 
inhibitory binding site{s} of organotins, and help to elucidate their 
mode of inhibition. 
2.7 CONCLUSION 
The results presented in this Chapter have shown that 
DBCT, DBT, Ve2283 and most of the trialkyl tin compound studied, were 
potent inhibitors of mitochondrial energy-transfer reactions. However, 
unlike oligomycin and DCCD inhibition of the energy-transfer reactions, 
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inhibition by most organotins examined was reversible by dithiols 
(Tables 2.6-2.9). The mechanism(s) by which the organotins inhibit 
these processes is (are) not known, but the experimental findings 
seem to suggest that the modes of inhibition of oxidative phosphoryla-
tion and OS-ATPase activity were different. The results obtained, 
indicate that while an oligomycin-like activity is responsible forI 
the inhibition of OS-ATPase and ATP-driven transhydrogenase, an 
• uncoupling mode of action is responsible for the inhibition of 
oxidative phosphorylation. The results also suggest that ATP 
synthesis and hydrolysis occur at two different sites. 
CHAPTER 3 
3.1 
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CHARACTERIZATION OF DIBUTYLCHLOROMETHYL TIN CHLORIDE 
BINDING SITES IN BEEF HEART MITOCHONDRIA 
INTRODUCTION 
Inhibitors of oxidative phosphorylation and OS-ATPase 
activities in mitochondria, such as dicyclohexylcarbodiimide (DCCO), 
oligomycin and trialkyl tins can provide insight into the 
molecular requirements for these processes, provided sufficient 
information about their mechanisms of inhibition are known. For 
example, it has been shown that DC CD and oligomycin initiates 
inhibition of oxidative phosphorylation and OS-ATPase activities 
by binding covalently (177) and non-covalently to their respective, 
specific binding proteins. However, although trialkyl tins 
exhibit similar inhibitory properties, they have never been found 
to bind specifically to any protein component of the OS-ATPase 
complex. 
Previous studies on the binding of trialkyl tin compound 
to rat liver mitochondrial membrane by Aldridge and Street (143), 
revealed the presence of high and low affinity binding sites for 
trialkyl tins on mitochondrial membrane. The oligomycin-like effect 
of trialkyl tin was correlated with the high affinity binding site, 
which for triethyl ti~was of the order of 0.8 nmol/mg protein. 
However, the high affinity binding site has never been shown to be 
present on any specific component of the oxidative phosphorylation 
system. Recent experiments by Griffiths et al.(149) using [3HJ-DBCT, 
(DBCT is proposed to behave as a specific covalent inhibitor of 
mitochondrial ATPase and oxidative phosphorylation) have suggested 
that trialkyl tins bind to dithiol components, present on the 
OS-ATPase complex. The [3HJ-DBCT labelled complex has been 
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isolated, and was found to be a small non-protein, hydrophobic 
molecule, distinct from the DCCD and oligomycin binding prot eo-
lipids. 
In this Chapter, the binding of [3H]-DBCT to submitochon-
drial particles is examined and the binding parameters compared with 
those derived from inhibition studies on OS-ATPase and oxidative 
phosphorylation. The,[3H]-DBCT-X' component was isolated, its 
Rf value in various solvent systems estimated, and an attempt made 
to identify it using mass spectrometry. 
3.2 MATERIALS 
[3H]-DBCT was a gift from Professor B. Beechey, Shell 
Research Ltd., Sittingbourne, Kent. 
Trialkyl tins, lipoic acid, dihydrolipoic acid, were obtained as 
previously stated in Materials section of Chapter 2. Precoated silica 
gel plates for analytical (TLC - silica gel 60F254 20 cm x 20 cm 
x 0.2 mm) and preparative (PSC - silica gel, 20 em x 20 cm x 2 mm) 
chromatography were purchased from E. Merck, Darmstadt. All organic 
solvents were of AnalaR grade and were redistilled before use. 
3.3 METHODS 
Beef heart submitochondrial particles were prepared 
as described in the Methods section of Chapter 2. 
[3H]-DBCT binding study: beef heart submitochondrial 
particles suspended in 0.25 M sucrose, )0 mM tris-CI, 1 mM EDTA, 
pH 7.5 (at 2 mg protein/ml) were incubated with various [3H]-DBCT 
concentrations for 16 hours at 40 C. 3 [ H]-DBCT was added as a 
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methanolic solution. The suspensions were centrifuged at 
100,000 g in the 40.3 rotor of the Beckman ultracentrifuge for 
30 minutes at SO C to 'pellet' the submitochondrial particles. 
Samples of the supernatant were taken for scintillation counting 
and the remaining supernatant discarded. The 'pellet' was solubilised 
by leaving overnight in J.O ml of 2% (w/v) Triton X-JOO. The radio-
activity was determined in 4 ml of a Triton X-IOO based scintillant 
cocktail (1 litre toluene, 0.5 litre Triton X-100, 7 g butyl PBD). 
Standards were counted with each batch of samples. Under these 
conditions 70-75% efficiency of counting was achieved. There 
was no significant binding of [3HJ-DBCT to the cellulose nitrate 
tubes. The distribution of the [3HJ-DBCT obtained on the basis 
of the equilibrium binding studies was analysed according to 
Scatchard (176). 
Competitive binding experiments were carried out using 
'cold' DBCT, tributyl tin chloride, Ve2283 and dibutyl tin dichloride. 
In these experiments submitochondrial particles were preincubated with 
'cold' DBCT, tributyl tin, Ve2283 or dibutyl tin dichloride (at 
15 nmol/mg protein) for 3 hours, before addition of various concentra-
tions of [3HJ-DBCT. The suspensions were centrifuged at 100,000 g 
in the 40.3 rotor of the Beckman ultracentrifuge for 30 minutes at 
50 C to pellet the submitochondrial particles. The pellet was 
solubilised in 1.0 ml 2% (w/v) Triton X-IOO, and the radioactivity 
determined as described above. 
. 3 
Extraction of [ HJ-DBCT-X from submitochondrial particles with 
acetone [Svoboda et al. (5)] 
Submitochondrial particles (2 mg/mt) were treated with 
varying concentrations of [3H]-DBCT as described previously. To 
0.5 ml of the suspension 0.5 mt 10% TCA was added. This mixture 
was filtered through a single Whatman GF/C filter, and the residue 
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left on the filter washed at a very low flow-rate (30-40 ml/min) 
with 45 ml of the following solutions: 
~ 
(a) 0.25 M sucrose, 10 mM tris-CI, 1 mM EDTA, pH 7.4, and 
(b) 10% water in acetone. 
As much as 90-95% of the protein remained on the filters. The filters 
were dried at 300 C on a hot plate for 15 minutes and the radioactivity 
determined by dropping the filter in a scintillation vial containing 
4.0 ml of the liquid scintillation cocktail mentioned above. 
Isolation of the DBCT-X complex 
Extraction of the DBCT-X complex from submitochondrial 
particles with chloroform/methanol (2:1, v/v) was carried out 
essentially as described by Cattell et al. (181). Submitochondrial 
particles ~OO.Omg) suspended at 20 mg protein/ml was incubated 
with [3HJ-DBCT at 20 nmol/mg protein for 16 hours. The submitochondrial 
particles were pelletted by centrifugation at 100,000 g in the 30 rotor 
of the Beckman ultracentrifuge for 90 minutes. The pellet was 
resuspended in an equal volume of 0.25 M sucrose, 10 roM tris-CI, 
1 mM EDTA pH 7.4 buffer and recentrifuged as before. < This process was 
repeated three times, after which the [3HJ-DBCT treated submitochondrial 
particles were resuspended in an equal volume of the same buffer, the 
suspension added to 25 volume of chloroform/methanol (2:1. v/v) and 
stirred at room temperature overnight. The mixture was filtered 
through a Whatman GF/C filter (under pressure if necessary) and the 
filtrate washed with 1/5 vol. water. The emulsion is allowed to 
separate into two distinct layers. and the lower chloroform/methanol 
layer isolated. The washed chloroform/methanol extract was vacuumed 
down to 1/5 vol. using a rotory evaporator,S vol. of ice cold 
diethyl ether added and the mixture left overnight at -200 C. The 
precipitated proteolipids were removed by centrifugation and 
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redissolved in chloroform. The supernatant from the centrifugation 
step was vacuumed down to minimal volume and the residue redissolved 
in chloroform. This is DBCT-X. Samples of this solution were 
subjected to analytical and preparative t.l.c. in various solvent 
systems on silica gel t.l.c. plates. The [3HJ-DBCT-X was purified 
by preparative thin layer chromatography on silica gel in CHCI3/MeOH 
(2:1) solvent system. 
Mass spectral analysis of the purified DBCT-X component 
was carried out by Mr. I. Katyal, Chemistry and Molecular Sciences 
Department, University of Warwick. 
3.4 RESULTS 
Fig. 3.1 shows the binding oj [3HJ-DBCT to beef heart 
submitochondrial particles, and the effect of increasing concentration 
of the inhibitor on the OS-ATPase activity in these particles. The 
binding curve (~ y) indicates that the saturation of the DBCT 
binding sites were not obtained within the [3HJ-DBCT concentration 
range used. However, the percentage bound DBCT decreases from 80-95% 
of the DBCT added at 0.3-2.0 nmol/mg protein to 50-40% of the DBCT 
added at higher concentrations (4-30 nmol/mg protein). These results 
indicate that there are at least two different types of binding sites, 
a high affinity binding site which is apparently saturated at 2-3 nmol 
DBCT/mg protein and low-affinity binding site which.is present at 
a much greater concentration. 
Parallel measurements of the ATPase activity revealed that 
the half-maximum inhibition of the enzyme activity was reached at 
~O.9 nmol DBCT/mg protein. In these conditions ~O.80 nmol of 
[3HJ-DBCT was bound per mg of submitochondrial particle protein 
(Fig. 3.1). Complete inhibition of the OS-ATPase activity was 
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Fig. 3.1 [3HJ- D;cr binding to beef heart submitochondrial 
a function of increasin concentrations 
Submitochondrial particles suspended at 2 mg protein/ml in 0.25 M 
sucrose; 10 mM tris-CI. pH 7.5; I mM EDTA, were preincubated with 
various concentrations of [3H]-DBCT for 16 hours. 100 ~g protein 
aliquots (50 ~l) were removed and assayed for ATPase activity. 
The suspensions were then analysed for bound [3HJ-DBCT as described 
in Methods ( .). Washing of [3H]-DBCT treated particles with 
10% water in acetone «() ) was carried out by the method of 
Swoboda et al. (5) as deicribed in Methods. The specific ATPase 
activity of the original submitochondrial particles is 2.5 ~mol 
ATP hydrolysed/min/mg protein. The inhibition data ( V) are 
presented in the figure a8 • per cent activity of this original 
value. Each data point represents the average of 4 duplicates. 
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obtained at 2.5-3.0 nmol [3HJ-DBCT/mg protein, when 1.8-2.0 nmol 
of [3HJ-DBCT was bound per mg protein. Comparison of the OS-ATPase 
activity and [3H]-DBCT binding curves, shows that DBCT is further 
bound even when maximum inhibition of the OS-ATPase activity is 
reached (Fig. 3.1). 
When acetone-water was used for washing the submitochondrial 
particles, the sh?pe of the binding curve was drastically modified 
(see Fig. 3.1). 3 The bound [ H]-DBCT was completely removed by the 
acetone-water treatment (Fig. 3.1). A solution of 10% water in 
acetone is known to extract the majority of the mitochondrial phospholipids 
(178). It could therefore be concluded that the [3HJ-DBCT is not bound 
to a protein component, but is bound, possibly to a phospholipid or a 
similar non-protein lipophilic component. The hydrophobic nature of 
the trialkyl tins in general, would indir.ate that such binding would 
occur non-specifically. The results also indicate that the inhibitory 
action of organotins is dependent upon a phospholipid, and is possibly 
manifested through a phospholipid-trialkyl tin complex. 
The data presented in Table 3.1 shows the effect of tributyl 
tin, dibutyl tin dichloride Ve2283 and 'cold' DBCT on the binding of 
[3H]-DBCT to submitochondrial particles. The results show that 
preincubation of submitochondrial particles with the above-mentioned 
trialkyl tins (at 15 nmol/mg protein) had no effect on the binding 
of [3H]-DBCT to the particles. The pattern of binding in the presence 
of tributyl tin, Ve22a3 and dibutyl tin dichloride was similar, but 
not identical to that in the absence of the added organotins; that is, 
below 2 nmol/mg 80-90% of the [3HJ-DBCT was bound whereas, at DBCT 
concentration greater than 3 nmol/mg protein, less than 60% remained 
bound (Fig. 3.2). When 'cold' DBCT was the added trialkyl tin, the 
pattern of binding was different, only 40-50% of the added [3H]-DBCT 
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1.0 2.0 1.0 4.0 5.0 
Total r3H]-DBCT (nmol/mg protein) 
The effect of various trialkyl tins on [3HJ-DBCT 
binding to submitochondrial particles 
Submitochondrial particle. suspended at 2.0 mg protein/ml were 
preincubated with dibutyl tin dichloride ('~). tributyl tin 
chloride (V ) and 'cold' DBCT ( D) at 15 I1I1lol/mg protein for 
16 hours at 40 C. The treated particles were then incubated 
with varying concentration. of r3H]-DBCT for 16 hours at 40 C. 
The suspensions were then analysed for bound (3H]-DBCT a. 
described in Methods. Experimental data is presented in the figure a. the amount of [lH)-DBCT bound plotted against the total 
concentration. Each data point is the average of duplicate •• 
Control binding curve. ( A). 
• 
Table 3.1 Effect of trialkyl tin compounds on [3H]-DBCT binding to beef heart submitochondrial particles 
Organotin 
None 
Tributyl tin chloride (2 nmol/mg) 
Tributyl tin chloride (5 nmol/mg) 
Tributyl tin chloride (10 nmol/mg) 
Tributyl tin chloride (15 nmol/mg) 
Tributyl tin chloride (25 nmol/mg) 
Dibytyl tin dichloride (5 nmol/mg) 
Dibutyl tin dichloride (10 nmol/mg) 
Dibutyl tin dichloride (20 nmol/mg) 
Dibutyl tin dichloride (30 nmol/mg) 
Ve2283 (2 nmol/mg) 
Ve2283 (5 nmol/mg) 
Ve2283 (10 nmol/mg) 
Ve2283 (15 nmol/mg) 
[3H]-DBCT (nmol/mg protein) 
A B. 
1.0 0.96 
1.0 0.92 
1.0 0.95 
1.0 0.88 
I .0 0.85 
1.0 0.86 
1.0 0.94 
1.0 0.94 
1.0 0.80 
1.0 0.84 
1.0 0.94 
1.0 0.94 
1.0 0.90 
1.0 0.91 
% inhibition 
of binding 
4.2 
1.0 
8.3 
11.5 
10.4 
2.0 
2.0 
16.7 
12.5 
2.0 
2.0 
6.2 
5.0 
A = Total [3HJ-DBCT (1.0 nmol/mg protein). B = bound [3HJ-DBCT. Submitochondrial particles suspended at 
2.0 mg protein/ml in 0.25 M sucrose; 10 roM tris-CI. pH 7.5; 1 roM EDTA buffer. were preincubated for 3 hours 
at 40 C with various concentrations of tributyl tin. dibutyl tin dichloride and Ve2283. The particles were then 
incubated with [3H]-DBCT at 1.0 nmol/mg protein for 16 hours. The suspensions were analysed for bound [3H]-DBCT 
as described in the Methods section. Each value is the mean of duplicates. 
I 
(Xl 
0\ 
I 
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was bound and the percentage bound vas independent of the concentration 
of the added [3HJ-DBCT over the range used (Fig. 3.2). The results 
of competition experiments thus indicate that DBCT does not bind to 
the same site as tributyl tin, Ve2283 or dibutyl tin dichloride. 
For evaluation of the maximum number of binding sites 
(B ) and the determination of the apparent dissociation constant 
max 
(kD), the data of [3HJ-DBCT binding were analysed according to 
Scatchard (176). The Scatchard plot (Fig. 3.3) reveals that there 
are clearlY, two classes of binding sites with different binding 
affinities. Analysis of the plot shows that the maximum number of 
high affinity binding sites is ~2.0 nmol/mg protein, having an 
apparent dissociation constant of 2.86 x ]0-7 M. The low affinity 
site has a concentration of approximately 33.44 nmol/mg protein 
and a kD of 30.4 ~M. The high affinity site clearly correlates 
with ISO value of 0.8 nmol/mg protein for the ATPase inhibition. 
This is also in agreement with the conclusion of Aldridge and Street (143) 
that the high affinity site in rat liver mitochondria represented 
the binding site responsible for the oligomycin-like effects of 
triethyl tin. 
Fig. 3.4 is a Dixon plot (ltv against [DBCT]), of the OS-ATPase 
inhibition data presented in Fig. 3.1 (179). The plot shows that there 
are more than one binding site for DBCT; at least two sites are 
present. Extrapolation of this plot to intercept the abscissa 
gave a k. of 0.4 nmol/mg protein (i.e. 0.4 ~M). This value is 
1 
almost equal to that of the dissociation constant of the high 
affinity site of ~0.3 ~M, suggesting that the high affinity site 
is also the inhibitor binding site of the OS-ATPase. 
Beechey et a1. (180) and Cattell et'al. (181) have 
shown that the DCCD binding protein can be extracted from the 
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6 
5 
o 1.0 2.0 
DBCT (nmol/mg protein) 
Dixon lot of the inhibition of the ATPase activit 
of submitochondrial particles by H]-DBCT 
The ATPase inhibition data presented in Fig. 3.1 (~), were analysed 
according to Dixon et al. (179). Each data point is the average of 
4 duplicate.. The experimental data is presented in the figure as 
the reciprocal of the specific ATPase activity (I/V) plotted against 
the total DBCT concentration (nmol/mg protein). 
3.0 
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mitochondrial membrane with chloroform-methanol (2:1, v/v). Consequently, 
an attempt was made to adopt the purification scheme devised by Cattell 
et ale (181), to isolate the DBCT binding component. The data presented 
in Table 3.2, shows that the DBCT binding component is readily extracted 
with chloroform-methanol from [3H]-DBCT 'labelled' submitochondrial 
particles. In this experiment, more than 87% of the bound [3H]-DBCT 
was extracted. The removal of extracted membranes from the organic-
solvent phase involves filtering through glass wool and this coupled 
with obvious phase partition effects invariably lead to some loss of 
extract (~15-20% of bound DBCT). Washing of the extract with water 
to remove all the non-proteolipid protein results in a small loss 
(5%) of radioactivity. The amount of protein removed by the 
washing procedure appears to be variable and there does not appear 
to be a correlation between protein remo~ed and radioactivity lost. 
The next step in the purification scheme is the ether 
precipitation step. This step is known to precipitate only protein 
[Kuntzel et al. (182)] and Cattell et al. (181) have shown that this 
procedure precipitates the DCCD-binding protein. Table 3.2 shows 
that 75-80% of the protein remaining after the water wash was 
precipitated, but only ~2% of the radioactivity was lost. This 
result is very different from the DCCD binding data reported by 
Cattell et al. (181) where 65-70% of the radioactivity is precipitated 
with 70-80% of the protein. The [3H]-DBCT binding component remained 
in the ether supernatant. 
Thin layer chromatographic analysis of the washed 
chloroform-methanol extract (Fig. 3.5) shows that the radioactivity 
is associated with a single spot with an Rf value (~0.8) in 
chloroform/methanol/HCli~ater. solvent system, which is vastly 
different from that of the free [3H]-DBCT (Rf 0.25). T.I.c. analysis 
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extract of DBCT labelled submitochondrial particles 
Fig. 3.5 Thin layer chromatography 'of purified'~hlor6f6rm/methanol 
extract of DBCT labelled submitochondrial particles 
Thin layer chromatographic analysis was carried out on Merck pre-prepared 
silica-gel TLC plates in a solvent system consisting of chloroform/ 
methanol/HCI/water (650/250/3/36; v/v). Radioactivity was determined 
by slicing the plates into 0.5 cm x 0.5 em strips, which were then 
dropped into a Triton-XIOO based scintillation cocktail and counted 
(as described in Methods) after leaving overnight. 
(A) 33' Free [ H]-DBCT and [ H]-DBCT labelled washed chloroform/ 
methanol extract (tJH]-DBCT-X). 
(B) [3HJ-DBCT-dihydrolipoic acid complex. 
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Table 3.2 Chloroform/methandlextraetion of DBCT'binding component 
Fraction Total DBCT % [3H]-DBCT % Protein Total c.p.m. (nmo1) 
Labelled particles 340,000 660.0 100 100 
CHCl3/CH30H extract 296,820 576.2 87.3 18.7 
Washed CHC13/CH3OH 265,200 514.8 78.0 4.0 
extract 
Ether precipitate 6,800 13.2 2.0 3.2 
Ether supernatant 258,400 501.6 76.0 < 1.0 
Submitochondrial particles (66.0 mg) suspended at 10 mg/ml in 
0.25 M sucrose, 10 mM tris-CI, pH 7.5; 1 mM EDTA buffer were 
preincubated with [3H]-DBCT at 10 nmol/mg protein for 16 hours 
at 40 C. The labelled particles were extracted for 18 hours 
with 20 volumes of chloroform/methanol (2:1, v/v). Washing of 
the extract and precipitation with ether were as described in 
method. The data presented in the table represents a typical 
extraction profile of the [3H]-DBCT-X compound. 
of the washed extract in two other solvent systems; propan-I-ol 
or light petroleum (b.p. 60-800 C)/diethy1 ether/acetic acid 
(90:10:1, v/v), also showed only one peak of radioactivity, which 
was separable from the free [3H]-DBCT and subunit 9. 
The labelled component was purified by preparative 
t.1.c. with two solvent systems (chloroform/methanol/HCl/water, 
65:25:0.31:3.~v/v; and chloroform/methanol/17% (v/v) NH3 , 
2:2:1, v/v). The purified component did not exhibit a Folin or 
ninhydrin reaction. From the above results it may be concluded 
that DBCT binds to a lipophilic non-protein component of the 
mitochondrial membrane which is distinct from the DCCD-binding 
protein (subunit 9). 
Preliminary investigation of the [3H]-DBCT labelled 
component by Cainet 'al. (149) have indicated that the reactive 
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component is possibly a dithiol residue of lipoic acid. Fig. 3. 5 
shows that the DBCT reacts with dihydrolipoic acid to form a 
complex, which is indistinguishable, (that is, they have the same 
Rf value) from the labelled component in the three t.l.c. systems 
mentioned above. However, because these compounds have the same 
Rf value in the different t.l.c. systems, this does not mean that 
they are one and the same compound, that is, that the unknown 
component is lipoic acid. A mass spectral analysis of the purified 
DBCT-component (Fig. 3.6) does not support the proposal that the 
unknown component is lipoic acid. Fig. 3.6 shows that the highest 
mass number obtained is 371, this mass is much lower than that 
expected for the molecular ion of the DBCT-lipoic acid complex 
of 489 (Fig. 3.1). From the mass spectral analysis, the estimated 
molecular weight of the unknown component X is 97-112. Fig. 3.8 
shows the mass spectra of lipoic acid (A) and DBCT (B). Fig. 3.8B 
indicates a molecular ion of lipoic acid of 206, and that further 
breakdown of the molecule into smaller molecular ions occurs 
initially with the loss of the sulphur atoms. 
3.5 DISCUSSION 
The results presented in this Chapter have shown that 
two types of binding sites (high affinity and low affinity binding 
sites) for DBCT is present on beef heart submitochondrial particles. 
The maximum number of high affinity sites is ~2.0 nmol/mg protein and 
the apparent dissociation constant (~) of these sites is 0.286 ~M 
(Fig. 3.3). The estimated number of low affinity sites on submitochondrial 
particles is 33.0 nmol/mg protein, having apparent dissociation 
constant of 30.5 ~M. The high affinity sites thus account for less 
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than 6% of the total number of binding sites present, and binds 
DBCT 100 times more tightly than the low affinity sites. The 
apparent dissociation constant of the high affinity site (~ ~ 0.3 ~M) 
almost equal to the inhibitor dissociation constant (k.) of 0.4 
1 
nmol/mg protein (~0.4 ~M) for DBCT inhibition of the ATPase 
activity of submitochondrial particles (Fig. 3.4). These values 
(ku ~ 0.3 ~M, ki ~ 0.4 ~M) are in good agreement with the concentration 
of nBCT required for inhibition of the ATPase activity (Fig. 3.1), 
but not with the concentration of nBCT required for inhibition of 
oxidative phosphorylation in submitochondrial particles (see 
Chapter 2). The maximum number of high affinity binding sites 
(~2.0 nmol/mg protein) is almost equal to the amount of DBCT bound 
(1.9 nmol/mg protein) at 90% inhibition of the ATPase activity 
(Fig. 3.1). These results thus show tqpt ATPase inhibition is 
correlated with the saturation of the high affinity binding sites. 
Contrary to Cain et a1. (149) and Aldridgeetal. 
(143) we believe that binding to the low affinity sites and "not 
binding to the high affinity sites is responsible for inhibition 
of oxidative phosphorylation. This conclusion is drawn from the 
fact that, at nBCT concentration (2-5 nmol/mg protein) causing 
saturation of the high affinity site and total inhibition of the 
ATPase activity (Fig. 3.1), oxidative phosphorylation in 
submitochondrial particles is not significantlY affected (see Chapter 2, 
Fig. 2.6). These results thus support the proposal in Chapter 2 
that tria1kyl tin inhibition of oxidative phosphorylation and 
ATP hydrolysis (ATP dependent reactions) occur by two different 
mechanisms, and re-enforce the proposal of Pedersen (81) that 
the OS-ATPase complex is at least bifunctional. 
Although Cain et a1. (149) have reported that the high 
affinity sites for nBCT and other tria1kyl tins were located in 
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the OS-ATPase complex, DBCT was not found to bind to any of the 
protein component of the complex and the fact that the high 
affinity sites for DBCT are not competed for by tributyl tin, 
dibutyl tin dichloride or the penta-coordinate compound Ve 2283 , 
indicating that DBCT binds at different sites from these organotin 
compounds. That DBCT does not bind to a protein component of 
the ATPase was shown by the fact that, unlike bound [14CJ-DCCD, 
all the bound [3HJ-DBCT can be removed by extraction with 10% 
water in acetone (Fig. 3.1). Extraction of the [3HJ-DBCT component 
complex by the method of Cattell et al (181) demonstrated that DBCT 
does not bind to subunit 9, the DCCD binding protein. These 
results thus suggest that DBCT binds a non-protein hydrophobic 
molecule. 
The nature of the DBCT binding component is still 
unknown. However, from preliminary studies Cain et ale (149) have 
suggested that it could be lipoic acid or one of its protein 
conjugated forms. However, extraction of the DBCT-X (binding component-
x) followed: by its purification by preparative thin layer 
chromatography; the compound gave netative Folin and ninhydrin 
test for protein. Although the compound had similar Rf values to 
authentic DBCT-lipoic acid in the solvent system tested, (Fig. 3.5) 
mass spectral analysis of DBCT-X (Fig. 3.6) and DBCT-lipoic acid 
indicates that they were not the same compound (i.e. X is~ lipoic 
acid). 
CHAPTER 4 
4. 
4.1 
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THE ROLE OF DIHYDROLIPOIC ACID 
IN OXIDATIVE PHOSPHORYLATION 
INTRODUCTION 
The ability of dihydrolipoic acid to drive ATP synthesis 
and stimulate energy-linked reactions in beef heart mitochondria has 
been reported by Griffiths (132) and Mitchell(243). However. no 
satisfactory explanation has been put forward to account for the actual 
role played by dihydrolipoic acid during ATP synthesis. Whilst 
Griffiths (132) has proposed a chemical coupling intermediate role for 
dihydrolipoic acid, D. Mitchell (243) has suggested that dihydrolipoic 
acid acts as a trans-membrane proton translocator. 
The findings that trialkyl tin inhibition of oxidative 
phosphorylation and other energy-linked reactions could be reversed by 
dihydrolipoic acid, combined with its ability to drive oligomycin-
sensitive ATP synthesis in mitochondria, led Griffiths (132) to suggest 
that dihydrolipoic acid might act as the high-energy intermediate 
proposed by Slater (14) and Sanadi etal. (244) in their chemical 
coupling hypothesis. Dihydrolipoic acid would then provide the link 
between the respiratory chain and the ATP synthase complex which 
catalyse the terminal reactions of oxidative phosphorylation. These 
terminal reactions, outlined in Fig. 4.1. are proposed by Griffiths 
to involve a cycle of transacylation and transphosphorylation reactions 
analogous to those involved in the succinic thiokinase system, in 
substrate level phosphorylation. The reaction sequence proposed by 
Nishimura and Grinnell (245) for the succinic thiokinase is shown 
below (equations 1-4). 
1. 
2. 
3. 
4. 
Succinyl-S-lipoate + 
Succinyl-S-CoA + Enz 
CoA-S-Enz + pi 
P"'Enz + GOP 
CoASH * Succinyl-S-CoA + lipoate 
* CoA-S-Enz + succinate 
~ PvEnz + CoASH 
* GTP + Enz 
Enz is the enzyme and PvEnz its phosphorylated complex. 
,~, represents the high energy bond. 
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The proposals of Griffiths, thus suggest that dihydrolipoic 
acid was directly involved in the generation of ATP, and that the 
respiratory chain was not required for dihydrolipoic acid driven ATP 
• 
synthesis in mitochondria. Support for Griffiths hypothesis is 
provided by Bertoli 'et 'al. (246) who has shown that yeast promitochondria 
lacking a functional electron transport system due to lack of 
cytochromes and ubiquinones (247, 248) but possessing a functional 
energy transfer syste~was able to catalyse dihydrolipoic acid, 
oleoyl-lipoate and oleoyl-phosphate driven ATP synthesis. 
Mitchell (243), contrary to Griffiths, has suggested that 
dihydrolipoic acid was indirectly involved in ATP synthesis. Mitchell 
(243) proposed that dihydrolipoic acid was not a high-energy chemical 
intermediate of oxidative phosphorylation, but that it acts as a 
transmembrane proton translocator used in building up the trans-
membrane potential gradient used to drive ATP synthesis and other 
energy-linked reactions. Unlike Griffiths, he claimed that a 
functional respiratory chain was required, since electron transport and 
proton transport were directly interdependent. The proposals of 
Mitchell can thus be represented diagramatically as: 
Fig. 4.1 
Cytosol M Matrix 
Li
P(Sj)2 :_B + 
LipS2 + B + 2H 
Transmembrane transport of protons by dihydrolipoic 
acid 
M • mitochondria inner membrane; A and B are components of the 
respiratory chain; Lip(SH)2' dihydrolipoic acid and LipS2' lipoic 
acid. 
-101-
The resulting transmembrane proton potential is thus used to drive 
ATP synthesis as postulated in the chemiosmotic hypothesis. 
In this Chapter we examine the ability of dihydrolipoic 
acid, oleoyl-lipoate and oleoyl-phosphate to drive ATP synthesis and 
some energy-linked reaction catalysed by beef heart mitochondria, 
submitochondrial particles and complex V. We try to provide an 
explanation for the role played by these compounds and their 
significance in mitochondrial energy-transfer processes. 
4.2 MATERIALS 
All reagents used were of AnalaR grade. AnalaR grade 
organic solvents such as methanol and chloroform were redistilled 
before use. Dihydrolipoic acid, oleic acid, oleoylchloride, CoASH 
and acyl-SCoA were obtained from Sigma Chemical Company. NAD, NADP, 
ATP, ADP and 5,5-dithiobis(2-nitrobenzoic) acid were obtained as previously 
stated in the Materia~sections of Chapter 2. 
4.3 METHODS 
Oxidative phosphorylation and ATP hydrolysis ATP-driven 
and succinate driven transhydrogenation were assayed as described 
in the Methods section of Chapter 2. The method of Ellman (158) was 
used to measure the concentration of thiol groups. 
Preparation of oleoyl-S-lipoate 
Dihydrolipoic acid (0.5 mmole) was dissolved in JO ml 
redistilled tetrahydrofuran + 10 ml triple distilled water. The 
pH was adjusted to 7.5 with 1 M NaOH. Oleoyl chloride (0.5 mmole) was 
then added to this reaction mixture with rapid stirring. The mixture 
was then stirred in the dark at room temperature for 3-4 hours; the 
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pH was monitored and kept between pH 7.5-8.0 by addition of 1 M 
NaOH. The mixture was assayed-for thiol content by the DTNB method of 
Ellman (158). When the reaction was adjusted to be complete (using 
the disappearance of thiol as the parameter), the reaction mixture 
was acidified to pH 2-3 by addition of ) M HCl and extracted with 
4 5 vol. of diethyl ether which was then removed from the reaction 
product by rotary evaporation. 
reaction product accounting for 
Oleoyl-S-lipoate was the major 
75 % of the final product. The 
crude oleoyl-S-lipoate was purified using preparative thin layer 
chromatography in a solvent system containing toluene; ethyl formate 
and formic acid (5:4:1, v/v). Oleoyl-S-lipoate was dissolved in 
dimethylformamide and assayed by the hydroxamate method of Lipmann 
and Tuttle (249). 
Oleoyl-phosphate preparation 
Oleoyl phosphate was prepared from anhydrous phosphoric acid 
and oleoyl chloride as described by Griffiths (132). Dry orthophosphoric 
acid (0.325 g) was weighed into a round bottomed, quickfit, 250 ml flask, 
to which was added 30 ml dry, redistilled acetonitrile. The contents 
were then stirred using a magnetic stirrer and follower. Triethylamine 
(500 pI) was added to facilitate the dissolution of the orthophosphoric 
acid. Oleoyl chloride (1 ml) was then added, and the reaction was 
allowed to proceed for 11 hours in the dark at room temperature. The 
reaction was stopped py addition of 100 ml I M sodium chloride, followed 
by the addition of 70 ml redistilled chloroform. The reaction mixture 
was shaken and transferred to a separating funnel where the chloroform 
and aqueous phases were allowed to separate. The chloroform phase was 
isolated and the aqueous phase re-extracted with 30 ml chloroform and 
the chloroform phases were pooled. This was then shaken with water 
to remove any free phosphoric acid and after separation the chloroform 
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layer was dried over anhydrous sodium sulphate for 10-20 minutes. 
The chloroform layer was decanted from the sodium sulphate and 
filtered through chloroform washed Whatman No 1 filter to remove 
any suspended sodium sulphate. The filtrate was then evaporated to 
dryness on a rotary evaporator. The residue is crude oleoyl-phosphate. 
Thin layer chromatography in a chloroform/methanol (2:1, v/v) solvent 
system shows it to consist of one spot. Hydroxamate assay of this 
residue shows that it was 90-95% pure oleoyl-phosphate. 
Hydroxamate assay for acyl esters (249) 
Tubes containing the acyl ester under test and 100 ~l 
10% sodium dodecyl sulphate (electrophoretic grade) were made up to 
a final volume of 0.5 ml with distilled water. 0.5 ml of hydroxyl-
amine reagent [28% hydroxylamine-HCI and 14% NaOH, (w/v) and 0.5 ml 
acetate buffer 0.1 M acetic acid, 0.1 sodium acetate mixed 2:8, 
(v/v}J were then added, the mixture vortexed and allowed to stand for 
10 minutes at room temperature. 0.5 ml 36% Hel, 0.5 ml 12% trichloro-
acetic acid and 0.5 ml of ferric chloride reagent (6% FeCl3 .6H20 in 
0.1 M HCI) were added with mixing. The mixtures were allowed to stand 
for 15 minutes at room temperature and their optical density at 490 nm was 
measured in a Unicam SP1800 spectrophotometer. The amount of acyl 
ester was then estimated from a standard curve constructed using 
acetyl phosphate, or methyl oleate as standard •. 
4.4 RESULTS 
The results presented in Table 4.1, depict the ability of 
dihydrolipoic acid to drive ATP synthesis in beef heart mitochondria 
in the presence or absence of the respiratory inhibitors; rotenone 
and antimycin A. The results show that ATP synthesis driven by 
Table 4.1 
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Dihydrolipoic acid drivenATP Synthesis·in 
Beef Heart Mitochondria 
ATP synthesised 
Additions 
None 
Lip(SH)2 (I llmol) 
Lip(SH)2 (2 pmol) 
a-Lipoic acid (J pmol) 
pyruvate/malate 
Succinate (20 llmol) 
Ascorbate/TMPD 
Lip(SH)2 + Rotenone (2 pg) + antimycin ~ (2 llg) 
Succinate (20 llmol) + rotenone (2 llg) + 
antimycin A (2 llg) 
pyruvate/malate + rotenone (2 llg) + 
antimycin A (2 llg) 
Asborbate/TMPD + rotenone (2 llg) + antimycin A 
(2 pg) 
Lip(SH)2 + rotenone (2 pg) 
Lip(SH)2 + antimycin A (2 llg) 
nmol/min/mg 
protein 
0.0 
43.0 + 15.0 
-
70.0 + 25 
-
0.0 
192.5 + 10 
135.0 + 10 
-
94.0 + 20 
-
0.0 
0.0 
0.0 
89.0 + 20 
-
0.0 
0.0 
........ 
ATP synthesis was assayed in a 'glucose-hexokinase trap' system as 
described in Materials and Methods. Mitochondria (2 mg) were 
preincubated in phosphorylation medium ~ rotenone (2 pg) and 
antimycin A (2 llg), for 5 minutes at 300 C. The reaction was 
then initiated by addition of the appropriate substrate. Each 
value represents the mean of five duplicates. 
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dihydrolipoic acid in beef heart mitochondria, only occurs in the 
absence of rotenone and antimycin A. The rate of ATP synthesis was 
found to be dependent upon the concentration of dihydrolipoic 
acid, and to be much slower than the rates of pyruvate/malate, succinate 
or ascorbate/TMPD driven ATP synthesis (Table 4.1). This difference in 
rate is due primarily to the low concentration of dihydrolipoic acid 
(2 mM) (compared with 20 mM pyruvate or 20 mM succinate) used in the 
assay. The use of low concentration of dihydrolipoic acid is 
unavoidable since higher concentration (4-5 mM) inhibits (uncouples) 
ATP synthesis. In the presence of rotenone and/or antimycin A 
dihydrolipoic acid driven ATP synthesis in beef heart mitochondria 
is completely inhibited (Table 4.1). Table 4.2 shows that dihydrolipoic 
acid alone was ineffective in driving ATP synthesis in submitochondrial 
particles, either in the presence or absence of rotenone and 
antimycin A. 
The results presented in Tables 4.1 and 4.2, thus suggest 
that oxidation of dihydrolipoic acid via, the respiratory chca.n is 
necessary for ATP synthesis driven by dihydrolipoic acid in 
mitochondria. This is supported by the fact that a-lipoic acid does 
not drive ATP synthesis in mitochondria or submitochondrial particles. 
The finding (Table 4.1) that rotenone and/or antimycin A alone is able 
to inhibit dihydrolipoic acid driven ATP synthesis in mitochondria, 
indicat~that the electrons deriving from dihydrolipoic acid enters the 
respiratory chci.n at site I (Fig. 4.2). However, the fact that ATP 
synthesis does not occur in submitochondrial particles actively synthesising 
ATP driven by succinate (Table 4.2), suggests that the electron deriving 
from dihydrolipoic acid does not enter the respiratory chain directly, 
but through an intermediate electron carrier. 
The results presented in Tables 4.3 and 4.4 illustrate 
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Table 4.2 ATP synthesis "in SUbmitochondrial particles 
Additions 
ATP synthesised 
nmol/min/mg 
" ..... " . . protein 
None 0.0 
Lip(SH)2 (1 ~mol) 0.0 
Lip(SH)2 (2 ~mol) 0.0 
a-Lipoic acid (I ~mol) 0.0 
Succinate (20 ~mol) 90.0 
Lip(SH)2 (2 ~mol) + Rotenone (2 ~g) + antimycin A 0.0 
Succinate (20 ~mol) + Rotenone (2 ~g) + antimycin A 0.0 
Lip(SH)2 (1 ~mol) + Succinate (20 ~mol) 85.0 
Lip(SH)2 (1 ~mol) + succinate (2 ~mol) + rotenone (2 ~g) 0.0 
+ antimycin A (2 ~g) 
ATP synthesis was assayed as described in Table 4.1 except that 
submitochondrial particles (2 mg) were used instead of mitochondria. 
Each value is the mean ~ s.d. of four duplicates. Amount of each 
component added is indicated in brackets. Lip(SH)2, dihydrolipoic 
acid. 
that ATP synthesis in mitochondria and submitochondrial particles 
is concomitant with the oxidation of dihydrolipoic acid. The results 
show that in the presence of rotenone and/or antimycin A, no 
oxidation of dihydrolipoic acid (monitored using Ellman's reagent 
DTNB) or synthesis of ATP occur in mitochondria (Table 4.3). 
However, in the absence of rotenone and antimycin A, oxidation of 
dihydrolipoic acid, and synthesis of ATP occurs simultaneously, and 
under the conditions of the experiment a Pi/dihydrolipoic acid 
ratio of 2.4 + 0.15 was obtained. This ratio was found to be fairly 
Table 4.3 Dihydrolipoic acid ATP synthesis in mitochondia 
Experiment A 
None 
Lip(SH)2 (1 llmol) 
Lip(SH)2 (2 llmol) 
Additions 
Lip(SH)2 (1 llmol) + rotenone + antimycin A 
Lip(SH)2 (2 llmol) + rotenone + antimycin A 
Lip(SH)2 (2 llmol) + rotenone (2 llg) 
Lip(SH)2 (2 llmol) + antimycin A (I llg) 
EXEeriment B 
Lip(SH)2 (2 llmol) 20 min incubation 
Lip(SH)2 (2 llmol) 40 min incubation 
Li~(SH)2:(2 llmol) 60 min incubation 
Lip(SH)2 (2 llmol) 80 min incubation 
Il llmol Lip(SH)2 
(oxidised) 
0.78 
1.4 
0.0 
0.0 
0.0 
0.0 
1.12 + 0.0 
1.40 + 0.0 
1.56 + 0.0 
1.89 :!: 0.0 
6. llmol pi 
(uptake) 
0.96 
3.90 
0.0 
0.0 
0.0 
0.0 
2.85 :!: 0.0 
3.90 :!: 0.0 
4.1 :!: 0.0 
4.3 :!: 0.0 
Pi/Lipoic acid 
1.2':!: 0.0 
2.8 :!: 0.2 
0.0 
0.0 
0.0 
0.0 
2.54 + 0.1 
2.80 :!: 0.0 
2.63 + 0.0 
2.0 :!: 0.0 
ATP synthesis was assayed by pi uptake as described in Fig. 4.1. Oxidation of dihydrolipoic acid was monitored 
by measuring the disappearance of free thiol groups using the method of Ellmann. (ISS). Each value is the mean 
of 5 duplicates. Lip(SH)2 dihydrolipoic acid. 
I 
-0 
...., 
I 
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independent of the time of incubation, but var~appreciably from one 
mitochondrial preparation to another (1.8-2.8). Table 4.4 shows that 
oxidation of dihydrolipoic acid and synthesis of ATP by submitochondrial 
+ particles only occurs when the cofactor NAD (nicotinamide adenine 
dinucleotide) is added to the assay system. The efficiency of conversion 
of dihydrolipoic acid to ATP is very low giving a Pi/dihydrolipoic acid 
ratio of less than 1 (Table 4.4). As in the case of mitochondria, 
dihydrolipoic acid oxidation, and the concomitant ATP synthesis is 
complete1yinhibited by rotenone and antimycin A (Table 4.4). The 
results presented in Tables 4.3 and 4.4 thus confirm the suggestion 
that the electrons deriving from dihydro1ipoic acid enter the 
respiratory chain at site I, and indicate that the intermediate 
electron carrier was NAD+. 
Dihydro1ipoic acid driven AlP synthesis in mitochondria 
is sensitive to inhibitors (oligomycin, DeeD) and uncouplers 
(TTFB, '1799' valinomycin) of oxidative phosphorylation (Table 4.5). 
The data presented in Table 4.5 shows that in the absence of the 
respiratory inhibitors, rotenone and antimycin A, the uncouplers 
and ionophores examined cause complete oxidation of dihydrolipoic 
acid without concomitant synthesis of AT~. Oligomycin and DeeD, 
unlike the uncouplers, not only cause complete inhibition of ATP 
synthesis, but also inhibit the rate of oxidation of dihydrolipoic 
acid in mitochondria. In the presence of oligomycin or DeeD 25% 
and 50% of the dihydrolipoic acid was oxidised, respectively. 
However. the ability of oligomycin to inhibit dihydrolipoic acid 
oxidation was dependent upon the mitochondrial preparation. Addition 
of the uncoupler TTFB to oligomycin treated mitochondria, causes 
complete oxidation of dihydrolipoic acid (Table 4.5). The results 
thus demonstrate that a typical energy transfer system is functioning' 
during dihydro1ipoic acid driven ATP synthesis, similar to that 
Table 4.4 Dihydrolipoic acid driven ATP synthesis in submitochondrial particles 
Lip(SH)2 (1 llmol) 
Lip(SH)2 (2 ~mol) 
Lip(SH)2 (1 ~mol) 
Lip(SH)2 (2 ~mol) 
Succinate 
Additions 
+ + NAD (50 nmol) 
+ + NAD (50 nmol) 
Lip(SH)2 (2 ~mol) + rotenone (2 llg) + 
antimycLn A (2 ~g) 
Lip(SH)2 (2 llmol) + NAD+ + 
rotenone (2 ~g) + antimycin A 
Lip(SH)2 oxidised 
(llmol) . . 
0.0 
0.0 
1.0 
2.0 
0.0 
0.0 
Pi uptake 
........ (pmol) . 
0.0 
0.0 
0.30 
1.18 
5.1 
0.0 
Q.O 
Pi/lipoic acid 
0.0 
0.0 
0.30 
0.59 
0.0 
0.0 
ATP synthesis and dihydrolipoic acid oxidation were assayed as described in Table 4.5. Submito~hondrial particles 
(2 mg) were preincubated in phosphorylation medium [± rotenone (2 llg) antimycin A (2 llg) ! NAn (50 nmol)] for 
5 minutes at 300 C. The reaction was initiated by addition of dihydrolipoic acia (lor 2 llmol) and allowed to 
run for 40 minutes. Total volume 1.1 mI. Each value is the mean of five duplicates. 
1, ': t,~ •• " ! " 
o 
..0 
I 
Table 4.5 
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Inhibitor sensitivity of dihydrolipoic acid driven ATP 
synthesis in mitochondria 
(DHL) oxidised ATP synthesised 
.. lJmol .. lJmol Pi Additions 
Dihydrolipoic acid (2 lJmol) 1.83 + 0.47 4.46 :!: 1.2 
" + DCCD 0.98 + 0.3 0.0 
-
0.54 + 0.40 0.0 
-
" + oligomycin 
" + TTFB 2.00 0.0 
" + CCCP 2.00 0.0 
" + '1799' 2.00 0.0 
" + gramicidin 2.00 0.0 
" + valinomycin 2.00 0.0 
" + 2,4-DNP 2.00 0.0 
" + oligomycin 2.00 0.0 
Succinate (20 lJmol) 4.86 
... , .. 
ATP synthesis and dihydrolipoic acid oxidation were assayed as 
described in Table 4.3. Mitochondria (2 mg) were incubated in 
phosphorylation buffer ! the inhibitor indicated above (2 lJg each) 
for 5 minutes at 300 C. The reaction was initiated by addition of 
dihydrolipoic acid (2 lJmol) or succinate and allowed to proceed 
for 20 minutes. Total volume 1.1 mI. Samples were removed for 
estimation of inorganic phosphate and free thiols. Each value is 
the mean of five duplicates. 
obtained when pyruvate/malate or succinate is used as respiratory 
substrate. 
When dihydrolipoic acid was replaced by oleoyl-lipoate as 
substrate, no ATP synthesis was obtained either in mitochondria 
(Table 4.6), submitochondrial particles (Table 4.7) or complex V 
(Table 4.8), either in the presence or absence of rotenone and 
antimycin A. Addition of catalytic amounts (10-20 nmol) of oleoyl-
phosphate, oleoyl-SCoA and/or oleic acid did not stimulate oleoyl-
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Table 4.6 ATP synthesis'in'mitochortdriadrivert'by'various'substrates 
Additions 
Experiment A 
None 
Lip(SH)2' (2 pmol) 
pyruvate/malate (20/2 pmol) 
Succinate (20 pmol) 
Oleoyl-lipoate (1 pmol) 
Oleoyl-lipoate (2 pmol) 
Total pi • 
t k ATP syntheslsed 
up,a e . nmol/min/mg (~mol ,20,mln).",.,.,.,.," " 
1.86 93.0 
3.4 170.0 
2.7 135.0 
0.0 0.0 
0.0 0.0 
Experiment B (+ rotenone + antimycin A) 
None 0.0 
Lip(SH)2(2 pmol) 0.0 
Oleoyl-lipoate (I pmol) 0.0 
Oleoyl-lipoate (2 pmol) 0.0 
Experiment C 
Succinate + oleoyl-phosphate (1 pmol) 0.0 
Succinate + oleoyl-lipoate (1 ~mol) 0.0 
Pyruvate/malate + oleoyl-lipoate (1 pmol) 0.0 
Lip(SH)2 + oleoyl-lipoate (1 pmol) 
Lip(SH)2 + oleoyl-phosphate(1 ~mol) 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
ATP synthesis was assayed as described in Table 4.1. Mitochondria 
(1 mg) ! rotenone (rot) and antimycin A (2 Pg each) were preincubated 
in phosphorylation at 300 C for 5 minutes. The appropriate substrates 
were then added to initiate the reaction. Final volume 1.1 mI. Each 
value is the mean of four duplicates. 
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Table 4.7 Ability of various substrates to drive ATP synthesis 
catalysed by submitochondrial particles 
Additions 
EXEeriment A 
None 
Lip(SH)2 (2 llIDol) 
Oleoyl-lipoate (1 \.lmol) 
Oleoyl-lipoate (2 \.lmol) 
Oleoyl-phosphate (1 lJmol) 
Oleoyl-phosphate (2 umol) 
Succinate (20 lJmol) 
Succinate + oleoyl-lipoate (J \.lmol) 
Succinate + oleoyl-phosphate (I Umol) 
Experiment B (+ rotenone + antimycin A) 
Lip(SH)2 + oleoyl-lipoate (10 nmol) 
Lip(SH)2 + oleoyl-CoA (10 nmol) 
Lip(SH)2 + oleoyl-phosphate (10 nmol) 
Succinate 
ATP synthesis/20 min/mg 
umol .1'i .. umol G6P 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
2.7 2.2 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
0.0 0.0 
, . , ... ...... 
ATP synthesis was estimated in a glucose-hexokinase trap system as 
described in Table 4.1. Submitochondrial particles (2 mg) were 
pre incubated in phosphorylation medium containing rotenone (2 Ug) 
and antimycin A, for 5 minutes at 300 C. The reaction was initiated 
by the addition of the appropriate substrates as indicated in the 
Table. The reaction was allowed to proceed for 20 minutes. Samples 
were then removed for estimation of inorganic phosphate and glucose-6-
phosphate. Each value is the mean of four duplicates. 
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Table 4.8 ATP synthesis catalysed by complex V 
Additions 
Lip(SH)2 (2 ~mol) 
Oleoyl-lipoate (1 ~mol) 
Oleoyl-lipoate (2 ~mol) 
Oteoyt-phosphate (1 ~mol) 
Oleoyl-phosphate (2 ~mol) 
Lip(SH)2 + oleic acid (10 nmol) 
Lip(SH)2 + oleoyl-CoA (10 nmol) 
Oleoyl-lipoate + CoASH (10 nmol) + Lip(SH)2 
ATP synthesised 
nmol/min/mg 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
Oleoyl-phosphate (10 nmol) + CoASH (10 nmol) + Lip(SH)2 ...... ~.O 
ATP synthesis was estimated in a glucose-hexokinase trap system as 
described in Materials and Methods. Complex V (0.5 mg) prepared by 
the method of Hatefi (151) was preincubated in phosphorylation 
medium for 5 minutes at 300 C. Total volume 1.0 mI. The reaction 
was initiated by the addition of the appropriate substrate as 
indicated in the Table. The reaction was allowed to proceed for 
20 minutes and samples removed for estimation of glucose-6-phosphate. 
Glucose-6-phosphate was assayed as described in Materials and Methods. 
Each value is the mean of five duplicates. 
lipoate driven ATP synthesis in submitochondrial particles (Table 4.7) or 
complex V (Table 4.8). Although catalytic amounts (10 nrnol) of 
oleoyl-lipoate did not affect succinate drivenATP synthesis in 
mitochondria or submitochondrial particlespsubstrate amount (1 ~mol) 
of oleoyl-lipoate was found to inhibit succinate driven ATP syntnesis 
completely (Tables 4.6 and 4.7). The inhibition of succinate 
driven ATP synthesis by oleoyl-lipoate and oleoyl-phosphate is 
probably due to their 'detergent-like' properties at such high 
concentrations (1 roM). This caused disruption of the mitochondrial 
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membrane structure and results in uncoupling of oxidative phosphoryla-
tion. Similar results to those presented in Tables 4.6-4.8 were 
obtained recently by Dickinson (250), Beauclerk (223) and Solaini 
(173) working on the same systems. These results are not surprising, 
since most fatty acids and their acyl-phosphate este~s have been 
shown to be potent uncouplers of oxidative phosphorylation, and 
energy-linked reactions in mitochondria, and submitochondrial 
particles (see Chapter 5). 
4.5 EFFECT OF DIHYDROLIPOIC ACIDANDOLEO~LIPOATEON 
NADH/NADP TRANSHYDROGENASE REACTION OF BEEF "HEART 
SUBMITOCHONDRIAL PARTICLES 
The ability of dihydrolipoic acid and oleoyl-lipoate to 
drive the energy-linked NADH/NADP+ transhydrogenase reaction in beef 
heart submitochondrial particles was investigated. The results 
presented in Table 4.9 show that neither dihydrolipoic acid, oleoyl-
lipoate nor oleoyl-phosphate was able to drive the NADH/NADP+ trans-
hydrogenase reaction in beef heart submitochondrial particles, 
having very active ATP and succinate driven transhydrogenase 
activity. This experiment was repeated on over sixty different 
preparations of beef heart submitochondrial particles, and on no 
occasion was dihydrolipoic acid or oleoyl-lipoate found to 
stimulate or drive transhydrogenation. Although dihydrolipoic acid 
driven transhydrogenase activity in submitochondrial particles has 
been reported by M. Carver (240), it must be emphasised that the 
reported frequency of occurrence was less than once in every 
hundred cases. This points to experimental error on his part, or 
an artefactual reaction. However, Carver has suggested that 
dihydrolipoic acid was not the high energy chemical intermediate, 
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Table 4.9 Effect of dihydrolipoicacid and certain acyl-esters 
on energy-linked transhydrogenaseactivity'in 
submitochondrial particles 
Additions 
None 
Lip(SH)2 (2 ~mol) 
Oleoyl-lipoate (I ~mol) 
Oleoyl-phosphate (1 ~mol) 
Lip(SH)2 + oleic acid (10 nmol) , 
oleol-CoA (10 nmol) 
Oleoyl-lipoate (1 mol) + oleoyl-CoA (10 nmol) 
oleoyl-phosphate (10 nmol) 
llP 
ATP + oleic acid (1 ~mol) 
ATP + oleoyl-phosphate (1 ~mol) 
ATP + oleoyl-lipoate (1 ~mol) 
Succinate (50 ~mol) 
Succinate + oleic acid (1 ~mol) 
Succinate + oleoyl-phosphate (1 ~mol) 
Succinate + oleoyl-lipoate (I ~mol) 
Transhydrogenase 
activity 
(omol NADPHf/min/mg) 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
48.0 
0.0 
0.0 
0.0 
62.0 
50.0 
58.0 
60.0 
Transhydrogenase activity was assayed as described in Materials 
and Methods. Submitochondrial particles (I mg) were pre incubated 
in transhydrogenase buffer containing 0.25 M sucrose, 50 mM 
tris-HCI, pH 8.0 (! oleic acid, oleoyl-CoA, oleoyl-phosphate) for 
5 minutes at 200 C. The reaction was initiated by the addition of 
the appropriate substrate, as indicated in the Table. Each value 
is the mean of four duplicates. 
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and that the intermediate responsible for driving the transhydrogenase 
activity might be one of the many reaction pro?ucts of dihydrolipoic 
acid. 
The data presented in Table 4.9 also show that addition 
of catalytic amounts (10 nmol) of either oleoyl-CoA, oleoyl-phosphate 
or oleic acid did not stimulate a dihydrolipoic acid or oleoyl-lipoate 
driven transhydrogenase activity. Although catalytic amounts 
(10 nmol) of oleic acid, oleoyl-phosphate and oleoyl-lipoate did not 
affect ATP driven transhydrogenase activity. substrate amounts 
(I ~mol) of these compounds completely abolished the reaction. 
However, succinate driven transhydrogenase activity was not 
significantly affected by ~mol oleic acid, oleoyl-phosphate or 
oleoyl-lipoate (Table 4.9). These results suggest that the 
oleoyl-lipoate, oleoyl-phosphate, and oleic acid uncouples ATP-driven 
transhydrogenase (cf. oxidative phosphorylation), but does not 
uncouple the respiratory chain linked reaction. 
4.6 DISCUSSION 
The results presented in this chapter confirm previous 
findings (132) that dihydrolipoic acid is able to drive ATP 
synthesis in intact beef heart mitochondria. However, ATP synthesis 
in submitochondrial particles was dependent on the addition of NAD+ 
(Table 4.4). Oleoyl-lipoate and oleoyl-phosphate were found to be 
inactive as substrates for generating ATP (Tables 4.7-4.8). Like 
dihydrolipoic acid, oleoyl-lipoate and oleoyl-phosphate were found 
to be incapable of driving the energy-linked trans hydrogenase 
activity in submitochondrial particles (Table 4.9). 
The evidence provided indicates that dihydrolipoic acid 
does not drive ATP synthesis in mitochondria or submitochondrial 
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particles by acting as a proton translocator (243) or 
a high energy chemical intermediate (132), but by acting as a 
respiratory substrate. This is illustrated by the results presented 
in Tables 4.3 and 4.4, which show that ATP synthesis in mitochondria 
and submitochondrial particles is dependent upon the oxidation of 
dihydro1ipoic acid. Inhibition of dihydro1ipoic acid oxidation 
in mitochondria and submitochondrial particles in the presence of 
NAD+, by the respiratory inhibitors rotenone and/or'antimycin A also 
causes inhibition of ATP synthesis. Further support for a 
respiratory substrate role for dihydro1ipoic acid is obtained in the 
work of Griffiths (]32) who showed that cyanide inhibition (at 
site 3) of dihydro1ipoic acid oxidation in mitochondria also resulted 
in inhibition of ATP synthesis. The findings that rotenone, antimycin A 
(Tables 4.],4.3-4.5) or cyanide alone ~]32) inhibited dihydrolipoic 
acid oxidation and ATP synthesis in mitochondria, indicate that the 
electrons deriving from dihydro1ipoic acid oxidation are donated to 
the respiratory chain at site I (see Fig. 4.2). However, the inability 
of submitochondrial particles to cata1yse the oxidation of 
dihydrolipoic acid in the absence of NAD+, indicat~that the electrons 
deriving from dihydrolipoic acid are not donated directly to the 
respiratory chain as suggested by Orlando (251), but are donated 
indirectly, via, the intermediate electron carrier NAD+. 
The evidence provided, thus suggests that the oxidation 
of dihydro1ipoic acid in mitochondria and the concomitant synthesis 
of ATP occurs in two steps. The mechanism of the overall process 
is shown in Fig. 4.2. The first step of the process is the reduction 
of NAD+ to NADH by dihydrolipoic acid (Fig. 4.2 reaction 1). This 
reaction is catalysed by the dihydro1ipoic acid reductase (E 1). The 
second step of the process, is the oxidation of the NADH produced in 
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(1) 
1\ ""'--7 \' 17\' ?4t NADH (2) 
ATP ADP+pi ATP ADp+pi ATP ADP+pi 
Overall reaction is 
Fig. 4.2 
Mechanism for dihydrolipoic acid driven ATP synthesis in beef heart 
mitochondria. 
(3) 
the first step, (reaction 1), by the respiratory chain, resulting in 
the synthesis of ATP in coupled mitochondria. The mechanism proposed 
in Fig. 4.2 is similar to that proposed for e-hydroxybutyrate driven 
oxidative phosphorylation in mitochondria (252). The proposed 
mechanism (Fig. 4.2) is supported by the fact that oxidised lipoic 
acid (a-lipoic acid) does not drive ATP synthesis (Tables 4.1 and 
4.2) and by the observed Pi/Lip(SH)2 (;pi/2e or pi/O) ratio of 2.4 
in mitochondria (Table 4.3). A Pi/Lip(SH)2 ratio of 3.0 in mitochondria 
has been reported previously (132). 
The inability of submitochondrial particles to catalyse 
dihydrolipoic acid oxidation or dihydrolipoic acid driven ATP synthesis 
in the absence of NAD+, can therefore be attributed to the loss of the 
cofactor (NAD+) during the preparation of submitochondrial particles 
from whole mitochondria. Similarly, the loss of cofactor and loss 
of active respiratory chain would also explain the inability of 
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complex V to catalyse dihydrolipoic acid oxidation, or dihydrolipoic 
acid driven ATP synthesis (Table 4.8, see ref. 132). 
Support for the mechanism outlined in Fig. 4.2 is 
enhanced by the finding that the dihydrolipoic acid reductase, EI , 
proposed in Fig. 4.2, is present in mitochondria and on well-washed 
submitochondrial particles (see Appendix II). The enzyme activity 
could not be removed from the submitochondrial particles by washing 
with 0.1% Triton, suggesting that the enzyme was tightly bound to the 
membrane. The enzyme was found to co-purify with the Fl ATPase 
when the chloroform extraction method of Tyler and Webb (152) 
was used. However, the extracted enzyme could be separated from 
Fl ATPase by ion exchange chromatography on a DEAE-Sephadex column 
(see Appendix II). The characteristic properties of the reductase 
such as, Km' Vm and pH optimum, were fo~nd to be independent of the 
presence of the membrane. Evidence for the presence of a mitochondrial 
dihydrolipoic acid reductase has been reported by a number of workers 
(253-254),many of whom have suggested that there were more than one 
type of dihydrolipoic acid reductase present. 
The reduc tiol1 potential of the pig heart dihydrolipoic 
acid reductase has been determined by L. J. Reed (206) from the extent 
of reduction at different NADH/NAD+ and Lip(SH)2/LipS2 ratios. Values 
of 0.32 ! 0.01 V and 0.325 V at pH 7.0 and 250 C were obtained 
\ 
respectively. These values are consistent with the reversibility of 
reaction 1 of Fig. 4.2, since the energy change in going in either 
direction is virtually zero. The direction of the reaction will, 
therefore, depend on the relative concentration of NADH, NAD+, 
Lip(SH)2 and LipS2 and also the pH of the reaction medium. Investigation 
of the dependence of the reductase activity on pH, showed that the 
pH optima of the forward reaction and reverse reaction were pH 8.0 
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and pH 6.3 respectively (see Appendix II). Thus, under the conditions 
of the phosphorylation experiment (NAD+ > NADH. Lip(SH)2)LipS2' and 
pH 7.4) the forward reactio~that is, the reduction of NAD+ to NADH, is the 
favoured reaction. The reaction is further driven forward due to the 
fact that the NADH produced (reaction 1, Fig. 4.2) is oxidised by the 
respiratory chain (reaction 2, Fig. 4.2). 
The fact that dihydrolipoic acid driven ATP synthesis is 
inhibited by inhibitors and uncouplers of oxidative phosphorylation 
(Table 4.5), indicate that a typical energy transfer reaction is 
occurring, similar to that occurring during succinate driven oxidative 
phosphorylation. The evidence provided, indicated that dihydrolipoic 
acid drives ATP synthesis in mitochondria, by acting as a respiratory 
substrate (cf.S-hydroxybutyrate), and thus refutes the cofactor roles 
proposed previously by other authors (1~2, 243). 
Oleoyl-lipoate and oleoyl-phosphate were found to be 
incapable of driving ATP synthesis catalysed by either, mitochondria, 
submitochondrial particles or complex V. Although catalytic amounts 
(5-10 nmol) of oleoyl-lipoate or oleoyl-phosphate did not have any 
effect on succinate driven oxidative phosphorylation in mitochondria, 
or submitochondrial particles, substrate quantities (1-2 ~mol) were 
found to uncouple succinate driven oxidative phosphorylation (Table 4.6). 
These results are in agreement with those reported by D. Dickinson 
(250) and Beauclerk (223) who have shown that oleoyl-lipoate and 
oleoyl-phosphate does not drive ATP synthesis. The results, however, 
conflict with the earlier reports of Griffiths (152) and Criddle (256), 
who have demonstrated oleoyl-lipoate and oleoyl-phosphate driven ATP 
synthesis. However, it is rather surprising that oleoyl-lipoate 
and oleoyl-phosphate should have been found to drive ATP synthesis 
in submitochondrial particles, since substrate concentrations 
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of these compounds inhibited succinate driven oxidative phosphoryla-
tion. It is inconceivable that oleoyl-lipoate and oleoyl-phosphate 
should uncouple succinate driven oxidative phsophorylation, but 
still drive an uncoupler sensitive ATP synthesis. Furthermore, 
oleic acid, one of the final products of the proposed reaction 
(Fig. 5.) for the oleoyl-lipoate driven ATP synthesis and oleoyl-
phosphate are potent uncouplers of oxidative phosphorylation 
(see Chapter 5). 
The inability of dihydrolipoic acid, oleoyl-lipoate 
or oleoyl-phosphate to driv~the energy-linked NADH/NADP transhydro-
genase reaction of submitochondrial particles, indicat~ that these 
compounds are not high energy chemical intermediates, nor do they 
give rise directly to-an energised state. The fact that oleoyl-
lipoate and oleoyl-phosphate inhibits AIP driven transhydrogenase 
reaction, but does not significantly affect the succinate driven 
reaction (Table 4.9) indicat~that oleoyl-lipoate ac~directly 
upon the ATP-synthase/ATPase energy coupling complex. 
The results presented in this Chapter demonstrate~ that 
dihydrolipoic acid drive ATP synthesis in mitochondria by acting as a 
NAD-linked respiratory substrate, in a similar way to e-hydroxy 
butyrate. The results do not provide any support for either the 
chemosmotic or chemical coupling hypothesis of oxidative 
phosphorylation, since dihydrolipoic acid does not act as a proton 
trans locator or high energy chemical intermediate. 
Although dihydrolipoic acid has been shown to drive ATP 
synthesis in mitochondria, [Table 4.1 (132)] and to stimulate photo-
phosphorylation in chloroplast (256) and NADH/NADP transhydrogenase 
activity in Rhodopseudomonas spheroides (251); these reactions 
might be biologically insignificant and artifactual, since in these 
reactions it acts as an artificial electron donor. At present there 
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is no convincing evidence of any other natural function of lipoic 
acid other than its established role in CoA and NAD-linked 
oxidative decarboxylation of a-keto acids (245). 
CHAPTER 5 
5. 
5.1 
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THE EFFECT OF FATTY ACIDS AND THEIR ACYL-ESTERS ON 
OS-ATPase, OXIDATIVE PHOSPHORYLATION AND ENERGY-
LINKED REACTIONS OF MITOCHONDRIA 
INTRODUCTION 
Long chain fatty acids occupy an important position in 
the energy metabolism of the cell. They are good respiratory 
substrates whose oxidation is coupled to the generation of ATP (183), 
but they can also be potent uncoup1ers of oxidative phosphorylation 
(184-186). It has therefore been suggested that fatty acids 
(or their acyl-esters) may playa role in the regu1ati~n of the 
degree of coupling between (184-189) respiration and the synthesis 
of ATP. Two different mechanisms have been proposed to explain the 
regulation of the degree of coupling between mitochondrial respiration 
and phosphorylation by fatty acid. Joel et a1. (190), Prusiner 
et a1. (191) and a number of other workers (192-194) have proposed 
that fatty acids regulate oxidative phosphorylation by acting as 
uncoup1ers of oxidative phosphorylation (~. FCCP Appendix I). 
Such a regulatory role of fatty acid has recently been postulated 
for the brown adipose tissue for which the main physiological role 
is thermoneogenesis(192-194). In brown adipose tissue, the fatty 
acids released by lipolysis are absorbed onto the mitochondria 
causing uncoupling of oxidative phosphorylation, while ensuring 
maximal rate of respiration. The energy released by oxidation 
is transformed directly to heat. Evidence in support of an 
uncoup1er mode of action of fatty acids, have been provided by 
Falcone and Mao (195) and a number of other workers (193-196) who 
have shown that fatty acids uncouple oxidative phosphorylation and 
32p_ATP exchange in mitochondria. These workers (193-196) also 
showed that the inhibitory action of fatty acids could be reversed 
by addition of bovine serum albumin. 
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Recently, however, fatty acids have been proposed to play 
a specific cofactor role in the terminal reactions of mitochondrial 
oxidative phosphorylation. The possibility that fatty acids and 
their acyl esters might act as intermediates of oxidative 
phosphorylation, was first proposed by Bode and Klingenberg (197), 
who suggested that the energy required for the formation of the 
acyl-S-CoA esters of fatty acids could be supplied directly by the 
high-energy intermediates of oxidative phosphorylation. Evidence 
that this process occurred in rat liver mitochondria was brought 
forward by Wojtczak et a1. (198-199). However, Pierrot"etal. 
(200) have demonstrated that the DNP and oligomycin insensitive 
fatty acid activation observed by Bode and Klingenber (197) and Wojtczak 
et a1. (198, 199) was due to substrate-level phosphorylation linked to 
the oxidation of the oxo-glutarate step of the TCA cycle. Inhibition 
of substrate-level phosphorylation with arsenite completely abolishes 
fatty acid activation in DNP treated mitochondria. The possibility 
that high-energy intermediates of oxidative phosphorylation cou1~ 
activate fatty acids without the intermediate formation, ,of nwdeotide triphosphate 
must, therefore, be ruled out. 
More recently, however, a cofactor role for lipoic acid 
and unsaturated fatty acids in oxidative phosphorylation has been 
postulated, and net synthesis of ATP catalysed by mitochondrial 
particles and ATP synthase preparations has been demonstrated 
utilising oleoyl-S-lipoate and oleoyl phosphate as substrates (132). 
Oleoyl phosphate dependent ATP synthesis by submitochondrial particles 
and ATP synthase preparations (complex V) was shown to be insensitive 
to uncoup1ers such as FCCP, TTFB and '1799' and to oligomycin and 
triethy1tin, but was sensitive to DCCD and F)-ATPase inhibitors such 
as efrapeptin ()32). These findings led Griffiths ()32) to propose 
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the 'oleoyl cycle' (Fig. 5.]) as a 'framework' for the investigation 
of the roles played by fatty acid, CoA and acyl-S-CoA esters in 
oxidative phosphorylation. In the 'oleoyl cycle' hypothesis, 
Griffiths proposed that the terminal steps of oxidative phosphorylation 
proceeded by a series of reactions involving acylation, transacylation 
phosphorylation and transphorylation (Fig. 5.]). Available evidence 
in support of such a series of reactionsis rather limited, and are 
contrary to those reported by a number of workers (19]-]96). 
Because of the controversial nature of the proposed 'oleoyl-cycle' 
of oxidation (and controversy always surrounds any new proposal for 
oxidative phosphorylation) we decided to investigate a possible 
cofactor role for fatty acids (especially oleic acid) and their 
derivativ~ in oxidative phosphorylation. 
In this Chapter we look at the effect of fatty acids 
and their acyl ester derivatives on oxidative phosphorylation, 
ATPase activity and other energy-linked reactions of mitochondria. 
Fig. 5.1 The oleoyl cycle of oxidative phosphorylation (224) 
Respiratory 
Lipoic acid (reduced) 
chain ~OleOYl-S-liPoate ~ CoASH-ACP 
Oleate. .:leOIl-S-COA-ACP 
ATP ~ Oleoyl phosphate +--- pi 
t 
~P 
ACP acyl carrier protein 
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5.2 MATERIALS 
All reagents were of AnaiaR grade. All fatty acids, and 
their acyl esters were obtained from Sigma Chemical Company. 
Mitochondria and submitochondrial particles were prepared as described 
in the Methods section of Chapter 2. Oleoyl-phosphate palmitoyl-
phosphate and elaidoyl-phosphate were prepared as described in the 
Methods section of Chapter 4. 32pi was obtained from the 
Radiochemical Centre, Amersham. 
5.3 METHODS 
Oxidative phosphorylation, ATPase activity, and trans-
hydrogenase activity were measured as dascribed in the Methods section 
of Chapter 2. 
ATP-pi exchange 
ATP-Pi exchange activity was determined as described 
by Stigall et al. (241). To 0.5 ml of a solution containing 50 mM 
tris-CI, pH 7.5; 500 mM sucrose; 30 mM MgS04; 40 mM potassium 
h h t (H 7 5) dd d 0 5 106 f· f 32. P osp a e p • ,was a e • x c.p.m. 0 carr1er ree P1 
and water to bring the volume to 0.90-0.95 mI. Submitochondrial 
particles, 1 mg (in 50-100 ~l volume)were then added and the 
mixture preincubated with any inhibitors or effectors for 5 minutes 
at 30° C. The reaction was started by adding 12 lJmoles ATP (50 lJI 
0.24 M ATP, pH 7.5) and terminated after 10 minutes by addition of 
0.5 ml I M PCA (perchloric acid) or 0.5 ml 10% trichloroacetic acid 
(TCA). Coagulated protein was removed by bench centrifugation and a 
0.5 ml aliquot from the supernatant taken for determination of 32p 
labelled ATP by a method based on that described by Pullman (242). 
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The 0.5 ml assay aliquot was taken into a 10 ml glass test tube 
containing 1.0 ml 5%ammonium molybdate in 5 N H2S04; I ml acetone 
was then added and the mixture mixed vigorously on a vortex shaker. 
0.1 ml bromine water was added followed by 5 mls water-saturated 
isobutanol/toluene (1:1, v/v). The mixture was vortex mixed for 
30 seconds and the upper layer removed by aspiration. The process 
was repeated. 5 ml of water-saturated isobutanol was then added, the 
mixture vortexed and the upper layer removed by aspiration. The 
remaining aqueous layer was extracted twice by water-saturated 
diethylether (5 ml) which was also removed by aspiration. Aliquots 
• . 1 d • • f 32p from the remaInIng aqueous ayer was taken for etermInatIon 0 
by liquid scintillation counting. 
5.4 RESULTS AND DISCUSSION 
Fig. 5.2 and Fig. 5.3 show the effect of various fatty 
acids on succinate driven oxidative phosphorylation in beef heart 
mitochondria and submitochondrial particles respectively. It can 
be seen that all the fatty acids investigated inhibit oxidative 
phosphorylation in mitochondria and submitochondrial particles and 
that the effectiveness of a fatty acid as an inhibitor depended on 
the nature of the fatty acid. For example, oleic acid, petroselenic 
acid, palmitic acid, stearic acid, elaidic acid and cis-linoleic acid 
at 80-100 nmol/mg protein fully inhibit oxidative phosphorylation 
(Table 5.1) in mitochondria. Oleic acid, elaidic acid and 
petroselenic acid were found to be twice as potent as the other fatty 
acids, causing 80-90% inhibition of ATP synthesis at 50 nmol/mg 
protein (Fig. 5.2, Table 5.1). Most of the fatty acids investigated 
were found to be much less effective in inhibiting oxidative phospho-
rylation in submitochondrial particles than in mitochondria 
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Fig. 5.2 Inhibition of succinate driven oxidative phosphorylation 
in beef heart mitochondria by fatty acids 
Oxidative phosphorylation was assayed as described in Materials 
and Methods. Mitochondria (I mg) were preincubated for 5 minutes 
at 300 C in phosphorylation medium containing 2 ~g rotenone and 
varying concentrations of fatty acid/derivatives. C) • oleic 
acid; () • petroselenic acid; V • stearic acid; T • palmitic 
acid;. • cis-vaselenic; [] • methyl palmitate. The reaction 
was initiated by addition of 20 ~mol succinate and allowed to 
run for 20 minutes. The specific rate of ATP synthesis of' 
mitochondria in a system containing no fatty acid i. 135 nmol 
ATP .ynthesised/min/mg protein. Experimental data has been 
,presented in the figure as a per cent inhibiti~n of this 
original value. Each point is the average of 4 duplicates • 
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Fatty acid (nmol/mg) 
Fatty acid/derivatives inhibition of succinate driven 
oxidative phosphorylation in submitochondrial particles 
All conditions for the measurement of ATP synthesis were as 
described in the legend of Fig. 6.2, except that submitochondrial 
particles and noJ mitochondria were used in the assay. ~ , 
oleic acid; • ,petroselenic acid; 0 ,stearic 'acid; ~ , 
palmitic acid. Specific rate of ATP synthesis in controlle~ 
samples containing no fatty acid is 110 nmol ATP synthesised/min/mg 
protein. Experimental data has been presented in the figure as a 
'per cent inhibition of this original value. Each data point i. 
the average of duplicates. 
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Table 5.1 Effect of fatty acids (derivatives) on succirt~te 
driven oxidative phosphorylation in mitochondria 
Fatty acid/derivative ATP synthesis % Activity (nmol/min/mg) 
None 135.0 100.0 
Oleic acid (100 runo!) 1 0.0 0.0 
Methyl oleate (100 runo!) 117.5 87.0 
Ethyl oleate (100 ronol) 126.5 93.5 
Butyl oleate (100 runol) 135.0 100.0 
Oleoy! phosphate (100 runol) 0.0 0.0 
Oleoyl-SCoA (25 nmol) 15.0 11. 1 
Palmi tic acid (100 nmol) 0.0 0.0 
Methyl palmitate (100 nmol) 135.0 100.0 
Ethyl palmitate (100 nmol) - 125.0 92.0 
Palmi toy! phosphate (100 nmol) 0.0 0.0 
Palmitoyl-SCoA (30 nmol) 37.5 27.5 
Elaidic acid (100 nmol) 0.0 0.0 
Elaidoyl phosphate (100 nmol) 0.0 0.0 
Petro selenic acid (100 nmol) 0.0 0.0 
FCCP (5 llg) 0.0 0.0 
, ...... 
ATP synthesis was estimated in a glucose-hexokinase trap system as 
described in Materials and Methods. Mitochondria were suspended 
in 0.25 M sucrose, 10 roM tris-HCI pH 7.4 at 20 mg/ml. Aliquots 
(1 mg protein) were added to the phosphorylation medium containing 
2 Vg rotenone and the fatty acids/derivatives presented in the 
Table. Total volume 1.0 mI. The amount of each fatty acid/derivatives 
added is presented in brackets. The mitochondria were preincubated 
for 5 minutes with ~nhibitors and fatty acid/derivatives, prior to 
initiation of the assay by addition of 20 vmol succinate. The data 
presented in the table represents the average of 4 duplicates. 
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(Figs. 5.2, 5.3) producing on average 30-40% inhibition in 
submitochondrial particles comparedwith 70-100% inhibition in 
mitochondria at 100 nmol/mg protein. However, oleic acid, 
petroselenic and elaidic acid were found to be Just as effective 
as inhibitors of oxidative phosphorylation in submitochondrial 
particles as in mitochondria, causing 80-100% inhibition 
(Tables5.1 and 5.2). The results presented in Tables 5.1 and 5.2 
show that the methyl, ethyl and butyl esters of oleic acid and 
palmitic acid had no effect on succinate ATP synthesis in mitochondria 
or submitochondrial particles. However, the acyl-phosphates of oleic, 
palmitic and elaidic acid were found to inhibit succinate driven 
oxidative phosphorylation in mitochondria and submitochondrial 
particles, while the acyl-S-CoA derivatives only inhibited ATP synthesis 
in intact mitochondria. 10-15 nmol/mg ~rotein of acyl-S-CoA was found 
to inhibit ATP-synthesis in intact mitochondria by 70-80%. 
Except for oleic acid and oleoyl-phosphate all fatty 
acids and their acyl-ester derivatives were found to have no significant 
effect on ATP-driven transhydrogenase activity of beef heart 
submitochondrial particles, not even at concentrations exceeding 
500 nmol/mg protein (Table 5.3, Fig. 5.4). Oleic acid and 
oleoyl-phosphate on the other hand were found to inhibit ATP-driven 
transhydrogenase by 70% and 65% respectively at 500 nmol/mg protein. 
However, like the other fatty acids and their acyl ester derivatives, 
oleic acid and oleoyl-phosphate were found to have no effect on the 
succinate driven transhydrogenase activity (Table 5.3). 
The results presented in Table 5.4 show that the Pi-ATP 
exchange activity of submitochondrial particles was significantly 
inhibited by oleic acid,elaidic acid and oleoyl-phosphate at 
100 nmol/mg protein. However, palmitic acid, its acyl ester 
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Table 5.2 Effect of fatty acids/derivatives on succinate driven 
oxidative phosphorylation in submitochondrial particles 
Fatty acid/derivative ATP synthesis % Activity (runol/min/mg) 
None 110.0 100.0 
Oleic acid (100 runol) 0.0 
Methyl oleate (J 00 runol) 110.0 100.0 
Ethyl oleate (J 00 runol) 110.0 100.0 
Butyl oleate (100 runol) 110.0 100.0 
Oleoyl phosphate (100 runol) 0.0 0.0 
Oleoyl-SCoA (40 runol) J 10.0 100.0 
Palmitic acid (100 runol) 65.0 57.6 
Methyl palmitate (J 00 runol) 110.0 100 
Palmitoyl-SCoA (50 runol) 92.0 84.0 
Elaid ic acid (100 nmol) 31.0 28.0 
Elaidoyl phosphate (100 runol) 0.0 0.0 
Carboxyatractyloside (1 ~ g) 106.0 96.2 
Petroselenic acid (100 runol) 24.0 23.0 
Oxidative phosphorylation was assayed as described in Methods. 
Submitochondrial particles (I mg) were preincubated in 1 ml phosphory-
lation buffer containing 2 ~g rotenone and fatty acid/derivatives 
(amount added indicated in brackets) for 5 minutes. The reaction 
was initiated by addition of 20 ~mol succinate and allowed to run 
for 20 minutes. The data presented in the Table represents the 
average of 4 duplicates. 
derivatives, oleoyl-S-CoA and oleoyl-S-lipoates did not significantly 
affect the pi-ATP exchange reaction (Table 5.4). These results are 
in complete contrast with those previously reported by Hyams"et "al., 
who found that oleic acid and its acyl ester derivatives were able 
to stimulate pi-ATP exchange activity more than 20 fold (225). 
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100 200 300 400 500 
Oleic acid (nmol/mg protein) --------~ 
Effects of fatty acids/derivatives on ATP-driven 
trans hydrogenase 
600 
Conditions of ATP-driven transhydrogenase assay were as described 
in Table 5.3. Submitochondrial particles were incubated at 
various concentrations of fatty acids/derivatives for 20 minutes 
at 250 C. I mg aliquots were then assayed for ATP driven 
transhydrogenase. The specific activity of the original 
submitochondrial particles is 36.3 ! 0.8 nmol NADPH formed/min/mg 
protein. Experimental data are expressed in the figure as a 
per cent of this original value. Each data point is the average 
of duplicates. ( ... ). methyl palmitate; (A). palmitic acid. 
(D). oleic acid and ([] ) oleoyl phosphate. 
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Table 5.3 Effect of fatty acids/derivatives on ATP-driven and 
succinate driven transhydrogenase activity of 
submitochondrial particles 
ATP-driven Succinate-driven 
Fatty acid/derivatives nmo 1 NADPHf / nmo 1 NADPHf / 
min/mg min/mg. 
None 36.3 60.0 
Oleic acid (200 nmol) 18.0 60.0 
Methyl oleate (200 runol) 35.8 60.0 
Ethyl oleate (200 nmol) 36.0 60.0 
Butyl oleate (200 runol) 36.7 60.0 
Oleoyl phosphate (200 nmol) 25.0 58.0 
Oleoyl CoA (50 nmol) 36.4 60.0 
Palmitic acid (200 runol) 30.2 60.0 
Methyl palmitate (200 runol) 36.0 60.0 
Palmitoyl phosphate (200 runol) 36.4 60.0 
Palmitoyl-SCoA (70 runol) 36.3 60.0 
Elaidic acid (200 runol) 36.5 60.0 
Elaidoyl phosphate (200 nmol) 35.9 60.0 
Transhydrogenase activity was assayed as described in Materials and 
Methods. Submitochondrial particles (1 mg) were preincubated in 
transhydrogenase assay medium containing 1 ~g rotenone (+ 1 ~g 
antimycin A), 50 roM tris-C1 pH 8.0, 0.25 M sucrose, 1 roM-EDTA, 
66 llH NAD+,0.33rrMNADP+, 10roM ethanol, 10 units alcohol dehydrogenase, 
and varying concentrations of various fatty acids/derivatives for 
5 minutes. The reaction was then initiated by adding ATP (12 ~mol) or 
succinate (50 ~mo1). NADPHf = NADPH formed. The data presented 
represents the average of duplicates. 
The inhibition of oxidative phosphorylation by fatty 
acids has been attributed to several different modes of action 
(198, 200). They have been proposed to act as uncoup1ers, 
having a similar mode of action to that of 2,4-dinitropheno1 (198, 200). 
Fatty acids are also powerful swelling agents of mitochondria 
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Table 5.4 The effect of fattr acids/derivatives ort 32p-ATP 
exchange catalysed by submitochondrial particles 
. . . . . . . . . 
Pi-AIP 
Exchange activity % Activity 
nmoles/min/mg 
None 280 + 20 100.0 
-
Palmitic acid (100 nmol) 260 + 10 93.0 
-
Palmitoyl phosphate (100 nmol) 260 + 12 93.0 
-
Palmitoyl-SCoA (50 ronol) 280 + 10 100.0 
-
Elaidic acid (100 nmol) 160 + 25 57.0 
-
Oleic acid (l00 runol) 95 + 15 34.0 
-
Oleoyl phosphate (100 runol) 100 + 12 35.7 
-
Oleoyl-SCoA (40 nmol) 260 + 18 93.0 
-
Oleoyl-S-lipoate (100 nmol) 210 + 17 75.0 
-
Oligomycin (2 Jlg) 0 0.0 
DNP (2 Jlg) 0 0.0 
TTFB (2 lIg) 0 0.0 
pi-ATP exchange activity was assayed as described in Materials and 
Methods. The reaction mixture 25 mM tris-S04, pH 7.5, 15 mM MgCI2' 20 mM potassium phosphate, 250 mM sucrose 0.5 x 106 c.p.m. 32p and 
1.0 mg submitochondrial particles. The reaction mixture was 
pre incubated with added fatty acid/derivatives! inhibitors (2 ~g) 
(added as methanolic solutions) for 5 minutes at 300 C. The reaction 
was initiated by addition of 50 ~l. 0.24 M ATP pH 7.5. Final volume 
1.0 mI. Each value presented is the mean! s.d. of five duplicates. 
No correction for ATP hydrolysis was made in calculation of Pi-ATP 
exchange activity. The amount of fatty acid/derivatives added is 
presented in brackets. 
(186, 226) and their uncoupling action has been correlated with their 
swelling action. Both effects have been shown by Wojtczak and others 
(186, 198, 198) to be strongly dependent on the length of the carbon 
chain and on the presence or absence of double bonds, the most 
potent being the longchain unsaturated fatty acids. An uncoupling 
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mode of action for fatty acids on oxidative phosphorylation is 
supported by the findings that, fatty acid aVo concentration (100 nmol/ 
mg) which maximally stimulate succinate oxidation (186, 198), inhibits 
32pi-ATP exchange (Table 5.4 and ref. 198) and ATP synthesis (Figs. 5.2 
and 5.3) does not induce significant mitochondrial swelling (186, 189, 
198) or affect the OS-ATPase activity. Fatty acids are thus proposed 
to uncouple oxidative phosphorylation and other energy-linked reactions 
by acting as a protonophore which transporaproton across the mitochon-
drial membrane, resulting in the elimination of the proton gradient. 
Recent studies by Carafoli and Rossi (227) has shown that fatty acids 
facilitate the transport of protons across the mitochondrial membrane. 
The uncoupling action of fatty acids, thus depend on the ability of 
the fatty acid to transport protons, which in turn will depend on the 
presence of a 'free' carboxylic group aud on its pKa. This is borne 
out by the fact that the methyl, ethyl and butyl esters of oleic acid 
and palmitic acid does not affect oxidative phosphorylation or 
energy-linked reactions (Tables 5.1-5.3). The acyl-phosphates, however, 
because of their anionic nature, are potent uncouplers of oxidative 
phosphorylation and energy-linked reactions (Table 5.1-5.4). 
The results presented in Tables 5.1 and 5.2, also show 
that although the CoA esters of oleic and palmitic acid do not affect 
ATP synthesis in submitochondrial particles at low concentration 
(30 nmol/mg protein), they inhibit ATP synthesis in intact 
mitochondria by 70-80% at 20-30 nmol/mg protein. The inhibition of 
ATP synthesis by these acyl-CoA esters have been attributed to 
their inhibition of adenine nucleotide translocation in mitochondria 
(228-232). This makes the availability of ADP the rate limiting step 
in oxidative phosphorylation. The inhibition of ADP translocation is 
supported by the fact that the acyl-CoA esters do not affect 
succinate driven oxidative phosphorylation in submitochondrial 
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particles. Acy1-CoA esters have also been shown to bind specifically 
to the adenine nucleotide translocase (a 30,000 molecular weight 
protein identical to the one bound by carboxy atracty10side and 
bongkrekic acid) thus causing inhibition, by blocking a conformational 
change that is obligatory for the action of the translocase (198, 
232). However, in contrast to atractyloside and bongkrekic acid, 
long chain fatty acyl-CoA esters bind and inhibit the ADP/ATP 
translocase from both the cytosolic and the matrix sides of the 
inner membrane (228-232). 
A controversial issue which is recognised as one of the 
most fundamental in bioenergetics is whether or not the ADP/ATP 
carrier is rate limiting in the overall reaction of oxidative 
phosphorylation (233). Another important question under consideration 
is whether or not long chain acyl-CoA e£ters are physiological 
effectors of adenine nucleotide translocation (228, 229). The two 
issues are closely inter-related, and it would seem logical to 
expect that a reaction that is carefully regulated, is itself rate 
limiting or vice versa. Davis and Lumeng (234) reported marked 
effects of palmitoy1 CoA on the steady state internal and external 
phosphorylation potentials generated by respiring mitochondria under 
experimental conditions where the ADP/ATP carrier was rate limiting. 
The present results, on the effect of oleoy1 and palmitoyl CoA 
esters on oxidative phosphorylation in beef heart mitochondria 
presented in Table 5.1, provide independent support for the more 
recent reports (235-236), which conclude that the adenine nucleotide 
translocase is the rate limiting step in oxidative phosphorylation. 
Peculiar, and not typical of other uncouplers of 
oxidative phosphorylation, is the effect of fatty acids on ATPase 
activity in mitochondria (198, 237, 238), submitochondrial particles 
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and the soluble Ft-ATPase. This is shown on Figs. 5.5-5.9. 
Under the experimental conditions employed, increasing the amount of 
oleic acid was found to stimulate the latent ATPase activity in 
mitochondria (Fig. 5.5), submitochondrial particles (Figs. 5.5, 5.6) 
and F)-ATPase (Fig. 5.7), attaining a maximum usually at 400-500 nmol/mg 
protein. At oleate concentration above 400 nmol/mg protein the ATPase 
activity of mitochondria and submitochondrial particles becomes 
insensitive to inhibition by oligomycin, dicyc10hexylcarbodiimide 
(DCCD) and dibuty1ch10romethy1tin ch1o~ide (DBCT) (Fig. 5.8). 
Stimulation of the latent ATPase activity of submitochondrial particles 
was also obtained with most of the fatty acids studied (Fig. 5.6) 
but the degree of stimulation were much smaller than that obtained 
with oleic acid. The stimulation and the sensitivity to oligomycin 
DBCT, and DCCD can be reversed by serum albumin (Table 5.5 and 
Fig. 5.9). The results presented on Fig. 5.9 also show that the 
amount of serum albumin required to completely reverse DBCT inhibition 
of oleic acid treated submitochondrial particles was dependent upon 
the amount of oleic acid used, and that the serum albumin did not 
affect the ATPase activity in submitochondrial particles. 
The effects of fatty acids on the ATPase activity of 
mitochondria, submitochondrial particles and F] are contrary to those 
of 2,4-dinitropheno1 and other typical uncouplers, which has been 
shown to stimulate only the membrane bound oligomycin sensitive ATPase 
which is irreversible by serum albumin. The effects however are 
strikingly similar to the action of the surface active agent 
deoxycholate on mitochondrial ATPase (198). The stimulation of the 
ATPase activity in intact mitochondria has been suggested (198) 
to be due to the increased permeability of the mitochondria, 
brought about through breakdown of the mitochondrial membrane structure 
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Oleic acid (nmol/mg) 
Stimulation of ATPase activity in mitochondria and 
submitochondrial particles by oleic acid 
1200 
ATPase activity was assayed as described in Methods. Mitochondria 
and submitochondrial particles suspended at 10 mg/ml, were 
preincubated for 30 minutes at 250 C with various concentrations 
of oleic acid. 10 ~l aliquots (IOO ~g) were then assayed for 
ATPase activity. The specific activity of the original mitochondria 
(O ) is 1.2 ~mol/min/mg protein. and submitochondrial particles 
( • ) is 2.5 vmol/min/mg. Each data point is the average of 
duplicates. 
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Fatty acids (nmol/mg) 
Stimulation of ATPase activity in beef heart submito-
chondrial particles by fatty acids 
Submitochondrial particles were treated with various fatty acid 
concentrations and assayed for ATPase activity as described in 
the legend of Fig. 5.5 (<) ) t oleic acid; (.). cis-vaselenic: 
acid; (0), elaidic acid; (0). palmitic acid. 
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Fig. 5.7 Stimulation of the FI ATPase activity by oleic acid 
ATPase activity was assayed as described in Methods. Fl ATPase 
(10 ~g) was preincubated for 5 minutes at 300 C in 1 ml (50 ruM 
tris-Cl. pH 8.5; 5 roM MgC12) buffer with various concentrations 
of oleic acid. Each point on the graph represents the mean of 
five duplicates. 
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Oleic acid (nmol/mg) 
Reversal of DBCT and oligomycin inhibited ATPase 
activity of submitochondrial particles by oleic 
acid 
ATPase activity was assayed as described in Materials and 
Methods. Submitochondrial particles suspended at 10 mg/ml 
pretreated with oligomycin or DBCT (5 nmol/mg) were incubated 
with various concentration of oleic acid. 10 ~l aliquots 
(100 ~g) were removed and assayed for ATPase activity. (0) 
uninhibited. (~ ) inhibited with DBCT. (4o ) inhibited wi th 
oligomycin. 
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BSA (mg/ml) -----. 
Effect of bovine serum albumin on oleic acid reversal 
of OBCT inhibited ATPase activity in submitochondrial 
particles 
Submitochondrial particles suspended at 10 mg/ml, pretreated with 
OBCT (S nmol/mg protein) were treated with oleic acid at 
SO nmol/mg protein (~) and 100 nmol/mg protein (0). 100 ~g 
aliquots were then preincubated in J.O ml of ATPase buffer con-
taining various concentrations of bovine serum albumin (BSA) 
for 5 minutes and assayed for ATPase activity. Specific ATPase 
activity of untreated submitochondrial particles is 2.0 ~mol/min/mg 
plJtein. Experimental data are presented in the figure as a 
per cent of this value. (0), not treated with OBeT; (.) + 
OBCT - oleic acid • 
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by oleic acid. Under these conditions the penetration of ATP into 
the mitochondria is no longer dependent on the rate limiting action 
of the ADP/ATP translocase. The insensitivity of the ATPase 
activity under these conditions to atractyloside has been used (198) 
as evidence to support this explanation. However, although oleate-
induced increased permeability might be partially responsible for 
the increased ATPase activity in mitochondria, increased permeability 
cannot be used to explain the stimulation of the ATPase activity in 
submitochondrial particles and F1-ATPase since the avai:ability of 
ATP is not a rate limiting factor, nor the inhibitor insensitivity 
induced by oleate (Fig. 5.7). The simplest explanation is that 
oleate, due to its detergent effect at high concentration, causes 
solubilisation of the more active F1-ATPase from the membrane. The 
F.-ATPase activity which is insensitive. to oligomycin, DCCD and DBCT 
being further stimulated by the oleic acid. However, the fact that 
oleate stimulation of ATPase activity and its induced inhibitor 
insensitivity can be reversed with serum albumin (Table 5.5), suggests 
that the F1-ATPase is not solubilised off the membrane. This was 
confirmed by using a procedure in which oleate treated submitochondrial 
particles (500 nmol/mg protein) were centrifuged at 100,000 g for 
one hour. Using this procedure all the ATPase activity was found 
to be present in the 'pelleted' membrane fraction. 
The results are more suitably explained by the induction 
of a morphological change in membrane structure, which cause a 
'dislocation' of the F)-ATPase on (not dis-association from) the 
membrane. This results in increased ATPase activity, and induce 
inhibitor insensitivity. Removal of the oleate with serum 
albumin releases the dislocation concommitantly reversing 
inhibitor sensitivity. The induced insensitivity of the ATPase 
activity to DCCD, oligomycin and DBCT by oleate has been suggested 
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Table 5.5 Sensitivity of the ATPase activity of oleate treated 
submitochondrial particles to ATPase inhibitors 
Addition 
Specific % Activity ATPase activity 
umol/min/mg protein of control 
None 2.00 100 
1 mg serum albumin/mg SMP 1.94 97.0 
Oligomycin (2 ~g/mg protein) 0.07 3.5 
Oligomycin + BSA 0.09 4.5 
Oleic acid (500 nmol/mg) 3.20 160.0 
Oleic acid + BSA 2.15 107.5 
Oligomycin + oleic acid 3.30 165.0 
Oligomycin + oleic acid + BSA 0.38 19.0 
neCD (5 nmol/mg protein) 0.04 2.0 
DCCD + BSA 0.04 2.0 
DCCD + oleic acid 3.25 162.5 
DBCT (5 nmol/mg protein) 0.08 4.0 
DBCT + oleic acid 3.40 170.0 
Efrapeptin (2 ~g/mg) 0.0 0.0 
Efrapeptin + oleic acid 0.0 0.0 
Submitochondrial particles suspended at 10 mg/ml were preincubated 
with various ATPase inhibitors for 30 minutes at 40 C. 2 mg aliquots 
of this suspension were preincubated with oleic acid (500 nmol/mg 
protein! bovine serum albumin (1 mg BSA/mg SMP) at 250 C for 60 minutes. 
The BSA was added after 30 minutes preincubation with oleic acid. 
ATPase activity was then assayed as described in Methods. Each value 
presented in the table is the mean of 5 duplicates. 
by Bertoli (239) to be due simply to the sequestering of the inhibitors 
by oleate, making them unavailable for inhibition. However, such a 
mechanism could not be used to explain the induced insensitivity to 
DC CD which, unlike DBCT and oligomycin is a covalent inhibitor of the 
ATPase (181). 
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The insensitivity of the ATPase of oleate-treated 
submitochondrial particles to DCCD has also been reported by 
M. Carver (240) who suggested that oleic acid was playing a 
cofactor role in the ATPase reaction. This, in my view was a 
gross mis-interpretation of the results. 
5.5 CONCLUSION 
The results presented in this Chapter have shown that 
most fatty acids and their acyl-esters are potent uncouplers of 
oxidative phosphorylation and energy-linked reactions at relatively 
low concentration (100 nmol/mg). At higher concentration, 
200-500 nmol/mg, they stimulate ATPase activity and induce insensitivity 
to oligomycin, DCCD and DBCT in mitochoudria and submitochondrial 
particles, which is reversible by treatment with serum albumin. The 
acyl-CoA esters at low concentration, (10-20 nmol/mg protein} inhibit 
ATP synthesis only in intact mitochondria, whereth¥ inhibits the 
ADP/ATP translocase. The results do not indicate a cofactor role for 
oleic acid or any of its acyl-ester derivatives in oxidative phosphory-
lation or energy--linked reactions. 
CHAPTER 6 
6. 
6.1 
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'ENZYMIC METHOD 'FOR 'THE QUANTITATIVE DETERMINATION 
OF N&~OMOLE'AMOUNTS OF TOTAL LIPOIC ACID AND 
LIPO&~IDE 
INTRODUCTION 
a-Lipoic acid (1,2-dithiolane-3-valeric acid) was 
discovered independently in several laboratories in the late ]940's, 
and was shown to be an accessory growth factor for a variety of 
micro-organisms (20]-207). It is a five-membered cyclic dithiolane 
with a five carbon carboxylic acid side chain (Fig. 6.]). The 
pure crystalline compound is pale yellow in colour (A 330 nm), 
max 
25 has a pKa of 4.7 and is optically active ([aJD - 96.7). The 
chiral centre at C6 of the lipoic acid molecule is responsible 
for the optical activity. Lipoic acid~s relatively stable in the 
solid state. However, when it is heated above its melting point, 
or its solutions are exposed to light, it undergoes thermal or 
photochemical fission of the disulphide linkage into thiyl 
radicals which subsequently polymerise (208). a-Lipoic acid is 
readily oxidised to the sulphoxide (B-lipoic acid) with mild 
oxidising agents such as hydroperoxides, or when allowed to stand 
in air (207). The unique reactivity and instability of lipoic 
acid has been attributed to the ring strain inherent in the 
Fig. 6.1 Structure of lipoic'acid 
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molecule (207, 209). The ring strain is thought to arise from 
electron repulsion (orbital overlap) between the filled non-bonding 
p-orbitals on adjacent sulphur atoms of the dithiolane ring. The 
ring strain has been estimated from spectral and thermal combustion 
analysis to have a value of 17-29 kJ/mole (207, 210). It is this 
high reactivity of the disulphide bond of the dithiolane ring that is 
responsible for the biological activity of lipoic acid. 
Lipoic acid is widely distribu ted among micro-organisms, 
plants and animals. Although it has been shown to stimulate growth 
in micro-organisms (201-207), it has never been shown to stimulate 
growth response in higher animals. However, there is no doubt that 
lipoic acid plays a vital role in animal metabolism. At present, 
the only well defined role of lipoic acid is that of a prosthetic 
group in multienzyme complexes, which catalyse the oxidative 
decarboxylation of a-keto acids, such as, pyruvate and a-ketoglutarate 
(207, 211-214). The presently accepted mechanism of the pyruvate 
dehydrogenase complex, which catalyses the overall reaction 
o 0 
II + II CH3-C-COOH + NAD + CoASH ~ CH3-C-SCoA + CO2 + NADH + H+, 
outlined in Fig. 6.2. The mechanism depicts a central role for 
lipoic acid, which serves a physical transport role within E2 
(Fig. 6.2) in addition to its chemical participation in the 
reaction sequence (212, 214). Recently, proposals implicating an 
energy coupling role for lipoic acid during photosynthetic and 
oxidative phosphorylation have been put forward by a number of 
workers (132). However, in studies carried out on spinach chloroplast 
(215), E. coli lipoic acid auxotrophs (216, 217) and beef heart 
mitochondria (see Chapter 4 of this thesis), no evidence was 
obtained to support these proposals. 
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o 
\I 
CH -C-CO H 3 2 
Fig. 6.2 Reaction mechanism of pyruvate dehydrogenase complex 
of E. coli. EI. pyruvate decarboxylase; E2. lipoyl-
transferase; E3. dihydrolipoic acid dehydrogenase; 
TPP, thiamine pyrophosphate (see refs. 207. 212-214). 
The conservative cellular distribution of lipoic acid 
and its apparent involvement in a number of biological functions, 
have generated continual interest for methods of analysis of this 
cellular component. Several turbidimetric and monometric methods 
[see (218) for review] have been described for the assay of lipoic 
acid. Most of these methods utilise the growth requirement of 
certain micro-organisms for lipoic acid. More recently, mutants 
of E. coli that are unable to synthesise lipoic acid have been 
characterised and found to have a lipoic acid requirement of 
0.5 ng/ml for half maximal aerobic growth (219). These bioassay 
techniques are very sensitive; lipoic acid at levels of 0.2-2.0 ng 
and 5-50 ng can be measured with the turbidimetric and polarographic 
metho~respectively. However, the values obtained are usually very 
sporadic and unreliable. This is due to the dependence of growth 
of the micro-organisms on such variables as pH and temperature. 
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Fig. 6.3 Proposed mechani~ for the catalytic reduction of 5.5'-dithiobis(2-nitrobenzoic acid) (DTNB) to 
thionitrobenzoic acid by NADH in the standard assay system. EJ i. lipoamide dehydrogenase. 
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fluctuation of which produces erratic growth. Furthermore, these 
methods of analysis are very laborious and can take up to six days to 
assay a single sample (218). 
In this Chapter we report in detail, the composition, 
mechanism and characteristic properties of a method for the 
measurements of nanomole amounts of lipoic acid. The method is 
based on the reduction of S,S-dithiobis{2-nitrobenzoic acid) (DTNS) 
by NADH, in the presence of catalytic amounts of lipoic acid (or 
lipoamide), in a system in which dihydrolipoic acid is continually 
regenerated from its oxidised form, in a cyclic manner. The mechanism 
on which this method is based is outlined in Fig. 6.3 and is essentially 
the same as that proposed by Perhamet ale (214) for the reduction 
of DTNB by the a-keto acid dehydrogenase complexes. The mechanism 
depicts a coupled assay system in which the formation of dihydrolipoic 
acid from oxidised lipoic acid in the presence of NADH and lipoamide 
dehydrogenase, is followed by the rapid reaction of dihydrolipoic 
acid with DTNB to produce oxidised lipoic acid and 2-nitro-thiobenzoic 
acid. The 2-nitrobenzoate anion is a chromophoric ion, having a molar 
absorption coefficient of 13,600 at 412 nm (214) which is about twice 
that of NADH at 340 nm. The reaction can therefore be conveniently 
followed by monitoring the increasing absorbance at 412 nm. Unlike 
previous methods of analysis, fue method described here measures 
the total lipoic (reduced + oxidised) content of unknown mixtures. 
It is not subjected to any appreciable interference by the presence 
of other thiol components. 
6.2 MATERIALS AND METHODS 
Reduced pyridine nucleotides, glutathione (reduced and 
oxidised) were obtained from Calbiochem. Cysteine hydrochloride, 
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pig heart lipoamide dehydrogenase were purchased from Sigma Chemical 
Company. DTNB was purchased from Aldrich Chemical Company. Lipoic 
acid, lipoamide and dihydrolipoic acid, 2,3-dimercaptopropanoI, 
jithiothreitol and mercaptoethano1 were obtained as indicated in 
Materials section of Chapter 2. Mitochondria and submitochondrial 
particles were prepared from beef heart as described in the Methods 
section of Chapter 2. Rat kidney, heart and liver homogenates 
were prepared by grinding the blotted and weighed tissues at 00 C 
in a Potter-E1vehjem apparatus with Teflon pestle. Pra-coated 
TLC plates were obtained as described in the Materials section 
of Chapter 3. 
Hydrolysis and extraction of lipoate from tissues 
Mitochondria (1.0 g), submitochondrial particles (0.4 g) 
and the 'total tissue homogenates' of liver, heart and kidney derived 
from rats were suspended at ~ 20 mg/m1 in 50 mM K H2P04 , 1 mM EDTA, 
pH 6.3 buffer. 4 ml aliquots of suspensions were placed in 5 ml 
long necked glass vials, and made ~ 0.]25 M NaOH by addition of the 
appropriate (100 ~l) amount of 5 M NaOH each of which was sealed under 
an atmosphere of nitrogen. The vials were then autoclaved at 15 psi for 
3 hours. The hydrolysates from each tissue were combined separately, 
diluted I:] with 3 x distilled water, acidified with 6 M HC! to 
pH 2-3, and extracted with 2 volumes of chloroform. Using a separating 
funnel, the lower organic layer containing the lipoic acid was run off 
into a round-bottomed flask and the remaining aqueous layer re-extracted 
with 2 vol. chloroform. The pooled organic extracts were rotary evaporated 
to remove the chloroform, and the residue resuspended in 0.5 ml of 
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chloroform. Samples of these extracts were 'spotted' onto analytical 
TLC plates and spread onto preparative TLC plates which had been 
previously cleaned by allowing the developing solvent to run to the 
top of the plates. 
All the plates were developed in a chromatography tank 
containing 150 ml of chloroform/methanol (2:1), which had previously 
been allowed to equilibriate for 3 hours. The plates were visualised 
by exposure to iodine in an enclosed chamber, and the band(s) running 
in the position corresponding to authentic lipoic acid scraped off 
the preparative TLC plates. The scrapings were added to a round 
bottomed flask containing 50 mls of distilled chloroform and allowed 
to stand for 24 hours. The supernatant was decanted off into another 
round bottomed flask, rotary evaporated to dryness and the residue 
resuspended in O.S ml methanol. This sQlution was then assayed for 
lipoate in the standard assay system. Controlled samples containing 
known amounts of lipoate, in which the lipoate was protected by 
BSA (20 mg/ml) were treated similarly. 
6.3 RESULTS 
A preliminary investigation of the dependence of 
5,S-dithiobis(2,nitrobenzoic acid) (DTNB) reduction on the components 
of the assay system, resulted in the adaptation of the experimental 
arrangement shown in Table 6.1, for the routine assay of lipoic acid. 
This protocol, which is referred to hereafter as the 'standard assay 
system', makes use of two reaction mixtures balanced with respect 
to all components except lipoic acid or lipoamide. The employment 
of such a balanced system was dictated by the necessity for 
correction of the background rate of DTNB reduction by the 
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NADH, lipoamide dehydrogenase pair alone (see Fig. 6.4, line I), 
a reaction which becomes significant at low concentrations of 
lipoate. The employment of the balanced system coupled with the 
use of a double beam spectrophotometer, allows automatic corrections 
to be carried out. 
Table 6.] Standard assay system 
Test cuvette Amount. .. Blank .cuvette .. 
• 
50 mM phosphate buffer (pH 6.3) 1.0 50 mM phosphate buffer 
DTNB 0.6 J.!mole DTNB 
Lipoamide dehydrogenase 100 J.!g Lipoamide dehydrogenase 
Lipoic acid or lipoamide x nmoles 
NADH 1 .2 J,UllO I NADH 
Components were dissolved in 50 mM sodium phosphate/O.s mM EDTA 
buffer pH 6.3, and were added in the amounts and in the order 
indicated. Lipoic acid or lipoamide were added as methanolic 
solutions. The final volume was ].36 mI. The rate of reaction 
at 200 C was usually expressed as the change in absorbance per 
6 minutes at 412 run. The reaction was initiated by the addition 
of NADH. 
Typical photometric tracings resulting from the reduction 
of DTNB in reaction mixtures containing 0-50 ornol lipoic acid and 
0-4 runol lipoamide are shown in Fig. 6.4. Fig. 6.4 shows that the rate 
of reduction of DTNB (i.e. the rate of increase of absorbance at 
~ 412 run) on addition of NADH to initiate the reaction, is linear max 
with time, well beyond the 6 minutes employed as the basis of 
measurement. The results presented on Fig. 6.5 show that the rate of 
DTNB reduction is independent of NADH concentration above 200 J.!M. This 
may be due to the fact that at 200 J.!M, the concentration of. the NADH 
is 8-10 fold greater than the Km (20-30 J.!M) of the enzyme for NADH 
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• T'lpical spectrophotometric tracings obtained during 
~eduction of DTNB by catalytic quantities of lipoic 
acid or lipoamide in the standard assay system 
containing NADH pig heart lipoamide dehydrogen~se 
Tracings were produced with the balanced system of Table 6.1 using 
(J),O.O; (2),10; (3),20.0; (4),50.0;(,.1)),75.0 nmol lipoic acid 
and (6), 0.2; (7), 2.0; (8), 4.0 nmol lipoamide. The system 
containing all the components except NADH was incubated for 2 minutes. 
NADH was then added to initiate the reaction. 
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DTNI 
0.5 1.0 1.5 2.0 
Component (~ moles) 
Dependence of the rate of DTNB reduction in the 
presence of catalytic amounts of lipoic acid on the 
concentration of the components of the 'standard 
assay system! 
50 nmol lipoic acid was added to the assay system containing 
100 ~g lipoamide dehydrogenase. 1.0 ~M NAnH and the DTNB concentra-
tion varied or SO nmol lipoic acid, 100 ~g lipoamide dehydrogenase 
and 0.5 ~mol DTNB and the NADH concentration varied. The data 
is presented on the figure as the 60D412 nm/6 min against the 
concentration of the varied component. [J , NADH; 12, DTNB. 
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(207, 210). Like NADH, DTNB at concentrations above that giving 
m~ximal reaction rate ( 0.6 roM) cause inhibition of the rate of 
DTNB reduction (Fig. 6.5). This inhibition may be due in part to 
the susceptibility of the lipoamide dehydrogenase to inhibition 
by sulphydryl reagents in general, or to diminution in the amount 
of lipoic acid formed cyclically in the reaction. The rate of the 
reaction was found to be proportional to the amount of enzyme added to the 
system. Systematic experiments showed that the rate of reduction of DTNB 
in the presence of catalytic amounts of lipoic acid or lipoamide, was 
not influenced by the order of addition of the components listed in 
Table 6.1. However, it was considered desirable to follow the specific 
order indicated in the foregoing protocol. This allows sufficient time 
for the nonenzymic reaction of DTNB with thiol components (e.g. cysteine) 
present in the mixture undergoing ana1~sis, prior to initiation of the 
enzymic reaction. 
Fig. 6.6 and 6.7 show that the rate of DTNB reduction 
(~OD4)2 nm /6 minutes) is directly proportional to the concentration 
of lipoic acid or lipoamide added to the system. Lipoamide was also 
found to be 20 fold more effective as a catalyst than lipoic acid in 
the reduction of DTNB. This difference in the rate of DTNB reduction, 
catalysed by lipoamide and lipoic acid is a direct 'reflection' of the 
difference in the rates of reduction of lipoamide and lipoic acid by 
the lipoamide dehydrogenase. The enzyme has a greater specificity for 
lipoamide than for lipoic acid and has been shown to reduce lipoamide 
20 times faster than lipoic acid (207, 210). The fact that the enzyme 
has a greater specificity for lipoamide than for lipoic acid, means 
that smaller qua~tities of lipoamide than lipoic acid can be 
determined. Thus, while it was possible to measure 0.1 nmol lipoamide 
fairly accurately, the limiting value of lipoic acid was approximately 
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Fig. 6.6 Calibration curve for lipoic acid 
DTNB reduction was assayed as described in Table 6.1. Each data 
point on the graph is the mean! s.d. of 5 duplicates • 
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Fig. 6.7 Calibration curve for lipoamide 
DTNB reduction was assayed as described in Table 6.1. Each 
data point on the graph is the mean + s.d. of 4 duplicates. 
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1.0 nmol under the conditions of the standard assay system. 
Although, under slightly modified conditions (time period > 6 minutes) 
and with the use of scale expansion it is possible to extend the 
method to measure smaller values; under the latter conditions the 
background reduction of DTNB would become very significant at such 
low levels of lipoate, requiring considerable care to be taken in the 
preparation of the respective reaction mixutres. It is nevertheless 
evident from Figs. 6.6 and 6.7 that the rate of DTNB reduction (~OD 412 nml 
6 minutes) maintains the same rectilinear dependence on.lipoate concentra-
tion at the lower concentrations as would be expected from data obtained 
within the higher range of concentration. 
In order to obtain some indication of the specificity of 
the enzymic assay for lipoic acid and lipoamide, systematic experiments 
were carried out in the presence of catalytic amounts of reduced 
glutathione (GSH); oxidised glutathione (GSSG); cysteine (CySH); 
2,3-dimercaptopropanol, mercaptoethanol and dithiothreitol. The 
results presented in Table 6.2 show that the addition of any of the 
above mentioned thiol or dithiol to the 'standard assay system', had no 
effect on the rate of DTNB reduction in the presence of lipoic acid 
(or lipoamide). Fig. 6.8 represents a typical spectrophotometric 
tracing obtained, when a monothiol such as glutathione or a dithiol 
such as 2,3-dimercaptopropanol is added to the standard assay system. 
Fig. 6.8 shows that, after an initial increase in optical density at 
412 nm due to the reaction of DTNB with the added free thiol groups, 
there is no further increase on addition of NADH to the system 
containing no lipoate (curve 1). However, on addition of lipoate 
before (curve 3) (or after) the addition of NADH, the reduction of 
DTNB proceeded at the normal rate (curve I). The results presented 
in Table 6.2 and on Fig. 6.8 confirm the impression that the enzymic 
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Table 6.2 The effect 'of monothiols 'and dithiols on the rate 
of DINB reduction (i.e~ 60D412nffi.!6 minutes) 
Additions 
60D412 nm/ 6 
Lipoate Thiol/Dithiol 
Lipoic acid (50 nmoles) 1.06 + 
-
" Cysteine 1.0 + 
-
" Glutathione (reduced) 1.04 + 
-
" Glutathione (oxidised) 1.02 + 
-
" 2,3-dimercaptopropanol 1.08 + 
-
" Dithiothreitol 1.02 + 
-
Lipoamide (5 nmoles) 1. 74 + 
-
" Cysteine 1. 76 + 
-
" 
Glutathione (reduced) 1.72 + 
-
" 
Glutathione (oxidised) J. 70 + 
-
" 
2,3-dimercaptopropanol 1.68 + 
-
" Dithiothreitol 1.74 + 
-
minutes 
0.02 
0.04 
0.0 
0.0 
0.06 
0.02 
0.08 
0.02 
0.0 
0.02 
0.06 
0.04 
DINB reduction was assayed as described in Table 6.1,50 nmole 
lipoic acid or 5 nmoles lipoamide was used as catalyst as depicted 
above. In all cases 20 nmoles of the thiol or dithiol was added 
to the standard assay system prior to initiation (t = 0) of the 
reaction with NADH. The values are the mean: s.d.of 4 duplicates. 
procedure described here constitutes a sensitive and specific method 
for the determination of the total lipoic acid (and/or lipoamide) 
content of unknown mixtures. 
In order to evaluate the usefulness of the foregoing 
analytical procedure, the lipoic acid content of a limited number 
of mammalian tissues were determined. The results presented in 
Table 6.3 indicate that the lipoate content of the tissues investigated 
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The effect of 2,3-dimercaptopropanol on lipoic acid catalysed 
reduction of DTNB 
DTNB reduction was assayed as described in Table 6.1. 20 nmoles 
2,3-dimercaptopropanol was added to standard assay system containing 
0.0 nmoles (curve 2) 20.0 nmol (curve J) lipoic acid. The system was 
incubated for 2 minutes and NAnH added to initiate the reaction. 
Curve I is the control system containing only 20 nmole lipoic acid. 
Table 6.3 
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Lipoic acid content of selected mammalian tissues 
and organelle 
Tissue Lipoic acid content pmol/mg protein 
~t liver 41.2 + 4.2 
-
~t kidney 8.6 + 4.2 
-
~t heart 15.8 + 3.8 
-
Ox heart mitochondria 170.0 + 12.5 
-
Ox heart submitochondrial particles 65.0 + 8.6 
-, , , , , 
The lipoic acid content of the methanolic solution of the purified 
(final) extract (see Method) was assayed for lipoic acid in the 
standard assay system, as described in Table 6.). The data is 
expressed in the table as picomol/mg protein. The data values 
represent the mean! s.d.of 10 duplicates, in the case of liver, 
4 duplicates, mitochondria; 4 duplicates, submitochondrial 
particles; and 4 duplicates of rat kidney and heart, in which the 
heart and kidney of 5 rats were pooled., 
was very low, ranging from ~ 9.0 pmol/mg protein in kidney to 
41.2 pmol/mg protein in liver. Mitochondria, containing )70 pmol/mg 
protein was found to have the highest lipoate content. This seems 
to suggest that lipoate is concentrated in the mitochondria, 
possibly in 'bound' form. The fact that some lipoic acid is found 
in preparations of submitochondrial particles (65 pmol/mg protein) 
could be due to entrapment of lipoic acid and/or the presence of 
bound lipoic acid on the submitochondrial particles. 
6.4 DISCUSSION 
In considering the underlying mechanism of the standard 
assay, evidence is provided which proves that the catalytic action 
of lipoate residues in its continual regeneration as outlined in 
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Fig. 6.3. For example, under the conditions of the experiment, in 
the absence of a cycling process, the maximal optical density that 
would be obtained with 20 nmol dihydrolipoic acid (40 nmol thiol) 
at 412 nm is 0.4. The fact that the optical density is more than 
twice this value after 10 minutes (> 2.0) and increases with time 
(Fig. 6.4), indicates that cyclisation of the lipoic acid is 
occurring. Further evidence in support of a cyclisation process, 
comes from the finding that cyclisation occurs when dihydrolipoic 
acid is added to the assay instead of oxidised lipoic acid 
(Fig. 6.9). Cyclisation to form the oxidised lipoic acid from 
the mixed disulphide form carrying one thiobenzoate group, has 
been demonstrated by Brown"et "al. (214) with free dihydrolipoamide 
. 
in solution. Results of experiments in which limiting amounts of 
DTSB was added to the standard assay sy~tem containing a catalytic 
amount of lipoic acid (50 nrnol) is shown in Fig. 6.10. The results 
show that complete reduction of the added DTNB (15 nmol) occurs, and 
that while the rate of DTNB reduction depended on the concentration 
of lipoic acid, the end point of the reaction depended only on the 
amount of DTNB present in the system. 
DTNB is catalytically reduced in the presence of NADH 
by 2-oxoglutarate dehydrogenase complex of beef heart (220), pyruvate 
dehydrogenase complex of yeast and their respective lipoyl transacetylase-
lipoamide dehydrogenase sub-complexes, but not by the free lipoamide 
dehydrogenase component in the absence of free lipoate (214, 220). 
To explain these reactions Erfle and Saucer (220) advanced a mechanism 
in which the lipoarnide dehydrogenase component of the complex 
catalytically reduced a mixed disulphide formed by reaction of one 
molecule of dihydrolipoic acid with two molecules of DTNB. However, 
in agreement with Brownet al. (214) we believe that the mechanism 
1 
N 
-4 
Q 
o 
1.0 
0.5 
Fig. 6.9 
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Lip(SH)2 
4 8 
Time (min.) --'t. 
Reduction of DTNB in the standard assay system with 
dihydrolipoic acid as a catalyst 
The standard assay system containing 20 nmol lipoic acid (curve I) 
12 
or 20 nmol dihydrolipoic acid (curve 2) was pre incubated for 4 minutes 
and the reaction initiated with NADH. In curve 3 (20 nmol)dihydro-
lipoic acid was used to initiate the reaction. 
1.0 
0.8 
0.6 
0.4 
0.2 
Fig. 6.10 
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o 10 20 30 40 
Time (mins.) 
Reduction of limiting amounts of DTNB in 
the standard assay system 
50 
DTNB reduction was assayed as desc~ibed in Table 6.1. Small 
aliquots (15 nmoles in 5 ~l) of DTNB were added to the reaction 
mixture containing (50 nmol) lipoic acid and NADH. DTNB was 
used to initiate the reaction. After complete reduction of the 
added DTNB occurred. further aliquots were added as indicated by 
the arrows (at B and C). 
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depicted in Fig. 6.3 is more likely than that proposed by Erfle 
and Saucer. for several reasons. Firstly, unlike the mechanism of 
Erfle and Saucer, it does not require the lipoamide dehydrogenase 
to catalyse a unique reaction. Secondly, the cyclisation to reform 
the oxidised lipoic acid from the mixed disulphide form carrying 
one thionitrobenzoate (see Fig. 6.3) can be observed with free 
dihydrolipoic acid or dihydrolipoamide (214) in solution, showing 
that this is a purely chemical step, which occurs spontaneously. 
Thirdly, it was found by titration that one mole of DTNB reacted 
with one mole of dihydrolipoic acid to give 2 moles of thionitrobenzoic 
acid. Finally, Wassarman and Major (221) have shown that DTNB 
catalyses the formation of an intrachain disulphide bridge between 
two cysteine residues in the active site of glyceraldehyde-3-phosphate 
dehydrogenase, by a similar mechanism. 
The utility of the 'standard assay' has been explored by 
conducting a number of lipoate assays on selected mammalian tissues 
and organelle. Although no comparable data to those presented in 
Table 6.3 has been reported for the lipoate content of beef heart 
mitochondria and the heart and kidney of rats. the lipoate content 
of rat liver has been determined by various workers (218). A 
comparison of the lipoate content of rat liver determined by different 
assay procedures is presented in Table 6.4. The data shows that the 
values obtained were in the same order of magnitude, that is, 
pmoles/mg protein. However, the value obtained with the 'standard 
assay system' (41.2 ! 5.0 pmol/mg protein) was much higher than that 
obtained with the 'best' biological method (15.0 pmol/mg protein). 
However, this is not to say that the 'standard assay system' is more 
sensitive than the turbidimetric method usingC.bovis, the main 
difference might be due to the preliminary treatment of the tissue 
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Table 6.4 Comparison of the lipoate content of ·rat liver, 
determined by different assay procedures 
Method Basis of method Lipoate content pmoles/mg protein. 
T. pyriformis n.d. 
C. bovis Turbidimetric 15.0 
C. bovis Pad plate 10.0 
s. faecalis Pad plate 10.0 
s. faecalis pyruvate oxidation n.d. 
(02 uptake measured) 
'Standard assay DTNB reduction 4].2 + 4.2 
system' 1.68+ 0.38 
(Ref.) 
(218) 
(218) 
(218) 
(218) 
(218) 
(A) 
(B) 
A and B indicate different methods of liberating free lipoic acid 
from its bound form. A - alkaline hydrolysis in an atmosphere of 
nitrogen (NaOH/N2); B - acid hydrolysis in air (6M Hel); n.d. = 
not determined. 
to liberate free lipoic acid from its protein bound form. Whereas 
Stokstad et al. (from whose work some of the data in Table 6.4 waS 
obtained) used acid hydrolysis in air to liberate the protein bound 
lipoatej alkaline hydrolysis in an atmosphere of nitrogen was the 
procedure adopted throughout this experiment. The latter method 
has been shown by Wagner et ale (222) and Beauclerk (223) to be 
the best method for liberating protein bound lipoate. These authors have 
shown that in test systems containing known amounts of lipoic acid, 80-90% 
of the added lipoic acid could be recovered using alkaline hydrolysis 
in an atmosphere of nitrogen compareq with less than 5% under acid 
hydrolysis in air. The results presented in Table 6.4 show that under 
acid hydrolysis in air the measurable lipoate content of rat liver 
was 1.68 ~ 0.38 pmol/mg protein. This value is less than 5% of the 
value obtained under alkaline hydrolysis in an atmosphere of nitrogen. 
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6.5 CONCLUSION 
The 'standard assay system' provides a simple, reliable 
method for the determination of lipoic acid and lipoamide. Its 
advantages of speed, low cost and reproducibility make it a much 
more applicable method than all the biological methods reported 
(218). The only drawback of the enzymic system is that it cannot 
distinguish between lipoic acid and lipoamide. 
The main stumbling block in measuring the lipoate content 
of mammalian tissue using the 'standard assay system' or any of the 
biological methods reported (218), is the preliminary treatment of 
the tissue to liberate and isolate the lipoate. Incomplete liberation 
of lipoate from its bound form (by hydrolysis) in addition to loss of 
lipoate due to its destruction during t~e hydrolytic and purification 
steps could lead to under-estimation of the true values. 
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APPENDIX I 
Compounds that inhibit energy linked reactions 
l. (a) Fl ATPase inhibitors 
(b) FIFO ATPase inhibitors 
2. Uncouplers 
3. Ionophores 
4. Electron transport inhibitors 
1. ATPase inhibitors 
(a) FlATPaSe inhibitors 
Aurovertins.- The aurovertins are a class of compounds having the 
general formula:-
• .... CHR 
R 1 
2 
Rl R2 · R3 R4 molecular weight 
Aurovertin A H Me COMe COMe 501 
B H Me COMe H 445 
C H H COMe H 451 
D OH Me COMe H 475 
E H Me H H 417 
They are obtained frem cultures of the fungus calcorisporium arbuscula 
and are potent inhibitors of mitochondrial ATP synthesis; ATPase; 
18 32 
"2 O-Pi exchange; ATP- pi exchange; ATP-driven transhydrogenase; ATP-
. 
driven reversed electron transport; uncoupler induced swelling. D and f, 
are the most potent forms. 
The locus of action appears to be at the Fl ATPase. 
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Efrapeptins.- Efrapeptins are a group of lipophilic polypeptides 
obtained from the hyphomyceee Tolypocladium inflatum. The structures a 
unclear, but hydrolysis yields glycine, leucine and alanine in a ratio 0, 
6:7:1 and an unknown amino acid. The polypeptides do not appear to 
possess N-terminal amino acids but do contain a free carboxyl group. 
They have a molecular we~ght somewhere in excess of 1500. They have a 
mode of action similar to'that of the aurovertins but,although they act 
on the Fl ATPase, they appear to have a binding site distinct from that 
of the aurovertins. 
(b) FIFO ATPase inhibitors 
Oligomycin 
HO 
Me 
HO 
molecular weight 
Oligcrnycin A H2 OH Me CH)CH2 760 
8 0 OH CH)CH2 784 
C H2 H CH3CH2 744 
0 0 OH CH) 760 
The oligomycins are a group of complex antibiotics obtained from 
cultures of Streptomyces diasto chromogenes (oligomycins h-C) and 
Streptomyces rutgersensis (NRRL. 8-1256 (oligomycin D, also known as 
ru tamycin) ) • 
The oligomycins are the 'classical inhibitors' of the FIFO ATPase 
in mitochondria, 'and are among the most potent known: 1 molecule is 
thought to be sufficient to completely inhibit 1 molecule of ATPase •. 
-172-
It inhibits oxidative phosphorylation, ATP-pi exchange, ATP-ADP 
exchange, FlFO ATPase and all energy linked activities consuming or 
producing ATP. It has no effect on the isolated FI ATPase. Its precise 
mode of action is unclear; it is thought either to block the formation 
of the '~p' state or to prevent proton pumping through the FO portion 
of the ATPase. It probably interacts with 'subunit 9' of the ATPase. 
Sulphydryl groups have beenimplicated in its binding site. 
Venturicidin The venturicidins are a group of compounds obtained from 
culture broths of Streptomyces griseolus, S. hastedii and S. xanthophaet 
CH3 
HO --
Ventur icidin A molecular weight 750 
B molecular weight 707 
Venturicidin has a mode of action similar to that of the oligomycin~ 
although it is slightly less potent. It acts on the Fo portion of the 
ATPase, inhibiting all ATP utilising and producing reactions. It appear~ 
to bind to subunit 6 of the ATPase. 
Leucinostatin This is a lipophilic polypeptide isolated from the fungt: 
Penicillium lilacinum A-267. Hydrolysis yields leucine and 4 unknown 
amino acids. It has a complex mode of action, being an uncoupler in 
high concentration but appearing to act like oligomycin or venbJricidin 
at lower concentrations. It has no effect on isolated FI ATPase. 
Dicyc lohexylcarbodi imide (DCCD) DeCO is a potent inhibitor of energl' 
linked reactions. It appears to exert its inhibitory chara9teristics 
by covalently binding to subunit 9 of the F ATPase in mitochondria and o . 
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to similar low molecular weight proteolipids in chloroplasts and 
bacterial vesicles. It inhibits all ATP utilising and producing 
activities in an oligomycin-like manner. Its binding site appears to 
be separate from that of oligomycin, however. 
DCCO 
Trialkyltins These are compounds having the general formula 
where RlR2R) are hydrocarbon groupings 
X = halogens or -OH (usually). 
They are potent inhibitors of ATP utilising or produ~ing energy linked . 
reactions (the compounds where RIR2R) are: n-ethyl or n-butyl,n-propyl 
or phenyl appear to be the most effective). They do not inhibit Fl 
ATPase activity and appear to bind to the subunit 9 component of the 
membrane bound (FO) portion of the ATPase. They generally act like 
oligomycin but may also facilitate a Cl ~ OH exchange reaction 
across the mitochondrial inner membrane. 
Dibutyl chloromethyl tin chloride This is a trialkyl tin, having the 
structure: -
CH3CH2CH2CHZ", ~CH2CL 
/sn" 
CH)CH2CH2CH2 Cl 
molecular weight 318 
It appears to bind to a nonprotein lipophilic component of the inner 
mitochondrial membrane. It has a similar efficacy, and general 
properties like; the other tr ialkyl tin compounds. 
Compound VE228) This is a pentacovalent organotin compound hav.ing the structur 
CH3 / 
C(CH2N-CH3 I ! /CH2CH 3 ~ Sn 
/' ......... Br CH2CH3 
molecular weight )90 
It appears to act like oligomycin and is at least as potent an inhibitor 
(on a molar basis). Its precise mode of action is at present under 
investigation. 
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2. Uncouplers 
These are compounds that dissipate the high energy state,'~', of 
the inner membrane; whether they act by dissipating a proton gradient 
or in a more specific manner (~. binding to a component of the energy 
couplirg apparatus) is not completely clear, although most are lipophiliCi 
weak acids or bases, capable of conducting protons across artificial 
lipid bilayers. For a more detailed discussion of the mechanism of 
uncoupling, see Chapter 2. 
Name 
m-chloro carbonyl cyanide 
phenyl hydrazone 
Cl~cture CN 
~NH-N-C~CN 
trifluoromethoxy carbonyl -0- ...... CN 
cyanide phenylhydrazone F 3 CO ~ /; NH-N-C ..... CN. 
bis hexafluoro acetonyl acetone rto -
4,5,6,7-tetrachloro-2-
trifluoromethylbenzimidazole . 
5-chloro-3-tert butyl-2'-
chloro-4'nitrosa1icy1ani1ide 
2,4-dinitrophenol 
Pentachlorophenol 
Cl 
Cl 
Cl 
CF3 0 CF3 I II I 
CCH -C-CH -C-OH I 2 2 I 
CF) CF3 
Cl 
Cl 
Cl 
N reF3 
H 
Cl 
Acronym 
CCCP 
FCCP 
'1799' 
TI'FB 
5-13 
DNP 
pcp 
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3. Ionophores 
These are a group of compounds that have the ability to transport 
cations across lipid membranes. They uncouple oxidative phosphorylation 
either by collapsing the ~~ component of the proton motive force or by 
facilitating energy linked, futile cycles of ions across bioenergetic 
membranes, thus dissipating '~'. 
Gramicidin 0 Isolated from cultures of Bacillus brevis. It is a lipo-
philic polypeptide consisting of 15 amino acids of alternating Land 0 
forms, i.e. 
Hco-val-gly-ala-leu-ala-val-val-val(tryp-leu}-tr¥p-NHCH2CH20H 
L L 0 L D L D 
It is thought to adopt a helical form in the membrane, effectively poking 
a hydrophilic hole through it, through which ions can pass; It transport 
+ d + 'h "1 ff" , (+ Ii h 1 +) K an H w~t s~m~ ar e ~c~enc~es K s g t y > H • 
Valinomycin This is isolated from Streptomyces fulvissimuD.It is one 
of the 'cage' form ionuphores which enclose cations with a hydrophobic 
shell. It contains 3 moles of L-valine, D-a-hydroxy isovaleric acid, 
D-valine, L-lactic acid, linked alternately to form a 36 membered ring. 
It principally transports potassium across membranes, but will also 
transport other monovalent cations with lowered effectivity. 
4. Electron transport inhibitors 
These are compounds that act by blocking electron flow between 
respiratory substrates and oxygen. 
Rotenone Obtained from derris root. It appears to block electron 
transport between NADH dehydrogenase and ubiquinone. 
molecular weight 393 
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Antimycin A Blocks electron transport between cyt band cyt c: it 
binds to a protein subunit of complex III. 
Antimycin Al 
Antimycin AJ 
R = n-hexyl 
R = n-butyl 
molecular weight 558 
molecular weight 530 
Cyanide, azide, sulphide, carbon monoxide All b_lock electron transport 
at the level of· cytochrome oxidase. They act by irreversibly binding to 
the 'free ligand' of the iron in cytochrome a 3 's haem grouping. 
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APPENDIX II 
Lipoamide Dehydrogenase 
This lipoamide dehydrogenase is present on 'well-washed' 
submitochondrial particles, prepared from beef heart mitochondria, 
as described in the Methods section of Chapter 2. The enzyme 
co-purifies with F)-ATPase when the F)-ATPase is prepared by chloroform 
extraction with the method of Tyler and Webb. However, the enzyme can 
be separated from the FI-ATPase by ion-exchange chromata&raphy on 
DEAE-Sephadex. Fig.II(i)shows the elution profile of the enzymes 
when the enzymic mixture bound on the column is eluted with buffers 
containing 20 mM tris-CI, pH 8.0; 2 mM EDTAj 4 mM ATP and 0.1 M Na2S04 
or 0.15 M Na2S04. Fig. II~i)shows that the F)-ATPase which accounts for 
more than 90% of the total protein, is eluted off the column before the 
lipoamide reductase. SDS-gel electrophoresis not shown indicates an 
estimated molecular weight of the lipoamide dehydrogenase of 
40-50,000. 
The specific activity of the purified lipoamide dehydrogenase 
was 103 ~mol/min/mg protein under optimum conditions (50 mM Pi, pH 6.5 
2 mM lipoamide, ).0 mM NADH). The reaction was followed by monitoring 
the oxidation of NADH (A 340 nm). The pH profile of the 'me:nbrane 
max 
bound' enzyme and the purified enzyme were almost identical, and the 
optimum pH depended upon the direction of the reaction; that is on the 
initial substrates. For example, in the reduction of oxidised lipoic 
acid by NADH: 
NADH + H+ + LipS2 ~ NAD+ + Lip(SH)2 
The optimum pH is 6.3-6.5, whereas in the reduction of NAD+ by Lip(SH)2 
the reversed reaction of the optimum pH is 7.8-8.0. 
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o 2 4 
0.1 M Na2S04 
in TEA buffer 
pH 8.0 
6 8 
See t~xt of Appendix II for 
methods of assay for protein 
content, ATPase and reductase 
activity. 
J 0 J 2 J4 J6 J8 20 
" 
~ ATPale activity 
IT' 
J.I W 
r t \\ 
22 24 26 
o. J 5 Na2S04 
in TF-A buffer 
pH 8.0 
28 
""O-O-Q,./ Reductase activi ty 
\ 
30 32 34 36 38 40 42 
Fraction No. ~ 
I 
-
-.,J 
00 
I 
Michaelis constants 
-6 28.6 x 10 M 
-3 1.86 x 10 M 
Enzyme and Protein Assays 
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Substrate Conditions 
N~H 
1 
50 mM Pi, pH 6.5 
Lipoamide I M EDTA 
ATPase activity was assayed as described previously in the 
Methods section of Chapter 2. Lipoamide reductase activity was 
measured by the method of Tasi, Templeton and Wand (256) 5-10 ~g 
of the soluble enzyme preparation was added to a cuvette containing 
N~H (300 ~M) and lipoamide (250 ~M) in 50 mM phosphate buffer, 
pH 6.3; total 3.1 mI. The enzyme was used to initiate the reaction. 
The oxidation of NADH was monitored by following the decreasing 
absorbance at 340 nm in a SP 1800 spectr~photometer. When submito-
chondrial particles were assayed for reductase activity (50-100 ~g) 
rotenone ] ~g/ml was added to the buffer. 
Protein was assayed by the biuret method for (submitochondrial 
particles) and the folin method (for the soluble preparations) as 
described previously in Chapter 2. 
(I) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
(10) 
(11) 
(12) 
(13) 
(14) 
(15) 
(16) 
(17) 
(18) 
(19) 
(20) 
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